[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 698
1. Hoseini AT, Razavi SM, Khabazian A: Lipoma in oral mucosa: two case reports. Dent Res J (Isfahan); 2010;7(1):41-3
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Lipoma in oral mucosa: two case reports.
  • Lipoma is a common tumor of soft tissue.
  • Its location on the oral mucosa is rare, representing 1% to 5% of benign oral tumors although it is the most mesenchymal tumor of the trunk and proximal por-tions of extremities.
  • Lipoma of the oral cavity may occur in any region.
  • The buccal mucosa, tongue, and floor of the mouth are among the common locations.
  • The overlying epithelium is intact, and superficial blood vessels are usually evident over the tumor.
  • Other benign connective tissue lesions such as granular cell tumor, neurofibroma, traumatic fibroma and salivary gland lesions (mucocele and mixed tumor) might be included in differential diagnosis.
  • We present two cases of oral lipoma in unusual locations: one in junction of soft and hard palate and the other in tongue.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Periodontol. 2001 Feb;28(2):109-12 [11168734.001]
  • [Cites] Int J Oral Surg. 1982 Feb;11(1):30-5 [6811454.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002 Feb;93(2):171-3 [11862206.001]
  • [Cites] J Oral Pathol Med. 2006 Jul;35(6):376-8 [16762019.001]
  • [Cites] J Med Case Rep. 2008;2:382 [19077289.001]
  • [Cites] J Oral Rehabil. 1995 Jan;22(1):83-5 [7897564.001]
  • [Cites] Int J Oral Surg. 1978 Jun;7(3):162-6 [99380.001]
  • [Cites] J Laryngol Otol. 2002 May;116(5):395-7 [12081004.001]
  • [Cites] Int J Oral Maxillofac Surg. 2003 Feb;32(1):49-53 [12653233.001]
  • [Cites] Med Oral. 2004 Mar-Apr;9(2):166-7, 163-6 [14990884.001]
  • [Cites] Ann Acad Med Singapore. 2004 Jul;33(4 Suppl):72-6 [15389313.001]
  • [Cites] Med Oral Patol Oral Cir Bucal. 2006 Aug;11(5):E437-9 [16878062.001]
  • [Cites] J Can Dent Assoc. 2007 Jun;73(5):431-4 [17555654.001]
  • [Cites] Rev Med Chir Soc Med Nat Iasi. 2007 Jul-Sep;111(3):754-8 [18293712.001]
  • [Cites] Rev Fac Odontol P Alegre. 1967;9:163-8 [5256791.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1984 Jan;57(1):77-80 [6582440.001]
  • [Cites] Niger J Med. 2001 Oct-Dec;10(4):189-91 [11806003.001]
  • (PMID = 21448446.001).
  • [ISSN] 2008-0255
  • [Journal-full-title] Dental research journal
  • [ISO-abbreviation] Dent Res J (Isfahan)
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Iran
  • [Other-IDs] NLM/ PMC3065337
  • [Keywords] NOTNLM ; Differential diagnosis / Lipoma / Pathology
  •  go-up   go-down


2. Esquenazi D, Bussoloti Filho I, Carvalho Mda G, Barros FS: The frequency of human papillomavirus findings in normal oral mucosa of healthy people by PCR. Braz J Otorhinolaryngol; 2010 Jan-Feb;76(1):78-84
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The frequency of human papillomavirus findings in normal oral mucosa of healthy people by PCR.
  • The human papillomavirus (HPV) is a DNA virus, which belongs to papillomaviridae family, being of low and high risk, which infect the skin and mucous membranes and can induce benign and malign tumor formation.
  • In the oral mucosa they have been associated with oral papilloma, focal epithelial hyperplasia, leucoplakia and oral neoplasia.
  • AIM: to study the frequency of HPV finding in oral mucosa of normal people.
  • One hundred volunteers, young adults, healthy, aged between 20 and 31 years, university students with no history, no complains, without oral or oropharyngeal lesions.
  • [MeSH-major] Alphapapillomavirus / isolation & purification. Mouth Mucosa / virology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20339693.001).
  • [ISSN] 1808-8686
  • [Journal-full-title] Brazilian journal of otorhinolaryngology
  • [ISO-abbreviation] Braz J Otorhinolaryngol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Brazil
  •  go-up   go-down


3. Torrijos-Aguilar A, Alegre-de Miquel V, Pitarch-Bort G, Mercader-García P, Fortea-Baixauli JM: [Cutaneous granular cell tumor: a clinical and pathologic analysis of 34 cases]. Actas Dermosifiliogr; 2009 Mar;100(2):126-32
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Cutaneous granular cell tumor: a clinical and pathologic analysis of 34 cases].
  • [Transliterated title] Tumor de células granulares cutáneo: análisis clínico-patológico de treinta y cuatro casos.
  • BACKGROUND: Granular cell tumor (GCT), also known as Abrikossoff tumor, is an uncommon benign neoplasm, probably of neural origin derived from Schwann cells.
  • OBJECTIVES: We aimed to analyze the clinical, histologic, and immunohistochemical characteristics associated with this tumor and to determine whether these findings correspond to those reported to date in the literature.
  • METHODS: In this retrospective study of 34 patients with histologic diagnosis of GCT, we analyzed clinical characteristics (site, age, sex, duration, and suspected diagnosis), histological findings (border, cell atypia and mitoses, involvement of adnexal structures, pseudoepitheliomatous hyperplasia, and presence of the recently described pustulo-ovoid bodies), and immunohistochemical findings (S-100 staining in 16 randomly selected cases).
  • The most common site was the oral cavity (61.76 %).
  • The most frequently suspected clinical diagnosis was fibroma (17.65 %).
  • CONCLUSIONS: Our series confirms the characteristics described previously for GCT, except for certain peculiarities, and supports the presence of pustulo-ovoid bodies as an additional histologic finding for diagnosis of this tumor.
  • [MeSH-major] Granular Cell Tumor / epidemiology. Mouth Neoplasms / epidemiology
  • [MeSH-minor] Adolescent. Adult. Biomarkers, Tumor. Child. Child, Preschool. Cytoplasmic Granules / ultrastructure. Diagnosis, Differential. Female. Fibroma / diagnosis. Humans. Male. Middle Aged. Retrospective Studies. Skin Neoplasms / chemistry. Skin Neoplasms / diagnosis. Skin Neoplasms / epidemiology. Skin Neoplasms / pathology. Staining and Labeling. Young Adult

  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19445877.001).
  • [ISSN] 0001-7310
  • [Journal-full-title] Actas dermo-sifiliográficas
  • [ISO-abbreviation] Actas Dermosifiliogr
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Spain
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


Advertisement
4. Orita Y, Hamaya K, Miki K, Sugaya A, Hirai M, Nakai K, Nose S, Yoshino T: Satellite tumors surrounding primary pleomorphic adenomas of the parotid gland. Eur Arch Otorhinolaryngol; 2010 May;267(5):801-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Satellite tumors surrounding primary pleomorphic adenomas of the parotid gland.
  • The occasional local recurrence of benign pleomorphic adenoma (PA) has generally been attributed to the vulnerability of the tumor capsule.
  • Although some reports have also noted the presence of satellite tumors associated with PA recurrence, only few reports have focused on this issue.
  • We paid special attention to the satellite lesions apart from the main tumors and discussed their frequency, origin, nature and the ways of treating them.
  • Four (3.7%) patients displayed a main mass with satellite tumors in a single parotid gland.
  • The immunohistochemical analysis of p53 and Ki-67 index showed no distinct difference between PAs with satellite tumors and those without.
  • Satellite tumors surrounding the main mass of parotid PA is relatively rare.
  • In most cases, such satellite tumors will arise from capsular perforation of the primary tumor cells.
  • Preoperative evaluation to recognize the existence of satellite tumors would be important and capsular dissection should be discouraged.
  • We could not find any evidence suggesting that primary PA with satellite tumors could be more biologically aggressive than those without.
  • [MeSH-major] Adenoma, Pleomorphic / pathology. Neoplasms, Second Primary / pathology. Parotid Neoplasms / pathology
  • [MeSH-minor] Adolescent. Child. Child, Preschool. Female. Genes, p53 / genetics. Humans. Immunohistochemistry. Infant. Infant, Newborn. Ki-67 Antigen / genetics. Magnetic Resonance Imaging. Male. Neoplasm Recurrence, Local. Point Mutation / genetics. Preoperative Care

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Oral Pathol Med. 1997 May;26(5):217-23 [9178173.001]
  • [Cites] Clin Otolaryngol Allied Sci. 2003 Jun;28(3):262-6 [12755769.001]
  • [Cites] Br J Surg. 1958 Mar 18;45(193):477-87 [13536351.001]
  • [Cites] Acta Otolaryngol. 2007 Nov;127(11):1207-13 [17851915.001]
  • [Cites] Int J Cancer. 1983 Jan 15;31(1):13-20 [6339421.001]
  • [Cites] Laryngoscope. 2001 Dec;111(12):2195-200 [11802025.001]
  • [Cites] J Laryngol Otol. 1977 Jul;91(7):629-32 [197179.001]
  • [Cites] J Laryngol Otol. 1976 Mar;90(3):295-8 [176288.001]
  • [Cites] Cancer. 1953 Nov;6(6):1065-133 [13106826.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 1986 Nov;112(11):1180-4 [3019368.001]
  • [Cites] N Engl J Med. 1993 Oct 28;329(18):1318-27 [8413413.001]
  • [Cites] Int J Oncol. 2000 Mar;16(3):477-83 [10675478.001]
  • [Cites] Cancer. 1997 Jun 15;79(12):2314-9 [9191518.001]
  • [Cites] Int J Oral Maxillofac Surg. 2004 Sep;33(6):531-4 [15308250.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000 May;89(5):613-7 [10807720.001]
  • [Cites] Otolaryngol Head Neck Surg. 2000 Mar;122(3):455-7 [10699827.001]
  • [Cites] Laryngoscope. 1984 Mar;94(3):324-9 [6321863.001]
  • [Cites] Am J Surg. 1977 Aug;134(2):242-3 [196513.001]
  • [Cites] Ear Nose Throat J. 2002 May;81(5):341-5 [12025006.001]
  • [Cites] J Oral Pathol Med. 2008 May;37(5):309-18 [18248354.001]
  • [Cites] J Laryngol Otol. 1983 Nov;97(11):1035-7 [6315839.001]
  • [Cites] Br J Surg. 1989 Jun;76(6):594-6 [2547497.001]
  • [Cites] Br J Cancer. 2003 Nov 3;89(9):1610-3 [14583757.001]
  • [Cites] Cancer Lett. 1992 Jul 31;65(1):61-71 [1324786.001]
  • [Cites] Head Neck. 2007 Aug;29(8):751-7 [17252593.001]
  • [Cites] Hum Pathol. 1996 Aug;27(8):782-6 [8760010.001]
  • [Cites] Acta Otolaryngol Suppl. 1964;188:SUPPL 191:1-99 [14156485.001]
  • [Cites] Cancer. 1995 Apr 15;75(8):2037-44 [7697591.001]
  • [Cites] Laryngoscope. 1982 Nov;92 (11):1265-8 [6292599.001]
  • [Cites] Histopathology. 2002 Dec;41(6):559-61 [12460210.001]
  • [Cites] Am J Surg. 1975 Oct;130(4):460-2 [1166937.001]
  • [Cites] Am J Surg. 1969 Nov;118(5):787-9 [4310431.001]
  • [Cites] Hum Pathol. 1995 Feb;26(2):135-8 [7860042.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999 Mar;87(3):341-5 [10102597.001]
  • (PMID = 19898859.001).
  • [ISSN] 1434-4726
  • [Journal-full-title] European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
  • [ISO-abbreviation] Eur Arch Otorhinolaryngol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Ki-67 Antigen
  •  go-up   go-down


5. Debnath SC, Saikia AK, Debnath A: Pleomorphic adenoma of the palate. J Maxillofac Oral Surg; 2010 Dec;9(4):420-3
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Pleomorphic adenoma is a benign tumor of the salivary glands that has elements of both epithelial and mesenchymal tissues.
  • The tumor most commonly arises in the parotid or submandibular glands.
  • We report a patient with PA over the hard palate, which resembled common intraoral diseases like oral papilloma, squamous cell carcinoma and condyloma acuminate.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 22190837.001).
  • [ISSN] 0974-942X
  • [Journal-full-title] Journal of maxillofacial and oral surgery
  • [ISO-abbreviation] J Maxillofac Oral Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC3177488
  • [Keywords] NOTNLM ; Palate / Pleomorphic adenoma / Salivary gland
  •  go-up   go-down


6. Gakiopoulou H, Korkolopoulou P, Levidou G, Thymara I, Saetta A, Piperi C, Givalos N, Vassilopoulos I, Ventouri K, Tsenga A, Bamias A, Dimopoulos MA, Agapitos E, Patsouris E: Minichromosome maintenance proteins 2 and 5 in non-benign epithelial ovarian tumours: relationship with cell cycle regulators and prognostic implications. Br J Cancer; 2007 Oct 22;97(8):1124-34
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Minichromosome maintenance proteins 2 and 5 in non-benign epithelial ovarian tumours: relationship with cell cycle regulators and prognostic implications.
  • Minichromosome maintenance proteins (MCM) have recently emerged as novel proliferation markers with prognostic implications in several tumour types.
  • In adenocarcinomas, the levels of MCM-2 and MCM-5 increased significantly with advancing tumour stage (P=0.0052 and P=0.0180, respectively), whereas both MCM-2 and MCM-5 increased significantly with increasing tumour grade (P=0.0002 and P=0.0006, respectively) and the presence of bulky residual disease (P<0.0001 in both relationships).
  • [MeSH-major] Cell Cycle Proteins / metabolism. Neoplasms, Glandular and Epithelial / metabolism. Nuclear Proteins / metabolism. Ovarian Neoplasms / metabolism
  • [MeSH-minor] Adult. Aged. Biomarkers, Tumor / analysis. Female. Humans. Immunohistochemistry. Kaplan-Meier Estimate. Middle Aged. Minichromosome Maintenance Complex Component 2. Neoplasm Staging. Prognosis

  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • antibodies-online. View related products from antibodies-online.com (subscription/membership/fee required).
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Hum Pathol. 2000 Jun;31(6):698-704 [10872663.001]
  • [Cites] Hum Pathol. 2005 Aug;36(8):899-907 [16112007.001]
  • [Cites] Curr Opin Genet Dev. 2001 Feb;11(1):64-70 [11163153.001]
  • [Cites] J Cell Sci. 2001 Apr;114(Pt 8):1447-54 [11282021.001]
  • [Cites] Int J Gynecol Cancer. 2001 May-Jun;11(3):187-93 [11437923.001]
  • [Cites] J Cell Sci. 2001 Jun;114(Pt 11):2027-41 [11493639.001]
  • [Cites] Neuropathol Appl Neurobiol. 2001 Aug;27(4):305-13 [11532161.001]
  • [Cites] Clin Cancer Res. 2001 Sep;7(9):2712-8 [11555583.001]
  • [Cites] Eur J Cancer. 2000 Dec;36(18):2317-28 [11094305.001]
  • [Cites] Clin Cancer Res. 2001 Oct;7(10):2984-97 [11595686.001]
  • [Cites] J Clin Oncol. 2001 Nov 15;19(22):4259-66 [11709570.001]
  • [Cites] Nature. 2002 Jan 31;415(6871):530-6 [11823860.001]
  • [Cites] Pathobiology. 2001;69(3):150-8 [11872961.001]
  • [Cites] Br J Neurosurg. 2002 Feb;16(1):10-5 [11928726.001]
  • [Cites] Clin Cancer Res. 2002 Apr;8(4):1075-81 [11948116.001]
  • [Cites] Gynecol Oncol. 2002 Jun;85(3):404-14 [12051866.001]
  • [Cites] Cancer J. 2002 May-Jun;8 Suppl 1:S22-30 [12075699.001]
  • [Cites] Int J Mol Med. 2002 Aug;10(2):161-8 [12119552.001]
  • [Cites] Cancer. 2003 Jan 15;97(2):389-404 [12518363.001]
  • [Cites] Eur Urol. 2003 Feb;43(2):138-45 [12565771.001]
  • [Cites] Cancer Cell. 2003 Feb;3(2):185-97 [12620412.001]
  • [Cites] Gynecol Oncol. 2003 Mar;88(3):369-78 [12648589.001]
  • [Cites] Histol Histopathol. 2003 Jul;18(3):761-70 [12792888.001]
  • [Cites] J Oral Pathol Med. 2003 Sep;32(8):468-74 [12901728.001]
  • [Cites] J Surg Oncol. 2003 Sep;84(1):24-30 [12949987.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10393-8 [12917485.001]
  • [Cites] J Clin Oncol. 2003 Dec 1;21(23):4306-13 [14645419.001]
  • [Cites] Br J Cancer. 2004 Apr 19;90(8):1583-90 [15083189.001]
  • [Cites] Cancer Res. 2004 May 1;64(9):2962-8 [15126326.001]
  • [Cites] Cancer Res. 2004 May 1;64(9):3103-11 [15126347.001]
  • [Cites] J Mol Biol. 2004 Jul 23;340(5):1197-206 [15236977.001]
  • [Cites] Pathobiology. 2004;71(4):193-200 [15263808.001]
  • [Cites] Control Clin Trials. 1981 Jun;2(2):93-113 [7273794.001]
  • [Cites] Eur J Biochem. 1986 Sep 15;159(3):529-34 [2428616.001]
  • [Cites] Biometrics. 1986 Sep;42(3):507-19 [3567285.001]
  • [Cites] J Cell Physiol. 2000 Mar;182(3):371-80 [10653604.001]
  • [Cites] Anticancer Res. 1999 Nov-Dec;19(6B):4935-45 [10697493.001]
  • [Cites] Exp Cell Res. 2005 Sep 10;309(1):56-67 [16005865.001]
  • [Cites] Br J Cancer. 2005 Oct 17;93(8):939-45 [16189522.001]
  • [Cites] Br J Cancer. 2005 Nov 28;93(11):1295-300 [16278669.001]
  • [Cites] J Cancer Res Clin Oncol. 2006 Mar;132(3):163-70 [16328436.001]
  • [Cites] Anticancer Res. 2006 Mar-Apr;26(2A):1071-5 [16619508.001]
  • [Cites] Lab Invest. 2001 Aug;81(8):1163-5 [11502867.001]
  • [Cites] Gene. 2000 Mar 7;245(1):13-20 [10713440.001]
  • [Cites] Arch Pathol Lab Med. 1987 Sep;111(9):794-5 [3632298.001]
  • [Cites] Nature. 1988 Apr 7;332(6164):546-8 [3357511.001]
  • [Cites] Biol Cell. 1991;72(1-2):47-50 [1756311.001]
  • [Cites] J Cell Sci. 1994 Jan;107 ( Pt 1):253-65 [8175912.001]
  • [Cites] EMBO J. 1997 Jun 2;16(11):3312-9 [9214646.001]
  • [Cites] EMBO J. 1997 Jun 2;16(11):3320-31 [9214647.001]
  • [Cites] Eur J Biochem. 1997 Jul 1;247(1):136-41 [9249019.001]
  • [Cites] Lab Invest. 1998 Jan;78(1):73-8 [9461123.001]
  • [Cites] Exp Cell Res. 1998 May 25;241(1):260-4 [9633535.001]
  • [Cites] Leukemia. 1998 Aug;12(8):1256-65 [9697881.001]
  • [Cites] J Biol Chem. 1998 Sep 18;273(38):24543-9 [9733749.001]
  • [Cites] Br J Cancer. 1999 Apr;79(11-12):1870-8 [10206307.001]
  • [Cites] Clin Cancer Res. 1999 Aug;5(8):2121-32 [10473096.001]
  • [Cites] J Cell Sci. 2004 Nov 15;117(Pt 24):5875-86 [15522891.001]
  • [Cites] J Pathol. 2005 Jan;205(2):123-9 [15643673.001]
  • [Cites] Annu Rev Biochem. 1999;68:649-86 [10872463.001]
  • (PMID = 17940502.001).
  • [ISSN] 0007-0920
  • [Journal-full-title] British journal of cancer
  • [ISO-abbreviation] Br. J. Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Cell Cycle Proteins; 0 / MCM5 protein, human; 0 / Nuclear Proteins; EC 3.6.4.12 / MCM2 protein, human; EC 3.6.4.12 / Minichromosome Maintenance Complex Component 2
  • [Other-IDs] NLM/ PMC2360432
  •  go-up   go-down


7. Agarwal P, Saxena S, Kumar S, Gupta R: Melanotic neuroectodermal tumor of infancy: Presentation of a case affecting the maxilla. J Oral Maxillofac Pathol; 2010 Jan;14(1):29-32
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Melanotic neuroectodermal tumor of infancy: Presentation of a case affecting the maxilla.
  • Melanotic neuroectodermal tumor of infancy is a rare, distinctive neoplasm of early infancy with rapid expansile growth and a high rate of recurrence.
  • One such case was diagnosed in the Department of Oral Pathology and Microbiology in Subharti Dental College, Meerut.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21180456.001).
  • [ISSN] 1998-393X
  • [Journal-full-title] Journal of oral and maxillofacial pathology : JOMFP
  • [ISO-abbreviation] J Oral Maxillofac Pathol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC2995998
  • [Keywords] NOTNLM ; Benign neoplasm / maxilla / melanotic neuroectodermal tumor of infancy
  •  go-up   go-down


8. Ruhin-Poncet B, Ghoul-Mazgar S, Hotton D, Capron F, Jaafoura MH, Goubin G, Berdal A: Msx and dlx homeogene expression in epithelial odontogenic tumors. J Histochem Cytochem; 2009 Jan;57(1):69-78
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Msx and dlx homeogene expression in epithelial odontogenic tumors.
  • Epithelial odontogenic tumors are rare jaw pathologies that raise clinical diagnosis and prognosis dilemmas notably between ameloblastomas and clear cell odontogenic carcinomas (CCOCs).
  • Although Msx1 expression imitates normal cell differentiation in these tumors, other genes showed a distinct pattern depending on the type of tumor and the tissue involved.
  • In benign ameloblastomas, ISH localized Dlx3 transcripts and inconstantly detected Msx2 transcripts in epithelial cells.
  • Bmp4 was always expressed in all the tumors.
  • Based on the established roles of Msx and Dlx transcription factors in dental cell fates, these data suggest that their altered expression is a proposed trail to explain the genesis and/or the progression of odontogenic tumors.
  • [MeSH-major] Homeodomain Proteins / biosynthesis. Jaw Neoplasms / metabolism. MSX1 Transcription Factor / biosynthesis. Odontogenic Tumors / metabolism. Transcription Factors / biosynthesis
  • [MeSH-minor] Adolescent. Adult. Ameloblastoma / metabolism. Bone Morphogenetic Protein 2 / biosynthesis. Bone Morphogenetic Protein 4 / biosynthesis. Female. Gene Expression Regulation, Neoplastic. Humans. Immunohistochemistry. In Situ Hybridization. Male. Middle Aged. Neoplasm Recurrence, Local. Reverse Transcriptase Polymerase Chain Reaction. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nat Genet. 1996 Aug;13(4):417-21 [8696335.001]
  • [Cites] Stem Cells. 1996 May;14(3):281-91 [8724694.001]
  • [Cites] Development. 1996 Oct;122(10):3035-44 [8898217.001]
  • [Cites] J Cell Biol. 1996 Dec;135(6 Pt 2):1879-87 [8991098.001]
  • [Cites] Hum Mol Genet. 1998 Mar;7(3):563-9 [9467018.001]
  • [Cites] Development. 1998 Jan;125(2):161-9 [9486790.001]
  • [Cites] Development. 1998 May;125(9):1627-35 [9521901.001]
  • [Cites] Pathol Int. 1998 Aug;48(8):618-22 [9736409.001]
  • [Cites] Development. 1998 Nov;125(21):4325-33 [9753686.001]
  • [Cites] J Dent Res. 1999 Jan;78(1):20-30 [10065942.001]
  • [Cites] Development. 1999 Sep;126(17):3831-46 [10433912.001]
  • [Cites] J Oral Pathol Med. 1999 Sep;28(8):343-9 [10478958.001]
  • [Cites] J Cell Biol. 2004 Dec 6;167(5):973-83 [15583034.001]
  • [Cites] Cancer Res. 2005 Feb 1;65(3):749-57 [15705871.001]
  • [Cites] Am J Med Genet A. 2005 Mar 1;133A(2):138-41 [15666299.001]
  • [Cites] Cancer Invest. 2005;23(3):222-8 [15945508.001]
  • [Cites] J Dent Res. 2005 Dec;84(12):1117-26 [16304440.001]
  • [Cites] Bone. 2005 Dec;37(6):799-809 [16172034.001]
  • [Cites] Orthod Craniofac Res. 2006 Feb;9(1):52-6 [16420275.001]
  • [Cites] World J Gastroenterol. 2005 Nov 21;11(43):6867-70 [16425399.001]
  • [Cites] Oral Dis. 2006 Mar;12(2):163-70 [16476038.001]
  • [Cites] J Oral Maxillofac Surg. 2006 Mar;64(3):484-94 [16487813.001]
  • [Cites] J Oral Pathol Med. 2006 May;35(5):278-85 [16630291.001]
  • [Cites] Genes Chromosomes Cancer. 2006 Sep;45(9):846-55 [16804919.001]
  • [Cites] Pathol Int. 2006 Dec;56(12):732-7 [17096730.001]
  • [Cites] Minerva Stomatol. 2006 Sep;55(9):503-13 [17146429.001]
  • [Cites] J Biol Chem. 2006 Dec 29;281(52):40515-26 [17060321.001]
  • [Cites] PLoS Med. 2006 Dec;3(12):e486 [17194187.001]
  • [Cites] J Gastroenterol Hepatol. 2007 Mar;22(3):389-94 [17295772.001]
  • [Cites] Oncol Rep. 2007 Apr;17(4):753-60 [17342311.001]
  • [Cites] J Oral Maxillofac Surg. 2007 Apr;65(4):777-83 [17368379.001]
  • [Cites] Pediatr Res. 1999 Dec;46(6):650-6 [10590019.001]
  • [Cites] J Histochem Cytochem. 2000 Feb;48(2):277-84 [10639494.001]
  • [Cites] Nat Genet. 2000 Apr;24(4):342-3 [10742093.001]
  • [Cites] Nat Genet. 2000 Apr;24(4):391-5 [10742104.001]
  • [Cites] Gene. 2000 Oct 3;256(1-2):1-11 [11054529.001]
  • [Cites] J Dent Res. 2007 Apr;86(4):331-5 [17384027.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Jun;103(6):799-807 [17448710.001]
  • [Cites] Bone. 2007 Nov;41(5):851-9 [17878071.001]
  • [Cites] Hum Pathol. 2008 Mar;39(3):350-8 [18187185.001]
  • [Cites] Cell. 2000 Dec 22;103(7):1099-109 [11163185.001]
  • [Cites] Dev Genes Evol. 2000 May;210(5):270-5 [11180832.001]
  • [Cites] Biochem Biophys Res Commun. 2001 Mar16;281(5):1234-40 [11243867.001]
  • [Cites] J Biol Chem. 2001 Mar 30;276(13):10016-24 [11113121.001]
  • [Cites] Bioessays. 2001 Jun;23(6):481-93 [11385628.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7336-41 [11390985.001]
  • [Cites] DNA Cell Biol. 2001 Jun;20(6):359-65 [11445007.001]
  • [Cites] Int J Dev Biol. 2001 Jun;45(4):681-4 [11461005.001]
  • [Cites] Oral Dis. 2001 May;7(3):171-6 [11495193.001]
  • [Cites] Nucleic Acids Res. 2002 Jan 15;30(2):515-22 [11788714.001]
  • [Cites] J Dent Res. 2002 Aug;81(8):525-30 [12147741.001]
  • [Cites] J Neurosci Res. 2002 Sep 15;69(6):803-9 [12205674.001]
  • [Cites] Stem Cells. 2002;20(5):364-79 [12351808.001]
  • [Cites] Oncol Rep. 2003 Jul-Aug;10(4):973-7 [12792755.001]
  • [Cites] Anticancer Res. 2003 Mar-Apr;23(2B):1479-88 [12820413.001]
  • [Cites] J Dent Res. 2003 Jul;82(7):551-7 [12821718.001]
  • [Cites] J Craniofac Surg. 2003 May;14(3):356-62 [12826807.001]
  • [Cites] J Leukoc Biol. 2003 Aug;74(2):302-5 [12885948.001]
  • [Cites] Am J Pathol. 2003 Nov;163(5):1707-12 [14578169.001]
  • [Cites] J Oral Pathol Med. 2004 May;33(5):292-9 [15078490.001]
  • [Cites] Anticancer Res. 2004 Mar-Apr;24(2B):955-62 [15161049.001]
  • [Cites] J Oral Pathol Med. 2004 Jul;33(6):360-7 [15200485.001]
  • [Cites] Oral Oncol. 2004 Sep;40(8):841-6 [15288841.001]
  • [Cites] J Oral Pathol. 1985 Sep;14(8):603-14 [3930670.001]
  • [Cites] J Electron Microsc (Tokyo). 1990;39(5):404-7 [2084197.001]
  • [Cites] Cell. 1993 Oct 8;75(1):45-58 [8104708.001]
  • [Cites] Nat Genet. 1994 Apr;6(4):348-56 [7914451.001]
  • [Cites] J Exp Zool. 1994 Nov 1;270(3):273-84 [7964557.001]
  • [Cites] Nature. 1994 Dec 15;372(6507):684-6 [7990961.001]
  • [Cites] Connect Tissue Res. 1995;32(1-4):137-43 [7554910.001]
  • [Cites] Development. 1996 Jan;122(1):121-9 [8565823.001]
  • [Cites] Nat Genet. 1996 Feb;12(2):149-53 [8563752.001]
  • [Cites] Oncogene. 1996 May 16;12(10):2137-46 [8668339.001]
  • (PMID = 18854600.001).
  • [ISSN] 0022-1554
  • [Journal-full-title] The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society
  • [ISO-abbreviation] J. Histochem. Cytochem.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / BMP2 protein, human; 0 / BMP4 protein, human; 0 / Bone Morphogenetic Protein 2; 0 / Bone Morphogenetic Protein 4; 0 / Distal-less homeobox proteins; 0 / Homeodomain Proteins; 0 / MSX1 Transcription Factor; 0 / MSX2 protein; 0 / Transcription Factors
  • [Other-IDs] NLM/ PMC2605714
  •  go-up   go-down


9. Patil K, Mahima VG, Shetty SK, Lahari K: Facial plexiform neurofibroma in a child with neurofibromatosis type I: a case report. J Indian Soc Pedod Prev Dent; 2007 Mar;25(1):30-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Plexiform neurofibroma is a non-circumscribed, thick and irregular benign tumor of the peripheral nerve sheath.
  • [MeSH-major] Facial Neoplasms. Neurofibroma, Plexiform. Neurofibromatosis 1 / complications

  • Genetic Alliance. consumer health - Neurofibroma.
  • Genetic Alliance. consumer health - Neurofibromatosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17456965.001).
  • [ISSN] 0970-4388
  • [Journal-full-title] Journal of the Indian Society of Pedodontics and Preventive Dentistry
  • [ISO-abbreviation] J Indian Soc Pedod Prev Dent
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  •  go-up   go-down


10. D'Angelica M, Are C, Jarnagin W, DeGregoris G, Coit D, Jaques D, Brennan M, Fong Y: Initial experience with hand-assisted laparoscopic distal pancreatectomy. Surg Endosc; 2006 Jan;20(1):142-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The preoperative diagnoses included benign and malignant conditions.
  • The mean tumor size was 4 cm (range, 2-7 cm), and the estimated blood loss was 125 ml (range, 50-1,250 ml).
  • The median time to resumption of a regular diet was 3.5 days (range, 2-9 days), and the time to conversion to oral pain medications was 3 days (range, 2-9 days).

  • MedlinePlus Health Information. consumer health - Pancreatic Diseases.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Pediatr Surg. 2003 Oct;38(10):E7-9 [14577094.001]
  • [Cites] Ann Surg. 1999 May;229(5):693-8; discussion 698-700 [10235528.001]
  • [Cites] Arch Surg. 2001 Apr;136(4):391-8 [11296108.001]
  • [Cites] Surg Endosc. 2000 Nov;14(11):991-6 [11116403.001]
  • [Cites] Ann Surg. 2002 Nov;236(5):612-8 [12409667.001]
  • [Cites] Ann Surg. 1995 Feb;221(2):165-70 [7531967.001]
  • [Cites] Semin Laparosc Surg. 2001 Jun;8(2):96-103 [11441398.001]
  • [Cites] Br J Surg. 1991 Aug;78(8):976-9 [1913121.001]
  • [Cites] Surg Endosc. 2002 Sep;16(9):1358-61 [11984672.001]
  • [Cites] Surg Endosc. 2002 Jun;16(6):996-1003 [12163971.001]
  • [Cites] Surg Laparosc Endosc Percutan Tech. 2001 Apr;11(2):139-43 [11330382.001]
  • [Cites] Ann Surg. 1996 Mar;223(3):280-5 [8604908.001]
  • [Cites] Surg Endosc. 2003 Feb;17(2):201-6 [12436230.001]
  • [Cites] J Gastrointest Surg. 1997 Jan-Feb;1(1):20-5; discussion 25-6 [9834326.001]
  • [Cites] Arch Surg. 2002 Feb;137(2):164-8 [11822953.001]
  • [Cites] Surg Endosc. 2000 Nov;14(11):985-6 [11116401.001]
  • [Cites] J Am Coll Surg. 2001 Sep;193(3):281-7 [11548798.001]
  • [Cites] Surg Endosc. 2004 Mar;18(3):407-11 [14752628.001]
  • [Cites] Am J Surg. 2002 Mar;183(3):237-41 [11943118.001]
  • [Cites] J Am Coll Surg. 1999 Mar;188(3):255-60 [10065814.001]
  • [Cites] Surg Laparosc Endosc. 1998 Jun;8(3):180-4 [9649039.001]
  • [Cites] Surg Endosc. 2003 Sep;17 (9):1499 [12802660.001]
  • [Cites] Ann Surg. 2002 Aug;236(2):149-58 [12170019.001]
  • [Cites] Injury. 2003 Mar;34(3):233-4 [12623258.001]
  • [Cites] N Engl J Med. 1994 Feb 10;330(6):409-19 [8284008.001]
  • [Cites] Ann Surg. 1996 May;223(5):506-11; discussion 511-2 [8651741.001]
  • [Cites] Br J Surg. 1999 Jul;86(7):895-8 [10417561.001]
  • [Cites] Urology. 2003 Sep;62(3):551 [12946773.001]
  • [Cites] World J Surg. 2002 Oct;26(10):1297-300 [12205557.001]
  • [Cites] J Gastrointest Surg. 2004 May-Jun;8(4):493-501 [15120376.001]
  • [Cites] Surg Endosc. 2002 Apr;16(4):700-2 [11972219.001]
  • (PMID = 16333550.001).
  • [ISSN] 1432-2218
  • [Journal-full-title] Surgical endoscopy
  • [ISO-abbreviation] Surg Endosc
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


11. Ram R: Ameloblastoma relapse after 16 years of resection in symphysis of mandible sparing the bone graft. Natl J Maxillofac Surg; 2010 Jul;1(2):190-3
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Ameloblastoma is a tumor derived from epithelium involved in odontogenesis.
  • Although it is considered a benign tumor, its clinical behavior may be regarded as lying between benign and malignant.
  • Diagnosis mainly from tissue biopsy and characteristic finding on plain X-rays does assist in differentiating between types of ameloblastoma.
  • The challenges in the management of this tumor are to provide complete excision as recurrence may occur in incomplete removal and also to reconstruct the bony defect in order to give reasonable cosmetic and functional outcome to the patient.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 22442598.001).
  • [ISSN] 2229-3418
  • [Journal-full-title] National journal of maxillofacial surgery
  • [ISO-abbreviation] Natl J Maxillofac Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC3304200
  • [Keywords] NOTNLM ; Ameloblastoma relapse / epithelial odontogenic tumor / mandibular reconstruction
  •  go-up   go-down


12. Huang Q, Dai DK, Qian XJ, Zhai RY: Treatment of gastric outlet and duodenal obstructions with uncovered expandable metal stents. World J Gastroenterol; 2007 Oct 28;13(40):5376-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Fifteen consecutive patients underwent peroral placement of Wallstent(TM) Enteral Endoprosthesis to treat gastric outlet and duodenal obstructions (14 malignant, 1 benign).
  • RESULTS: The technique success rate was 100%, and the oral intake was maintained in 12 of 14 patients varying from 7 d to 270 d.
  • Two patients remained unable to resume oral intake, although their stents were proven to be patent with the barium study.
  • Ten patients died during the follow-up period, and their mean oral intake time was 50 d.
  • Stent migration to the gastric antrum occurred in one patient 1 year after the procedure, a tumor grew at the proximal end of the stent in another patient 38 d post-stent insertion.
  • Indications for this procedure should be discreetly considered because a few patients may not benefit from gastrointestinal insertion, but some benign gastrointestinal obstructions can be treated using this procedure.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17879410.001).
  • [ISSN] 1007-9327
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] China
  • [Other-IDs] NLM/ PMC4171330
  •  go-up   go-down


13. Beil CM, Keberle M: Oral and oropharyngeal tumors. Eur J Radiol; 2008 Jun;66(3):448-59
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Oral and oropharyngeal tumors.
  • There is a large variability of tumors and tumor-like lesions, which are located in the oral cavity and oropharynx.
  • But more than 90% of all tumors in this area are squamous cell carcinomas (SCCs).
  • About 10% of all oral and oropharyngeal tumors are benign.
  • [MeSH-major] Carcinoma, Squamous Cell / diagnosis. Diagnostic Imaging. Mouth Neoplasms / diagnosis. Oropharyngeal Neoplasms / diagnosis
  • [MeSH-minor] Contrast Media. Humans. Mouth / pathology

  • MedlinePlus Health Information. consumer health - Diagnostic Imaging.
  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18457933.001).
  • [ISSN] 0720-048X
  • [Journal-full-title] European journal of radiology
  • [ISO-abbreviation] Eur J Radiol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / Contrast Media
  • [Number-of-references] 18
  •  go-up   go-down


14. Laikui L, Hongwei L, Hongbing J, Zhixiu H: Epithelial salivary gland tumors of children and adolescents in west China population: a clinicopathologic study of 79 cases. J Oral Pathol Med; 2008 Apr;37(4):201-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Epithelial salivary gland tumors of children and adolescents in west China population: a clinicopathologic study of 79 cases.
  • OBJECTIVE: Determine the clinical and histopathologic features of epithelial salivary gland tumors of children and adolescents.
  • METHODS: A total of 79 cases of epithelial salivary gland tumors of children and adolescents were retrieved from the files.
  • RESULTS: Sixty tumors (75.9%) were benign and 19 (24.1%) malignant.
  • The most common tumor overall was pleomorphic adenoma (PA).
  • PA was the most common type of benign tumor.
  • The most common malignant tumor was mucoepidermoid carcinoma.
  • One patient with mucoepidermoid carcinoma showed local recurrences and died from the tumor 3 years after the initial treatment.
  • CONCLUSIONS: Our data showed that the salivary gland tumors in children and adolescents may be the higher incidence of benign tumors, especially of PA; the slightly higher tendency for female predominance; the higher incidence of parotid glands.
  • Mucoepidermoid carcinoma was the most common malignant tumor, with majority of low grade.
  • Initial treatment should be planned to excise the tumor completely with satisfactory margins.
  • [MeSH-major] Adenoma, Pleomorphic / pathology. Carcinoma, Mucoepidermoid / pathology. Salivary Gland Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Salivary Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18205745.001).
  • [ISSN] 1600-0714
  • [Journal-full-title] Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
  • [ISO-abbreviation] J. Oral Pathol. Med.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Denmark
  •  go-up   go-down


15. de Oliveira FA, Duarte EC, Taveira CT, Máximo AA, de Aquino EC, Alencar Rde C, Vencio EF: Salivary gland tumor: a review of 599 cases in a Brazilian population. Head Neck Pathol; 2009 Dec;3(4):271-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Salivary gland tumor: a review of 599 cases in a Brazilian population.
  • Salivary gland tumors consist of a group of heterogeneous lesions with complex clinicopathological characteristics and distinct biological behaviors.
  • Worldwide series show a contrast in the relative incidence of salivary gland tumors, with some discrepancies in clinicopathological data.
  • Benign tumors represented 78.3% of the cases.
  • Parotid gland tumors were the most frequent (68.5% of cases) and patient age ranged from 1 to 88 years-old (median of 45 years old).
  • The most frequent tumors were pleomorphic adenomas (68.4%) and benign tumors were significantly more frequent in the parotid (75.9%), while malignant tumors were more frequent in the minor salivary glands (40%) (P < 0.05).
  • In conclusion, women and the parotid gland were the most affected and pleomorphic adenoma was the most frequent lesion, followed by adenoid cystic carcinoma and Warthin's tumor.
  • [MeSH-major] Salivary Gland Neoplasms / epidemiology. Salivary Gland Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Salivary Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Craniomaxillofac Surg. 2000 Feb;28(1):56-61 [10851675.001]
  • [Cites] West Indian Med J. 2001 Mar;50(1):62-5 [11398291.001]
  • [Cites] Odontostomatol Trop. 2002 Sep;25(99):19-22 [12430350.001]
  • [Cites] Rev Hosp Clin Fac Med Sao Paulo. 2002 Nov-Dec;57(6):271-6 [12612759.001]
  • [Cites] J Pathol. 1985 May;146(1):51-8 [4009321.001]
  • [Cites] Head Neck Surg. 1986 Jan-Feb;8(3):177-84 [3744850.001]
  • [Cites] Oral Oncol. 2008 Feb;44(2):187-92 [17418612.001]
  • [Cites] Int J Oral Maxillofac Surg. 2005 Jul;34(5):533-6 [16053874.001]
  • [Cites] Oral Dis. 2005 Nov;11(6):386-91 [16269031.001]
  • [Cites] Braz J Otorhinolaryngol. 2005 May-Jun;71(3):335-40 [16446938.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 May;103(5):e53-9 [17368055.001]
  • [Cites] J Oral Maxillofac Surg. 2007 Nov;65(11):2187-94 [17954313.001]
  • [Cites] Virchows Arch A Pathol Anat Histopathol. 1992;421(2):105-13 [1325087.001]
  • (PMID = 20596844.001).
  • [ISSN] 1936-0568
  • [Journal-full-title] Head and neck pathology
  • [ISO-abbreviation] Head Neck Pathol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] United States
  • [Number-of-references] 15
  • [Other-IDs] NLM/ PMC2811571
  •  go-up   go-down


16. Ansari MH: Salivary gland tumors in an Iranian population: a retrospective study of 130 cases. J Oral Maxillofac Surg; 2007 Nov;65(11):2187-94
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Salivary gland tumors in an Iranian population: a retrospective study of 130 cases.
  • PURPOSE: Tumors of the salivary glands are uncommon, comprising 3% to 10% of head and neck neoplasia.
  • In the absence of epidemiologic studies of these neoplasms in an Iranian population, we conducted a preliminary survey of 130 cases over the last 20 years in Hamedan, Iran.
  • PATIENTS AND METHODS: The medical records and case notes of all patients with histologically confirmed salivary gland tumors were reviewed retrospectively from February 1984 to March 2003.
  • This review found 89 patients with benign tumors and 41 patients with malignant tumors.
  • The collection of data included gender, age, location, and histopathology of the tumor.
  • Patients with benign and malignant tumors presented with a mean age of 41.3 and 47 years, respectively.
  • The frequency of benign tumors was 68.4% (n = 89) and 31.6% for malignant tumors (n = 41).
  • Tumors were localized in the parotid gland (63%; n = 82), the submandibular gland (23%; n = 30), and in the minor salivary glands (14%; n = 18).
  • The most common benign tumor was pleomorphic adenoma (65.4%; n = 85).
  • Among malignant tumors, mucoepidermoid carcinoma was the most frequent (11.5%; n = 15), followed by adenocarcinoma (10%; n = 13).
  • Greater than 63% of malignant tumors were treated surgically, and the remaining with combined therapy.
  • CONCLUSION: Between benign and malignant salivary gland tumors, frequency of pleomorphic adenoma and mucoepidermoid carcinoma was in keeping with studies reported previously.
  • In other salivary gland tumors, however, diversity was obvious and showed significant difference, requiring further studies.
  • [MeSH-major] Salivary Gland Neoplasms / epidemiology
  • [MeSH-minor] Adenocarcinoma / epidemiology. Adenoma, Pleomorphic / epidemiology. Adolescent. Adult. Aged. Carcinoma, Mucoepidermoid / epidemiology. Disease-Free Survival. Female. Follow-Up Studies. Humans. Iran / epidemiology. Male. Middle Aged. Neoadjuvant Therapy. Parotid Neoplasms / epidemiology. Retrospective Studies. Salivary Glands, Minor / pathology. Submandibular Gland Neoplasms / epidemiology. Survival Rate

  • MedlinePlus Health Information. consumer health - Salivary Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17954313.001).
  • [ISSN] 0278-2391
  • [Journal-full-title] Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons
  • [ISO-abbreviation] J. Oral Maxillofac. Surg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


17. Gallana-Alvarez S, Mayorga-Jimenez F, Torres-Gómez FJ, Avellá-Vecino FJ, Salazar-Fernandez C: Calcifying odontogenic cyst associated with complex odontoma: case report and review of the literature. Med Oral Patol Oral Cir Bucal; 2005 May-Jul;10(3):243-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The lesion is a mixed odontogenic benign tumor, and although most of the cases present cystic characteristics, a few are of the solid type (15%), and its rare malignant transformation is well documented.
  • The COC may occur in association with other odontogenic tumors, the most common is the odontoma, occurring in about 24% of the cases.
  • [MeSH-major] Maxillary Neoplasms / complications. Odontogenic Cyst, Calcifying / complications. Odontoma / complications

  • Genetic Alliance. consumer health - Odontoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15876968.001).
  • [ISSN] 1698-6946
  • [Journal-full-title] Medicina oral, patología oral y cirugía bucal
  • [ISO-abbreviation] Med Oral Patol Oral Cir Bucal
  • [Language] eng; spa
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Spain
  • [Number-of-references] 26
  •  go-up   go-down


18. Ghosh A, Saha S, Saha VP, Sadhu A, Chattopadhyay S: Infratemporal fossa myoepithelial carcinoma--a rare case report. Oral Maxillofac Surg; 2009 Mar;13(1):59-62
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • DISCUSSION: Unlike its benign counterpart, myoepithelial carcinoma is biologically very aggressive and prone to recur even after adequate therapy.
  • [MeSH-major] Myoepithelioma / diagnosis. Nose Neoplasms / surgery. Pterygopalatine Fossa. Skull Neoplasms / diagnosis
  • [MeSH-minor] Adolescent. Biomarkers, Tumor / analysis. Combined Modality Therapy. Female. Humans. India. Postoperative Complications / diagnostic imaging. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Myoepithelial carcinoma.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Auris Nasus Larynx. 2008 Sep;35(3):408-13 [18060711.001]
  • [Cites] ORL J Otorhinolaryngol Relat Spec. 1999 Mar-Apr;61(2):113-6 [10095203.001]
  • [Cites] J Laryngol Otol. 1986 Jun;100(6):687-98 [3014029.001]
  • [Cites] Am J Surg Pathol. 2003 Sep;27(9):1183-96 [12960802.001]
  • [Cites] Am J Surg Pathol. 2000 Jun;24(6):761-74 [10843278.001]
  • [Cites] ORL J Otorhinolaryngol Relat Spec. 2000 Sep-Oct;62(5):282-5 [10965266.001]
  • [Cites] Am J Surg Pathol. 2007 Dec;31(12):1813-24 [18043035.001]
  • [Cites] Arch Otolaryngol. 1964 May;79:498-504 [14120674.001]
  • (PMID = 19184133.001).
  • [ISSN] 1865-1569
  • [Journal-full-title] Oral and maxillofacial surgery
  • [ISO-abbreviation] Oral Maxillofac Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


19. Ferlito A, Elsheikh MN, Manni JJ, Rinaldo A: Paraneoplastic syndromes in patients with primary head and neck cancer. Eur Arch Otorhinolaryngol; 2007 Mar;264(3):211-22
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Paraneoplastic syndromes represent the clinical manifestations of the indirect and remote effects produced by tumor metabolites or other products.
  • Sometimes, paraneoplastic syndromes can be more serious than the consequences of the primary tumor itself and can precede, follow or be concurrent to the diagnosis of a malignancy; moreover, they can dominate the clinical picture and thus lead to errors with respect to the origin and type of the primary tumor.
  • Physicians who deal with cancer-associated syndromes should be able to differentiate the paraneoplastic syndromes from the benign disorders that mimic them.
  • Patients with a suspected paraneoplastic disorder should undergo a complete panel of laboratory studies, in addition to imaging studies and endoscopy.
  • Identification of paraneoplastic syndromes allow the clinician to make an early diagnosis and to provide adequate treatment of tumors, with a favorable oncologic outcome and improved life expectancy for the patient.
  • These syndromes can follow the clinical course of the tumor and thus be useful for monitoring its evolution.
  • [MeSH-major] Chorionic Gonadotropin, beta Subunit, Human / metabolism. Head and Neck Neoplasms. Paraneoplastic Syndromes

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Hum Pathol. 2003 Jul;34(7):717-9 [12874770.001]
  • [Cites] J Laryngol Otol. 1997 Jan;111(1):66-9 [9292137.001]
  • [Cites] Z Hautkr. 1986 Sep 1;61(17):1229-37 [3776278.001]
  • [Cites] Cutis. 2004 Nov;74(5):289-92 [15605965.001]
  • [Cites] Otolaryngol Head Neck Surg. 1995 Jan;112(1):125-7 [7816446.001]
  • [Cites] Brain. 1997 Aug;120 ( Pt 8):1279-300 [9278623.001]
  • [Cites] N Y State J Med. 1954 Aug 15;54(16):2333-6 [13194110.001]
  • [Cites] Dermatologica. 1990;180(4):212-6 [2192925.001]
  • [Cites] Cancer. 1995 Apr 1;75(7):1678-83 [8826927.001]
  • [Cites] Reumatismo. 2002;54(1):48-51 [12089614.001]
  • [Cites] Surv Ophthalmol. 2003 Jan-Feb;48(1):12-38 [12559325.001]
  • [Cites] J Otolaryngol. 1994 Dec;23(6):437-9 [7897775.001]
  • [Cites] Oral Oncol. 2005 Oct;41(9):878-83 [16154516.001]
  • [Cites] Presse Med. 1985 Feb 23;14(8):471-4 [3157147.001]
  • [Cites] Eur Arch Otorhinolaryngol. 2006 Jan;263(1):32-6 [15986184.001]
  • [Cites] Ann Neurol. 2001 Feb;49(2):146-54 [11220734.001]
  • [Cites] J Fr Otorhinolaryngol Audiophonol Chir Maxillofac. 1980 Mar;29(3):165-9, 171-2 [6449549.001]
  • [Cites] Gynecol Oncol. 1999 Jun;73(3):430-2 [10366473.001]
  • [Cites] Metabolism. 1976 Jun;25(6):697-721 [818477.001]
  • [Cites] Thyroid. 2005 Jun;15(6):618-23 [16029131.001]
  • [Cites] Head Neck. 2006 Dec;28(12):1142-6 [16721738.001]
  • [Cites] Otolaryngol Head Neck Surg. 1998 Mar;118(3 Pt 1):412-4 [9527129.001]
  • [Cites] Int J Oral Maxillofac Surg. 2003 Apr;32(2):174-80 [12729778.001]
  • [Cites] J Neuroophthalmol. 2001 Sep;21(3):173-87 [11725182.001]
  • [Cites] Am J Ophthalmol. 2001 Aug;132(2):273-5 [11476700.001]
  • [Cites] Otolaryngol Head Neck Surg. 1997 Dec;117(6):S239-42 [9419160.001]
  • [Cites] Ann Otolaryngol Chir Cervicofac. 1973 Apr-May;90(4):314-7 [4753178.001]
  • [Cites] Bone. 1991;12 (4):237-9 [1793672.001]
  • [Cites] Medicine (Baltimore). 1991 Jul;70(4):269-80 [2067411.001]
  • [Cites] J Otolaryngol. 2004 Oct;33(5):308-9 [15931816.001]
  • [Cites] Rev Neurol (Paris). 1989;145(12):851-2 [2616969.001]
  • [Cites] Am J Med. 1995 Dec;99(6):662-71 [7503090.001]
  • [Cites] Am J Med. 1986 Nov;81(5):946 [3777004.001]
  • [Cites] Ann Ital Med Int. 2005 Jan-Mar;20(1):28-38 [15859392.001]
  • [Cites] Ann Rheum Dis. 1992 Apr;51(4):556-7 [1586262.001]
  • [Cites] Ann Otol Rhinol Laryngol. 1996 Jun;105(6):487-9 [8638903.001]
  • [Cites] Br J Dermatol. 1981 Jul;105(1):65-9 [7020742.001]
  • [Cites] Oral Oncol. 1998 Nov;34(6):567-70 [9930372.001]
  • [Cites] Thyroid. 2003 Jun;13(6):601-5 [12930605.001]
  • [Cites] Med Pediatr Oncol. 1993;21(9):676-9 [8413003.001]
  • [Cites] J Fr Otorhinolaryngol Audiophonol Chir Maxillofac. 1978 May;27(5):353-7 [149835.001]
  • [Cites] Acta Pathol Jpn. 1985 Jul;35(4):915-23 [2416185.001]
  • [Cites] Head Neck Surg. 1982 Nov-Dec;5(2):125-9 [7169331.001]
  • [Cites] Ann Dermatol Venereol. 1981;108(11):885-8 [7325521.001]
  • [Cites] Cancer. 1996 May 15;77(10):1967-72 [8640657.001]
  • [Cites] Australas J Dermatol. 2000 Aug;41(3):178-80 [10954991.001]
  • [Cites] HNO. 2003 Apr;51(4):328-31 [12682736.001]
  • [Cites] Ann Otol Rhinol Laryngol. 1987 May-Jun;96(3 Pt 1):315-21 [3300506.001]
  • [Cites] Geriatrics. 1963 Oct;18:745-53 [14072774.001]
  • [Cites] Australas Radiol. 2001 Feb;45(1):71-3 [11259979.001]
  • [Cites] Head Neck. 2004 Jan;26(1):89-93 [14724912.001]
  • [Cites] J Clin Oncol. 1993 Dec;11(12 ):2434-42 [8246032.001]
  • [Cites] Ann Otol Rhinol Laryngol. 2001 Jan;110(1):76-82 [11201814.001]
  • [Cites] Rev Med Interne. 1988 Jan-Feb;9(1):81-4 [3368665.001]
  • [Cites] Arch Otolaryngol. 1984 Feb;110(2):123-6 [6320786.001]
  • [Cites] Arch Dermatol. 1979 Jun;115(6):734-5 [453878.001]
  • [Cites] Otolaryngol Head Neck Surg. 1995 Sep;113(3):301-4 [7675496.001]
  • [Cites] Acta Otorrinolaringol Esp. 1995 Jan-Feb;46(1):67-70 [7734170.001]
  • [Cites] Laryngoscope. 2006 Oct;116(10):1930-3 [17003734.001]
  • [Cites] Otolaryngol Head Neck Surg. 1992 Sep;107(3):475-7 [1408240.001]
  • [Cites] Cancer. 1996 May 1;77(9):1759-67 [8646671.001]
  • [Cites] N Z Med J. 2006 Jun 02;119(1235):U2006 [16751829.001]
  • [Cites] Singapore Med J. 1991 Apr;32(2):170-3 [2042083.001]
  • [Cites] Eur Arch Otorhinolaryngol. 1998;255(4):205-10 [9592679.001]
  • [Cites] J Drugs Dermatol. 2004 Sep-Oct;3(5):557-9 [15552609.001]
  • [Cites] Oral Oncol. 2004 Jul;40(6):553-62 [15063382.001]
  • [Cites] An Sist Sanit Navar. 2005 May-Aug;28(2):213-26 [16155618.001]
  • [Cites] Laryngol Rhinol Otol (Stuttg). 1976 May;55(5):414-9 [135167.001]
  • [Cites] BMC Ophthalmol. 2004 Jun 04;4:5 [15180904.001]
  • [Cites] Arthritis Rheum. 1987 Jul;30(7):825-9 [3040016.001]
  • [Cites] J Am Acad Dermatol. 1987 Jun;16(6):1179-82 [3597859.001]
  • [Cites] Respiration. 1989;55(3):186-8 [2813976.001]
  • [Cites] Eye (Lond). 2002 Jul;16(4):501-3 [12101466.001]
  • [Cites] Ann Otol Rhinol Laryngol. 1991 Apr;100(4 Pt 1):341-4 [2018296.001]
  • [Cites] Ophthalmology. 2002 Nov;109(11):2149-53 [12414431.001]
  • [Cites] Neoplasma. 1984;31(2):231-6 [6717693.001]
  • [Cites] Acta Otorrinolaringol Esp. 1998 Jun-Jul;49(5):414-5 [9717335.001]
  • [Cites] J Assoc Physicians India. 2003 Oct;51:1023-4 [14719600.001]
  • [Cites] Graefes Arch Clin Exp Ophthalmol. 1992;230(4):324-8 [1505762.001]
  • [Cites] Laryngoscope. 1995 Aug;105(8 Pt 1):789-94 [7630288.001]
  • [Cites] Br J Dermatol. 1964 Aug-Sep;76:349-56 [14201182.001]
  • [Cites] Ophthalmic Genet. 2006 Jun;27(2):57-61 [16754207.001]
  • [Cites] Auris Nasus Larynx. 1989;16(2):127-32 [2552973.001]
  • [Cites] Ann Dermatol Venereol. 2006 Jun-Jul;133(6-7):557-60 [16885844.001]
  • [Cites] J R Nav Med Serv. 1967 Summer;53(2):75-8 [6046981.001]
  • [Cites] Lung Cancer. 1998 Nov;22(2):149-52 [10022222.001]
  • [Cites] Cutis. 2003 Nov;72(5):399-402 [14655782.001]
  • [Cites] J Dermatol. 2005 Aug;32(8):650-3 [16334866.001]
  • [Cites] Hautarzt. 1999 Mar;50(3):198-202 [10231690.001]
  • [Cites] HNO. 2003 Apr;51(4):332-6 [12682737.001]
  • [Cites] Eur Arch Otorhinolaryngol. 1994;251(3):183-5 [8080640.001]
  • [Cites] Am J Otolaryngol. 1994 Sep-Oct;15(5):336-43 [7978037.001]
  • [Cites] Ann Otol Rhinol Laryngol. 2000 Jan;109(1):109-17 [10651424.001]
  • [Cites] Cancer. 1975 May;35(5):1430-7 [164276.001]
  • [Cites] Curr Opin Neurol. 2005 Jun;18(3):331-6 [15891421.001]
  • [Cites] Semin Diagn Pathol. 1989 Nov;6(4):329-50 [2692106.001]
  • [Cites] Med Klin. 1969 Aug 15;64(33):1470-5 [5805799.001]
  • [Cites] Laryngoscope. 1990 Dec;100(12):1323-5 [2243527.001]
  • [Cites] Otolaryngol Head Neck Surg. 2002 Oct;127(4):354-6 [12402019.001]
  • [Cites] Ann Otolaryngol Chir Cervicofac. 1977 Jan-Feb;94(1-2):47-52 [855978.001]
  • [Cites] Medicine (Baltimore). 1977 Jan;56(1):1-37 [834136.001]
  • [Cites] Head Neck. 1997 Dec;19(8):701-5 [9406749.001]
  • [Cites] Mund Kiefer Gesichtschir. 2002 Sep;6(5):331-5 [12448236.001]
  • [Cites] Ann Otol Rhinol Laryngol. 1997 Oct;106(10 Pt 1):878-83 [9342988.001]
  • [Cites] Ann Dermatol Venereol. 1992;119(6-7):483-5 [1444109.001]
  • [Cites] Otolaryngol Head Neck Surg. 1989 Jun;100(6):583-7 [2546116.001]
  • [Cites] Acta Otorrinolaringol Esp. 1999 Jun-Jul;50(5):405-9 [10491480.001]
  • [Cites] Laryngoscope. 1993 Jul;103(7):754-61 [8341101.001]
  • [Cites] Am J Clin Oncol. 1990 Oct;13(5):388-93 [2220659.001]
  • [Cites] Acta Otolaryngol. 2001 Sep;121(6):756-8 [11678176.001]
  • [Cites] Arch Neurol. 1999 Apr;56(4):405-8 [10199327.001]
  • [Cites] AJR Am J Roentgenol. 1977 Apr;128(4):679-81 [403806.001]
  • [Cites] Am Fam Physician. 1991 Oct;44(4):1325-9 [1927845.001]
  • [Cites] J Neurol. 2002 Jun;249(6):745-53 [12111309.001]
  • [Cites] J Am Acad Dermatol. 1989 Dec;21(6):1317 [2584473.001]
  • [Cites] Ann Otolaryngol Chir Cervicofac. 1979 Jun;96(6):349-58 [507641.001]
  • [Cites] Cancer. 1993 Nov 1;72(9):2723-31 [8402496.001]
  • [Cites] Rheumatol Int. 2003 Nov;23(6):309-11 [12838366.001]
  • [Cites] J Laryngol Otol. 1988 Feb;102(2):184-6 [3346603.001]
  • [Cites] Curr Opin Neurol. 2004 Feb;17(1):3-8 [15090871.001]
  • [Cites] Ann Otol Rhinol Laryngol. 1992 Nov;101(11):946-9 [1332568.001]
  • (PMID = 17206403.001).
  • [ISSN] 0937-4477
  • [Journal-full-title] European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
  • [ISO-abbreviation] Eur Arch Otorhinolaryngol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Chorionic Gonadotropin, beta Subunit, Human
  • [Number-of-references] 126
  •  go-up   go-down


20. Darom A, Gomatos IP, Leandros E, Chatzigianni E, Panousopoulos D, Konstadoulakis MM, Androulakis G: Molecular markers (PECAM-1, ICAM-3, HLA-DR) determine prognosis in primary non-Hodgkin's gastric lymphoma patients. World J Gastroenterol; 2006 Mar 28;12(12):1924-32
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Molecular markers (PECAM-1, ICAM-3, HLA-DR) determine prognosis in primary non-Hodgkin's gastric lymphoma patients.
  • AIM: To investigate the prognostic significance of PECAM-1, ICAM-3 and HLA-DR antigens in patients with primary non-Hodgkin's gastric lymphoma.
  • Ten non-malignant and ten healthy gastric tissue specimens were used as controls.
  • RESULTS: HLA-DR antigen expression was detected in 33 gastric lymphoma patients (91.7%) and 6 non-malignant patients (54.5%).
  • PECAM-1 stained tumor cells of 10 patients (27.8%), endothelial cells of 9 patients (25%) and inflammatory infiltrate of 4 patients (40%) with benign gastric disease.
  • ICAM-3 expression was observed on the tumor cells of 17 patients (47.2%), while 5 non-malignant patients (50%) were stained positive as well.
  • CONCLUSION: PECAM-1, ICAM-3 and HLA-DR are representative markers of tumor expansion potential and host immune surveillance respectively.
  • [MeSH-major] Antigens, CD / analysis. Antigens, CD31 / analysis. Cell Adhesion Molecules / analysis. HLA-DR Antigens / analysis. Lymphoma, Non-Hodgkin / chemistry. Stomach Neoplasms / chemistry

  • Genetic Alliance. consumer health - Gastric Lymphoma.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Semin Cancer Biol. 1991 Feb;2(1):47-54 [1912518.001]
  • [Cites] Eur J Clin Invest. 1990 Oct;20(5):481-6 [2124977.001]
  • [Cites] Lancet. 1992 Nov 7;340(8828):1120-4 [1279332.001]
  • [Cites] Nature. 1992 Dec 3;360(6403):481-4 [1448173.001]
  • [Cites] J Natl Cancer Inst. 1992 Dec 16;84(24):1875-87 [1281237.001]
  • [Cites] J Exp Med. 1993 Aug 1;178(2):449-60 [8340753.001]
  • [Cites] Am J Pathol. 1993 Aug;143(2):401-9 [7688183.001]
  • [Cites] Int J Cancer. 1993 Sep 30;55(3):371-4 [7690738.001]
  • [Cites] Eur J Immunol. 1993 Nov;23(11):2799-806 [8223855.001]
  • [Cites] J Biol Chem. 1995 Jan 13;270(2):877-84 [7822326.001]
  • [Cites] Ann Surg. 1995 Jun;221(6):706-18; discussion 718-20 [7794075.001]
  • [Cites] Hum Pathol. 1995 Nov;26(11):1196-200 [7590692.001]
  • [Cites] Oncology. 1996 Mar-Apr;53(2):127-32 [8604238.001]
  • [Cites] Leukemia. 1996 May;10(5):907-8 [8656688.001]
  • [Cites] Br J Oral Maxillofac Surg. 1996 Feb;34(1):37-41 [8645680.001]
  • [Cites] J Mol Med (Berl). 1996 Jul;74(7):353-63 [8841948.001]
  • [Cites] Tissue Antigens. 1996 Oct;48(4 Pt 1):271-7 [8946680.001]
  • [Cites] Virchows Arch. 1996 Dec;429(6):377-82 [8982383.001]
  • [Cites] Am J Clin Pathol. 1997 May;107(5):534-41 [9128265.001]
  • [Cites] Vet Pathol. 1997 Jan;34(1):61-73 [9150551.001]
  • [Cites] Int J Cancer. 1997 Jun 20;74(3):326-9 [9221813.001]
  • [Cites] Int J Cancer. 1997 Dec 19;74(6):582-7 [9421352.001]
  • [Cites] Clin Cancer Res. 1998 Jan;4(1):31-6 [9516949.001]
  • [Cites] Tissue Cell. 1998 Jun;30(3):377-82 [10091339.001]
  • [Cites] APMIS. 1999 Apr;107(4):383-8 [10230691.001]
  • [Cites] Microvasc Res. 1999 May;57(3):292-7 [10329255.001]
  • [Cites] Oncology. 1985;42(2):97-103 [3887261.001]
  • [Cites] Immunobiology. 1985 Apr;169(3):228-49 [3873401.001]
  • [Cites] Eur J Immunol. 1986 Feb;16(2):172-81 [2420606.001]
  • [Cites] Int J Cancer. 1986 Oct 15;38(4):459-64 [2428757.001]
  • [Cites] Ann Surg. 1987 Jun;205(6):634-40 [3592805.001]
  • [Cites] J Clin Pathol. 1987 Jul;40(7):760-5 [3305585.001]
  • [Cites] J Clin Pathol. 1987 Sep;40(9):948-58 [3312304.001]
  • [Cites] Blood. 2000 Mar 15;95(6):1900-10 [10706853.001]
  • [Cites] Cancer Metastasis Rev. 1999;18(3):345-57 [10721489.001]
  • [Cites] In Vivo. 2000 Jan-Feb;14(1):199-208 [10757078.001]
  • [Cites] World J Surg. 2000 May;24(5):608-14 [10787085.001]
  • [Cites] Arch Immunol Ther Exp (Warsz). 2000;48(3):201-4 [10912626.001]
  • [Cites] Lung Cancer. 2000 Sep;29(3):169-77 [10996419.001]
  • [Cites] Am J Surg Pathol. 2000 Dec;24(12):1641-9 [11117785.001]
  • [Cites] Pathologica. 2000 Dec;92(6):503-15 [11234301.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1258-64 [11483337.001]
  • [Cites] Hepatogastroenterology. 2001 Jul-Aug;48(40):1202-5 [11490834.001]
  • [Cites] Int J Cancer. 2001 Nov15;94(4):599-604 [11745451.001]
  • [Cites] Clin Cancer Res. 2002 May;8(5):1185-91 [12006536.001]
  • [Cites] Surgery. 2002 Jul;132(1):20-6 [12110791.001]
  • [Cites] Br J Surg. 1970 Dec;57(12):877-83 [5487028.001]
  • [Cites] Science. 1981 Jun 12;212(4500):1229-38 [6165083.001]
  • [Cites] J Cell Biol. 1982 Dec;95(3):974-81 [6185506.001]
  • [Cites] Cell. 1984 Jan;36(1):1-13 [6198089.001]
  • [Cites] Br Med Bull. 1987 Jan;43(1):217-27 [3315098.001]
  • [Cites] Biochim Biophys Acta. 1989 Feb;948(3):305-26 [2465781.001]
  • [Cites] Scand J Immunol. 1989 Aug;30(2):129-64 [2474849.001]
  • [Cites] Cancer. 1989 Sep 15;64(6):1208-17 [2670184.001]
  • [Cites] J Natl Cancer Inst. 1990 Jan 3;82(1):4-6 [1688381.001]
  • [Cites] Cancer. 1990 Sep 15;66(6):1154-7 [2400966.001]
  • [Cites] Surg Clin North Am. 1992 Apr;72(2):423-31 [1549801.001]
  • (PMID = 16610000.001).
  • [ISSN] 1007-9327
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / Antigens, CD31; 0 / Cell Adhesion Molecules; 0 / HLA-DR Antigens; 0 / ICAM3 protein, human
  • [Other-IDs] NLM/ PMC4087519
  •  go-up   go-down


21. Fukunari F, Okamura K, Zeze R, Kagawa T, Hashimoto K, Yuasa K: Cervical lymph nodes with or without metastases from oral squamous carcinoma: a correlation of MRI findings and histopathologic architecture. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Jun;109(6):890-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cervical lymph nodes with or without metastases from oral squamous carcinoma: a correlation of MRI findings and histopathologic architecture.
  • OBJECTIVES: The aim of this study was to describe the magnetic resonance images (MRIs) of the architecture of metastatic lymph nodes as well as healthy lymph nodes and to correlate the images with the histopathologic architecture of the lymph nodes from oral squamous cell carcinoma.
  • STUDY DESIGN: The signal intensities of 98 cervical lymph nodes from 20 patients with oral squamous cell carcinoma were evaluated on T2-weighted and diffusion-weighted whole-body imaging with background body signal suppression (DWIBS).
  • RESULTS: On T2-weighted images, very hyperintense and/or isointense areas were specific findings for lymph nodes containing metastases from oral squamous cell carcinoma.
  • Using DWIBS images with inverted black-and-white image contrast, cystic degeneration, keratinization, fibrous tissue, tumor tissue, and lymphoid tissue were either hypointense or intermediate in intensity.
  • CONCLUSIONS: On T2-weighted images, very hyperintense and/or isointense areas were characteristic findings for lymph nodes containing metastases from oral squamous cell carcinoma.
  • Using DWIBS images, it was difficult to differentiate metastatic from benign lymph nodes.
  • [MeSH-major] Lymph Nodes / radiography. Lymphatic Metastasis / radiography. Magnetic Resonance Imaging. Mouth Neoplasms / pathology. Neoplasms, Squamous Cell / radiography

  • MedlinePlus Health Information. consumer health - MRI Scans.
  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Mosby, Inc. All rights reserved.
  • (PMID = 20299250.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Comparative Study; Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


22. Durr ML, Mydlarz WK, Shao C, Zahurak ML, Chuang AY, Hoque MO, Westra WH, Liegeois NJ, Califano JA, Sidransky D, Ha PK: Quantitative methylation profiles for multiple tumor suppressor gene promoters in salivary gland tumors. PLoS One; 2010 May 26;5(5):e10828
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Quantitative methylation profiles for multiple tumor suppressor gene promoters in salivary gland tumors.
  • BACKGROUND: Methylation profiling of tumor suppressor gene (TSGs) promoters is quickly becoming a powerful diagnostic tool for the early detection, prognosis, and even prediction of clinical response to treatment.
  • Few studies address this in salivary gland tumors (SGTs); hence the promoter methylation profile of various TSGs was quantitatively assessed in primary SGT tissue to determine if tumor-specific alterations could be detected.
  • METHODOLOGY: DNA isolated from 78 tumor and 17 normal parotid gland specimens was assayed for promoter methylation status of 19 TSGs by fluorescence-based, quantitative methylation-specific PCR (qMSP).
  • There was a variable frequency and individual methylation quotient detected, depending on the TSG and the tumor type.
  • When comparing normal, benign, and malignant SGTs, there was a statistically significant trend for increasing methylation in APC, Mint 1, PGP9.5, RAR-beta, and Timp3.
  • Further study is needed to evaluate the potential use of these associations in the detection, prognosis, and therapeutic outcome of these rare tumors.

  • MedlinePlus Health Information. consumer health - Salivary Gland Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Hum Pathol. 1999 Oct;30(10):1242-6 [10534174.001]
  • [Cites] Cancer Res. 2004 Sep 1;64(17):5982-7 [15342377.001]
  • [Cites] Br J Cancer. 2004 Sep 13;91(6):1131-8 [15292943.001]
  • [Cites] Am J Surg. 1974 Oct;128(4):512-20 [4371368.001]
  • [Cites] J Pathol. 2005 Jan;205(2):172-80 [15643671.001]
  • [Cites] Oral Oncol. 2005 Feb;41(2):161-9 [15695118.001]
  • [Cites] Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):656-63 [15701853.001]
  • [Cites] Cancer Res. 2005 Jun 1;65(11):4963-8 [15930319.001]
  • [Cites] Clin Cancer Res. 2005 Jun 15;11(12):4400-5 [15958624.001]
  • [Cites] Cancer. 2005 Aug 15;104(4):771-6 [15959912.001]
  • [Cites] Clin Cancer Res. 2005 Dec 1;11(23):8321-5 [16322291.001]
  • [Cites] Lancet Oncol. 2006 Jan;7(1):77-82 [16389187.001]
  • [Cites] Curr Opin Oncol. 2006 May;18(3):258-65 [16552238.001]
  • [Cites] J Cell Physiol. 2006 Jun;207(3):654-9 [16447252.001]
  • [Cites] J Hum Genet. 2006;51(4):368-74 [16435073.001]
  • [Cites] J Natl Cancer Inst. 2006 Jul 19;98(14):996-1004 [16849682.001]
  • [Cites] Int J Cancer. 2006 Sep 15;119(6):1338-44 [16642472.001]
  • [Cites] Clin Cancer Res. 2006 Dec 15;12(24):7353-8 [17189407.001]
  • [Cites] Int J Oral Maxillofac Surg. 2007 Apr;36(4):350-3 [17223311.001]
  • [Cites] Cancer. 2007 Jul 1;110(1):87-95 [17520682.001]
  • [Cites] Clin Cancer Res. 2007 Oct 15;13(20):6122-9 [17947477.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2007 Nov;133(11):1131-8 [18025318.001]
  • [Cites] J Urol. 2008 Jan;179(1):346-52 [18006010.001]
  • [Cites] J Urol. 2008 Feb;179(2):743-7 [18082200.001]
  • [Cites] Clin Cancer Res. 2008 May 1;14(9):2664-72 [18451230.001]
  • [Cites] Oncol Rep. 2008 Dec;20(6):1489-95 [19020732.001]
  • [Cites] Stat Med. 1985 Jan-Mar;4(1):87-90 [3992076.001]
  • [Cites] Oncology (Williston Park). 1989 Feb;3(2):47-56; discussion 56, 58, 62 [2701410.001]
  • [Cites] Oncology (Williston Park). 1989 Mar;3(3):85-91; discussion 94, 99 [2701414.001]
  • [Cites] Am J Surg Pathol. 1997 Jun;21(6):691-7 [9199647.001]
  • [Cites] Cancer Res. 1999 Feb 15;59(4):798-802 [10029065.001]
  • [Cites] Mod Pathol. 2004 Dec;17(12):1475-82 [15195113.001]
  • [Cites] Clin Cancer Res. 2004 Dec 15;10(24):8472-8 [15623627.001]
  • [Cites] N Engl J Med. 2000 Nov 9;343(19):1350-4 [11070098.001]
  • [Cites] Cancer Res. 2001 Apr 15;61(8):3225-9 [11309270.001]
  • [Cites] Blood. 2001 May 1;97(9):2823-9 [11313277.001]
  • [Cites] Cancer Lett. 2001 Sep 10;170(1):73-9 [11448537.001]
  • [Cites] J Pathol. 2002 Jan;196(1):1-7 [11748635.001]
  • [Cites] Clin Cancer Res. 2002 Oct;8(10):3164-71 [12374684.001]
  • [Cites] Oncogene. 2003 Feb 13;22(6):924-34 [12584572.001]
  • [Cites] ORL J Otorhinolaryngol Relat Spec. 2003 Jan-Feb;65(1):26-32 [12624503.001]
  • [Cites] Nat Med. 2003 Apr;9(4):407-15 [12652295.001]
  • [Cites] Clin Cancer Res. 2003 Apr;9(4):1370-5 [12684406.001]
  • [Cites] Oncol Rep. 2003 May-Jun;10(3):555-60 [12684623.001]
  • [Cites] Cancer Res. 2003 Jul 1;63(13):3735-42 [12839967.001]
  • [Cites] Mod Pathol. 2004 Jun;17(6):637-45 [15044918.001]
  • [Cites] J Mol Diagn. 2004 Aug;6(3):180-90 [15269293.001]
  • [Cites] Clin Cancer Res. 2004 Aug 1;10(15):4933-8 [15297393.001]
  • [Cites] Cancer Res. 2000 Feb 15;60(4):892-5 [10706101.001]
  • (PMID = 20520817.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] ENG
  • [Grant] United States / NIDCD NIH HHS / DC / T32DC000027; United States / NCI NIH HHS / CA / 5P50CA096784-05; United States / NIDCR NIH HHS / DE / K08-DE018463; United States / NCI NIH HHS / CA / P50 CA096784; United States / NCI NIH HHS / CA / U01CA084986; United States / NIDCD NIH HHS / DC / T32 DC000027; United States / NIDCR NIH HHS / DE / K08 DE018463; United States / NCI NIH HHS / CA / U01 CA084986
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Tumor Suppressor Proteins
  • [Other-IDs] NLM/ PMC2877085
  •  go-up   go-down


23. Blacksin MF, White LM, Hameed M, Kandel R, Patterson FR, Benevenia J: Granular cell tumor of the extremity: magnetic resonance imaging characteristics with pathologic correlation. Skeletal Radiol; 2005 Oct;34(10):625-31
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Granular cell tumor of the extremity: magnetic resonance imaging characteristics with pathologic correlation.
  • OBJECTIVE: The purpose of this study is to delineate the magnetic resonance (MR) appearance of a granular cell tumor (GrCT) of the extremity and to correlate the imaging appearance with the microscopic findings.
  • DESIGN AND PATIENTS: A retrospective review of five patients with a histopathologic diagnosis of GrCT and pre-operative MR imaging of the neoplasm was done.
  • RESULTS: The benign subtype of GrCT is usually isointense or brighter than muscle on T1-weighted sequences, round or oval in shape, superficial in location, and 4 cm or less in size.
  • On T2-weighted sequences, benign lesions may demonstrate a high peripheral signal, as well as a central signal intensity that is isointense to muscle or suppressed fat.
  • A significant stromal component in the tumor and, hypothetically, a ribbon-like arrangement of tumor cells may influence the signal intensity demonstrated on the T1 and T2-weighted sequences.
  • The malignant subtype may demonstrate signal intensity characteristics and invasion of adjacent structures often seen with other aggressive neoplasms; sizes larger than 4 cm and association with major nerve trunks can be seen.
  • CONCLUSION: Benign GrCT has imaging characteristics which may distinguish this tumor from other soft tissue neoplasms, as well as the malignant type of this tumor.
  • [MeSH-major] Foot Diseases / pathology. Granular Cell Tumor / pathology. Hand / pathology. Shoulder / pathology. Soft Tissue Neoplasms / pathology. Thigh / pathology

  • MedlinePlus Health Information. consumer health - Foot Injuries and Disorders.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Skeletal Radiol. 1994 Jan;23 (1):63-6 [8160041.001]
  • [Cites] Cancer. 1977 Apr;39(4):1547-55 [856443.001]
  • [Cites] Ann Acad Med Singapore. 1993 May;22(3):384-6 [8373125.001]
  • [Cites] Skeletal Radiol. 1997 Feb;26(2):116-21 [9060104.001]
  • [Cites] Skeletal Radiol. 1999 Feb;28(2):96-9 [10197455.001]
  • [Cites] Cancer. 1984 Feb 1;53(3):524-9 [6692257.001]
  • [Cites] Cancer. 1962 Sep-Oct;15:936-54 [13893237.001]
  • [Cites] Clin Orthop Relat Res. 2000 Nov;(380):191-8 [11064991.001]
  • [Cites] Cancer. 1974 May;33(5):1417-22 [4823485.001]
  • [Cites] Med Oral. 2003 Aug-Oct;8(4):294-8 [12937391.001]
  • [Cites] J Surg Oncol. 1980;13(4):301-16 [6246310.001]
  • [Cites] Australas Radiol. 1995 Feb;39(1):86-9 [7695539.001]
  • (PMID = 16003548.001).
  • [ISSN] 0364-2348
  • [Journal-full-title] Skeletal radiology
  • [ISO-abbreviation] Skeletal Radiol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


24. Nazarian Y, Talmi YP, Wolf M, Horowitz Z, Bedrin L, Pfeffer R, Kronenberg J: [Recurrent pleomorphic adenomas of the parotid gland--treatment and outcome]. Harefuah; 2007 Feb;146(2):82-4, 168
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Epithelial tumors of the parotid gland comprise 3% of head and neck tumors, and 70%-80% of those are benign.
  • Pleomorphic adenoma is the most common tumor of the parotid gland.
  • Recurrence rate of pleomorphic adenomas (RPAs) following superficial parotidectomy was reported to be as high as 4%, sometimes associated with inadequate surgical treatment of the primary tumor.
  • These tumors have a very slow growth rate, and a ten-year follow-up period is mandatory.
  • [MeSH-major] Adenoma / pathology. Neoplasm Recurrence, Local / pathology. Parotid Neoplasms / pathology

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17352271.001).
  • [ISSN] 0017-7768
  • [Journal-full-title] Harefuah
  • [ISO-abbreviation] Harefuah
  • [Language] heb
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Israel
  •  go-up   go-down


25. Chen SP, Wang XP: Effect of Simotang oral liquid on anal exhaust in patients after abdominal gynecological operation. Chin J Integr Med; 2006 Sep;12(3):221-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Effect of Simotang oral liquid on anal exhaust in patients after abdominal gynecological operation.
  • OBJECTIVE: To study the effect of Simotang oral liquid and glycerin enema on the patients' bowel sound (BS) restoration and anal exhaust after abdominal gynecological operation.
  • METHOD: Ninety patients with benign tumor who had undergone gynecological operation were randomly divided into the Simotang group, treated after operation with Simotang oral liquid; the enema group, treated with glycerin enema, and the control group, non-treated.
  • CONCLUSION: Simotang oral liquid and glycerine enema both could benefit the restoration of anal exhaust and BS after abdominal operation.
  • [MeSH-major] Constipation / drug therapy. Drugs, Chinese Herbal / administration & dosage. Myoma / surgery. Postoperative Complications / drug therapy. Uterine Neoplasms / surgery
  • [MeSH-minor] Abdomen. Administration, Oral. Adolescent. Adult. Aged. Enema. Female. Gastrointestinal Motility / drug effects. Glycerol / administration & dosage. Humans. Middle Aged. Pregnancy. Pregnancy, Ectopic / surgery

  • MedlinePlus Health Information. consumer health - After Surgery.
  • MedlinePlus Health Information. consumer health - Constipation.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • Hazardous Substances Data Bank. GLYCERIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17005087.001).
  • [ISSN] 1672-0415
  • [Journal-full-title] Chinese journal of integrative medicine
  • [ISO-abbreviation] Chin J Integr Med
  • [Language] eng
  • [Publication-type] Journal Article; Randomized Controlled Trial
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Drugs, Chinese Herbal; PDC6A3C0OX / Glycerol
  •  go-up   go-down


26. Angiero F, Mellone P, Baldi A, Stefani M: Osteoblastoma of the jaw: report of two cases and review of the literature. In Vivo; 2006 Sep-Oct;20(5):665-70
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Osteoblastoma is a benign bone tumor of osteoblastic origin.
  • Both tumors were resected with wide surgical margins and neither patient had adjuvant radiation or chemotherapy.
  • Differential diagnosis and immunohistochemical features potentially useful for refining diagnosis of osteoblastoma are also discussed.
  • [MeSH-major] Biomarkers, Tumor / analysis. Jaw Neoplasms / pathology. Osteoblastoma / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17091775.001).
  • [ISSN] 0258-851X
  • [Journal-full-title] In vivo (Athens, Greece)
  • [ISO-abbreviation] In Vivo
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


27. Ramos LM, Cardoso SV, Loyola AM, Rocha MA, Durighetto-Júnior AF: Keratoacanthoma of the inferior lip: review and report of case with spontaneous regression. J Appl Oral Sci; 2009 May-Jun;17(3):262-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Keratoacanthoma (KA) is a self-limited benign epithelial proliferative lesion that eventually presents with very similar clinical features to squamous cell carcinoma.
  • This article reports the case of a 40-year-old female patient presenting with an exophytic ulcerative tumor in her lower lip that resolved after incisional biopsy.
  • [MeSH-minor] Adult. Carcinoma, Squamous Cell / diagnosis. Diagnosis, Differential. Female. Humans. Lip Neoplasms / diagnosis. Remission, Spontaneous

  • Genetic Alliance. consumer health - Keratoacanthoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19466263.001).
  • [ISSN] 1678-7765
  • [Journal-full-title] Journal of applied oral science : revista FOB
  • [ISO-abbreviation] J Appl Oral Sci
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Brazil
  • [Number-of-references] 11
  • [Other-IDs] NLM/ PMC4399544
  •  go-up   go-down


28. Weinreb I: Low grade glandular lesions of the sinonasal tract: a focused review. Head Neck Pathol; 2010 Mar;4(1):77-83
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • While most biopsies or resections encountered routinely consist of common diagnoses such as inflammatory polyps and papillomas, occasional cases are more difficult, and separating reactive or benign from malignancy can be challenging.
  • LGSNAC is a diverse group of bland tubular and/or papillary tumors, which have a recurrence potential but an as yet uncertain potential for metastasis or mortality.
  • However, complicating this category are controversies surrounding their nature as reactive lesions versus neoplasms, the histologic and immunohistochemical overlap, and possible precursor relationships between some of them.
  • [MeSH-major] Hamartoma / diagnosis. Nose Diseases / diagnosis. Paranasal Sinus Neoplasms / pathology. Paranasal Sinuses / pathology
  • [MeSH-minor] Biomarkers, Tumor / metabolism. Diagnosis, Differential. Humans. Nasal Cavity / metabolism. Nasal Cavity / pathology

  • MedlinePlus Health Information. consumer health - Nose Injuries and Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Virchows Arch. 2003 Aug;443(2):152-8 [12827515.001]
  • [Cites] Histopathology. 2000 Apr;36(4):376-7 [10841649.001]
  • [Cites] Laryngoscope. 1983 Apr;93(4):494-7 [6834978.001]
  • [Cites] Am J Surg Pathol. 1991 Apr;15(4):368-75 [2006716.001]
  • [Cites] Head Neck. 1992 Jul-Aug;14(4):321-7 [1517084.001]
  • [Cites] Ann Otol Rhinol Laryngol. 1995 Aug;104(8):639-45 [7639474.001]
  • [Cites] Hum Genet. 1996 Feb;97(2):240-3 [8566961.001]
  • [Cites] Int J Pediatr Otorhinolaryngol. 2005 Jan;69(1):87-91 [15627453.001]
  • [Cites] Am J Surg Pathol. 2006 Dec;30(12):1576-80 [17122514.001]
  • [Cites] Am J Rhinol. 2006 Nov-Dec;20(6):586-90 [17181098.001]
  • [Cites] Arch Pathol Lab Med. 2007 Apr;131(4):530-7 [17425380.001]
  • [Cites] Histopathology. 2009 Jan;54(2):205-13 [19207945.001]
  • [Cites] Am J Surg Pathol. 2009 Mar;33(3):401-8 [19011560.001]
  • [Cites] J Clin Pathol. 2009 Dec;62(12):1085-95 [19946095.001]
  • [Cites] Hum Pathol. 1999 Oct;30(10):1140-5 [10534159.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1974 Nov;38(5):760-2 [4530965.001]
  • (PMID = 20237993.001).
  • [ISSN] 1936-0568
  • [Journal-full-title] Head and neck pathology
  • [ISO-abbreviation] Head Neck Pathol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  • [Number-of-references] 18
  • [Other-IDs] NLM/ PMC2825529
  •  go-up   go-down


29. Shantaram M, Rao A, Aroor AR, Raja A, Rao S, Monteiro F: Assessment of total sialic acid and lipid-bound sialic acid in management of brain tumors. Ann Indian Acad Neurol; 2009 Jul;12(3):162-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Assessment of total sialic acid and lipid-bound sialic acid in management of brain tumors.
  • BACKGROUND: Glycoconjugate molecules expressed at the plasma membrane of mammalian cells have been reported to be associated with tumor progression.
  • The measurement of total sialic acid (TSA) and lipid-bound sialic acid (LBSA) in the cerebrospinal fluid (CSF) is suggested to be useful for the diagnosis of brain tumors.
  • But there are very few reports available on the serum glycoconjugate levels in patients with brain tumors.
  • OBJECTIVE: The objective of this study is to check the feasibility of using serum glycoconjugates such as TSA and LBSA as tumor markers in brain tumor patients.
  • MATERIALS AND METHODS: Colorimetric estimation of TSA using diphenylamine was done on 100 patients with intracranial tumors; follow-up study was carried out in 24 cases.
  • The LBSA fraction was isolated from the serum of 68 brain tumor patients and evaluated using phosphotungstic acid and resorcinol; follow-up study was done on 23 patients.
  • The various types of brain tumors included in this study were glioma, meningioma, and acoustic neurinoma as well as some other types such as medulloblastoma, secondary tumors, and craniopharyngioma.
  • DISCUSSION: TSA and LBSA do not have the ability to discriminate between benign and malignant brain tumors.
  • TSA and LBSA appear to be tumor markers of very limited value in patients with brain tumors.

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int Urol Nephrol. 1992;24(2):125-9 [1624255.001]
  • [Cites] Cancer Lett. 1991 Jun 14;58(1-2):91-100 [2049789.001]
  • [Cites] J Oral Maxillofac Surg. 1991 Aug;49(8):843-7 [2072195.001]
  • [Cites] Dis Colon Rectum. 1990 Feb;33(2):139-42 [2298100.001]
  • [Cites] Adv Cancer Res. 1989;52:257-331 [2662714.001]
  • [Cites] Bull Soc Sci Med Grand Duche Luxemb. 1989 Mar-Apr;126(1):17-20 [2663215.001]
  • [Cites] Thyroid. 2005 Jul;15(7):645-52 [16053379.001]
  • [Cites] Clin Biochem. 2005 Jun;38(6):535-9 [15885233.001]
  • [Cites] J Natl Cancer Inst. 2000 Jun 7;92(11):912-7 [10841826.001]
  • [Cites] Res Commun Chem Pathol Pharmacol. 1980 Oct;30(1):171-80 [7433766.001]
  • [Cites] Cancer. 1982 Nov 1;50(9):1815-9 [7116306.001]
  • [Cites] Clin Biochem. 1980 Oct;13(5):191-7 [7006855.001]
  • [Cites] Anticancer Res. 1984 Jul-Oct;4(4-5):313-6 [6486735.001]
  • [Cites] Cancer. 1986 Apr 1;57(7):1389-94 [3948121.001]
  • [Cites] Int J Biol Markers. 1988 Oct-Dec;3(4):243-8 [3235852.001]
  • [Cites] Clin Chim Acta. 1988 Sep 15;176(3):251-7 [3180477.001]
  • [Cites] Neurol Res. 1986 Jun;8(2):123-6 [2875407.001]
  • [Cites] Obstet Gynecol. 1988 Jan;71(1):20-6 [2827081.001]
  • [Cites] Biochim Biophys Acta. 2008 Mar;1780(3):421-33 [17991443.001]
  • (PMID = 20174496.001).
  • [ISSN] 1998-3549
  • [Journal-full-title] Annals of Indian Academy of Neurology
  • [ISO-abbreviation] Ann Indian Acad Neurol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC2824932
  • [Keywords] NOTNLM ; Brain tumors / lipid-bound sialic acid / total sialic acid / tumor markers
  •  go-up   go-down


30. De Oliveira Junior PA, Moreira A, Brum M, Chaves A, Santos FA, Groppo FC: Modified surgical approach for removal of an ivory osteoma in the paranasal sinus. A case report. Minerva Stomatol; 2008 Mar;57(3):127-31
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Osteomas are benign tumors that consist mainly of mature compact or cancellous bone.
  • After tumor removal and drainage of frontal and ethmoidal sinuses, the bone flap was repositioned using titanium microplates and screws.
  • [MeSH-major] Osteoma / surgery. Paranasal Sinus Neoplasms / surgery
  • [MeSH-minor] Adolescent. Humans. Male. Oral Surgical Procedures / methods. Osteotomy / methods

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18427381.001).
  • [ISSN] 0026-4970
  • [Journal-full-title] Minerva stomatologica
  • [ISO-abbreviation] Minerva Stomatol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


31. Gyulai-Gaál S, Takács D, Szabó G, Suba Z: Mixed odontogenic tumors in children and adolescents. J Craniofac Surg; 2007 Nov;18(6):1338-42
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mixed odontogenic tumors in children and adolescents.
  • The typical forms of mixed odontogenic tumors in the jaws of children and adolescents are ameloblastic fibroma, ameloblastic fibroodontoma, complex odontoma, and compound odontoma.
  • Ameloblastic fibromas (AFs) are true, mixed, soft tissue neoplasms, deriving from the proliferation of both odontogenic epithelium and mesenchyma.
  • Odontomas are calcifying benign hamartomas and represent the most common type of odontogenic jaw tumors among patients less than 20 years old.
  • In the present study, mixed odontogenic tumor cases are presented in patients under 20 years old.
  • [MeSH-major] Mandibular Neoplasms / pathology. Maxillary Neoplasms / pathology. Odontogenic Tumors / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17993878.001).
  • [ISSN] 1049-2275
  • [Journal-full-title] The Journal of craniofacial surgery
  • [ISO-abbreviation] J Craniofac Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


32. Pozzi EC, Altermatt HJ, Rees TD, Bornstein MM: Exophytic mass of the gingiva as the first manifestation of metastatic pulmonary adenocarcinoma. J Periodontol; 2008 Jan;79(1):187-91
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Metastasis of a malignant tumor to the oral cavity is rare, but it can be the first manifestation of a primary tumor.
  • Because the differentiation between carcinoma and sarcoma of spindle cell tumors was difficult, additional immunohistochemical evaluation was performed.
  • The intraoral healing after tumor removal was uneventful.
  • Finally, a biopsy of the lungs confirmed a poorly differentiated adenocarcinoma with multiple metastases, including the oral cavity.
  • CONCLUSIONS: An exophytic lesion on the gingiva can be the first sign of metastatic adenocarcinoma to the oral mucosa.
  • This case emphasizes that even apparently benign-looking gingival lesions in anamnestically healthy patients need to be examined histopathologically.
  • [MeSH-major] Adenocarcinoma / secondary. Gingival Neoplasms / secondary. Lung Neoplasms / diagnosis
  • [MeSH-minor] Biopsy. Diagnosis, Differential. Fatal Outcome. Female. Homeodomain Proteins / analysis. Humans. Immunohistochemistry. Keratin-7 / analysis. Mandible. Middle Aged. Nuclear Proteins / analysis. Transcription Factors / analysis

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18166110.001).
  • [ISSN] 0022-3492
  • [Journal-full-title] Journal of periodontology
  • [ISO-abbreviation] J. Periodontol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Homeodomain Proteins; 0 / Keratin-7; 0 / Nuclear Proteins; 0 / Transcription Factors; 0 / thyroid nuclear factor 1
  •  go-up   go-down


33. González-García R, Rodríguez-Campo FJ, Naval-Gías L, Sastre-Pérez J, Muñoz-Guerra MF, Usandizaga JL, Díaz-González FJ: Radial forearm free flap for reconstruction of the oral cavity: clinical experience in 55 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Jul;104(1):29-37
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Radial forearm free flap for reconstruction of the oral cavity: clinical experience in 55 cases.
  • OBJECTIVE: Since the advent of modern microvascular techniques, the radial forearm free flap (RFFF) has become a reliable method for reconstruction of defects within the oral cavity.
  • The purpose of the present study was to evaluate our experience with the use of the RFFF for the reconstruction of oral cavity defects after tumor resection.
  • STUDY DESIGN: During a 9-year period, 103 consecutive patients were treated in our department for the reconstruction of oral defects after tumoral ablation by means of microvascularized free flaps.
  • Patients were treated for benign (n = 1) and malignant (n = 54) entities.
  • RESULTS: Fifty-five patients underwent reconstruction by means of the RFFF after resection of the oral cavity.
  • CONCLUSION: Our results revealed that the RFFF is a reliable method for reconstructing a wide range of oral cavity defects with an acceptable low morbidity rate.
  • It provides adequate bulkiness and pliability, resulting in adequate reconstruction of a wide variety of defects within the oral cavity.
  • [MeSH-major] Mouth / surgery. Mouth Neoplasms / surgery. Postoperative Complications. Reconstructive Surgical Procedures / methods. Skin Transplantation / methods. Surgical Flaps

  • MedlinePlus Health Information. consumer health - After Surgery.
  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • MedlinePlus Health Information. consumer health - Plastic and Cosmetic Surgery.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17197203.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


34. McGregor D: Hydroquinone: an evaluation of the human risks from its carcinogenic and mutagenic properties. Crit Rev Toxicol; 2007;37(10):887-914
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Hydroquinone has been shown reproducibly to induce benign neoplasms in the kidneys of male F344 rats dosed orally either by gavage (25 and 50 mg/kg body weight) or diet (0.8%).
  • This evaluation showed that all renal tubule adenomas and all cases of renal tubule atypical hyperplasia occurred in areas of severe or end-stage chronic progressive nephropathy and that the neoplasms were not otherwise confined to any particular part of the kidney.
  • There were five studies by the oral route.
  • These included a mouse bone-marrow cell micronucleus test in which a weak, marginally positive response was obtained following a single oral dose of 80 mg/kg body weight.
  • The remaining oral route studies all showed no significant effect.
  • They included a mouse bone-marrow cell micronucleus test in which there was no genotoxic activity after exposure to a diet containing 0.8% hydroquinone for 6 days; two (32)P-post-labeling assays, one with targets of Zymbal gland, liver, and spleen in Sprague-Dawley rats, the other with the kidney as target in F344 rats; and the last oral assay was for 8-hydroxydeoxyguanosine adducts in F344 rat kidney DNA.
  • While glutathione conjugates could be responsible for the tumor induction, careful histology seems to show that the most actively toxic of several glutathione compounds tested, 2,3,5-triglutathion-S-yl hydroquinone, targets a very specific region of the kidney, the outer stripe of the outer medulla (OSOM), whereas hydroquinone-associated adenomas are more randomly distributed and occur in the cortex as well as the medulla.

  • Hazardous Substances Data Bank. HYDROQUINONE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18027166.001).
  • [ISSN] 1040-8444
  • [Journal-full-title] Critical reviews in toxicology
  • [ISO-abbreviation] Crit. Rev. Toxicol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Carcinogens; 0 / Hydroquinones; 0 / Mutagens; 123-31-9 / hydroquinone
  • [Number-of-references] 169
  •  go-up   go-down


35. de Vicente Rodríguez JC, Fresno Forcelledo MF, González García M, Aguilar Andrea C: Sebaceous adenoma of the parotid gland. Med Oral Patol Oral Cir Bucal; 2006 Aug;11(5):E446-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Tumors of the salivary glands constitute an important field of oral and maxillofacial pathology.
  • The majority of salivary gland neoplasms are benign, with malignant salivary tumors accounting for 15 to 32 percent.
  • The most common site for salivary gland tumors is the parotid gland, accounting up to 80 percent of all cases.
  • The tumor was composed of epithelial cells lining ducts and closely associated with broad areas of sebaceous differentiation.
  • The presence of sebaceous glands in salivary neoplasms is frequent, however, and in spite of this, salivary neoplasms constituted partially or entirely of these cells are rarely observed.
  • To the surgeon and pathologist, the major problem in dealing with sebaceous adenoma is the recognition of this rare entity, avoiding confusing with other more aggressive neoplasms.
  • [MeSH-major] Adenoma / pathology. Parotid Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16878064.001).
  • [ISSN] 1698-6946
  • [Journal-full-title] Medicina oral, patología oral y cirugía bucal
  • [ISO-abbreviation] Med Oral Patol Oral Cir Bucal
  • [Language] eng; spa
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


36. Qiu MZ, Yuan ZY, Luo HY, Ruan DY, Wang ZQ, Wang FH, Li YH, Xu RH: Impact of pretreatment hematologic profile on survival of colorectal cancer patients. Tumour Biol; 2010 Aug;31(4):255-60
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Pretreatment hematologic abnormalities have been reported to have prognostic value in patients with solid tumors.
  • We identified 363 patients with colorectal cancer and 315 patients with benign diseases for the final analysis.
  • The percentages of leukocytosis, anemia, and thrombocytosis were significantly higher in colorectal cancer patients than in patients with benign diseases.
  • Univariate analysis showed that advanced tumor stages, leukocytosis, anemia, thrombocytosis, and low histological grade were all significantly associated with shorter survival.
  • The multivariate Cox analysis revealed that low histological grade, tumor stage, pretreatment anemia, and thrombocytosis remained independent prognostic variables for survival.
  • [MeSH-major] Anemia / diagnosis. Colorectal Neoplasms / mortality. Colorectal Neoplasms / pathology. Leukocytosis / diagnosis. Thrombocytosis / diagnosis

  • Genetic Alliance. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Anemia.
  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Tex Med. 1990 Oct;86(10):80-3 [2247849.001]
  • [Cites] Clin Otolaryngol. 2008 Jun;33(3):245-51 [18559031.001]
  • [Cites] Cancer. 2001 Jun 15;91(12):2214-21 [11413508.001]
  • [Cites] Thromb Haemost. 2003 Jun;89(6):1098-106 [12783124.001]
  • [Cites] Eur Respir J. 1996 Sep;9(9):1826-30 [8880098.001]
  • [Cites] Thromb Haemost. 1998 May;79(5):916-8 [9609220.001]
  • [Cites] Ann Oncol. 2005 Jun;16(6):988-9 [15879160.001]
  • [Cites] Oncology. 2000 Feb;58(2):169-74 [10705245.001]
  • [Cites] Cancer. 2001 Nov 1;92(9):2399-405 [11745296.001]
  • [Cites] Cancer. 2005 Apr 15;103(8):1740-6 [15742330.001]
  • [Cites] Semin Oncol. 1998 Jun;25(3 Suppl 7):2-6 [9671322.001]
  • [Cites] Urology. 2004 Mar;63(3):447-50 [15028435.001]
  • [Cites] Thromb Haemost. 1990 Dec 28;64(4):501-5 [1964750.001]
  • [Cites] Tumour Biol. 2000 Sep-Oct;21(5):309-14 [10940827.001]
  • [Cites] Gynecol Oncol. 2004 Jan;92(1):211-4 [14751160.001]
  • [Cites] J Am Coll Surg. 2004 May;198(5):737-41 [15110807.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2003 Jul 1;56(3):778-87 [12788185.001]
  • [Cites] J Cancer Res Clin Oncol. 2009 Dec;135(12):1783-90 [19551407.001]
  • [Cites] Clin Chim Acta. 2007 May 1;380(1-2):208-12 [17368603.001]
  • [Cites] JAMA. 1982 Feb 19;247(7):1004-6 [7035703.001]
  • [Cites] Ann Surg Oncol. 2002 Apr;9(3):287-91 [11923136.001]
  • [Cites] J Cell Mol Med. 2009 Mar;13(3):555-61 [18429933.001]
  • [Cites] J Clin Epidemiol. 1996 Dec;49(12):1373-9 [8970487.001]
  • [Cites] Oral Oncol. 2007 Mar;43(3):283-8 [16920387.001]
  • [Cites] Neuro Oncol. 2007 Jul;9(3):335-42 [17504931.001]
  • [Cites] Hepatogastroenterology. 2004 May-Jun;51(57):847-53 [15143932.001]
  • [Cites] Nat Cell Biol. 2008 Mar;10 (3):295-305 [18297062.001]
  • (PMID = 20336401.001).
  • [ISSN] 1423-0380
  • [Journal-full-title] Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
  • [ISO-abbreviation] Tumour Biol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


37. Curien R, Moizan H, Gerard E: Gingival metastasis of a bronchogenic adenocarcinoma: report of a case. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Dec;104(6):e25-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The diagnostic assumptions considered were those of a pyogenic granuloma, of a primary gingival carcinoma, or of a metastasis of the bronchial tumor.
  • An excisional biopsy was carried out and the histopathologic examination confirmed the latter diagnosis.
  • The main clinical diagnostic difficulty is the distinction between benign lesion and malignant lesion, and between primary lesion and metastasis.
  • Even if gingival metastases are rare, their semiological value incites the histopathologic examination of any presumedly benign tumor of the gingiva.
  • [MeSH-major] Carcinoma, Bronchogenic / secondary. Gingival Neoplasms / secondary. Lung Neoplasms
  • [MeSH-minor] Diagnosis, Differential. Humans. Middle Aged

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17942337.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


38. Dilbaz B, Bayoglu Y, Oral S, Cavusoglu D, Uluoglu O, Dilbaz S: Laparoscopic resection of urinary bladder paraganglioma: a case report. Surg Laparosc Endosc Percutan Tech; 2006 Feb;16(1):58-61
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Tumor markers were within normal range.
  • Frozen section was performed revealing a benign cystic structure but the identification of the origin was left to definitive histopathological examination which showed paraganglioma of the bladder.
  • Immunohistochemically, the tumor cells were strongly positive for chromogranin A and synaptophysin and there was focal positiveness for neuron specific enolase although vimentin and cytokeratin were negative.
  • [MeSH-major] Paraganglioma / surgery. Urinary Bladder Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16552385.001).
  • [ISSN] 1530-4515
  • [Journal-full-title] Surgical laparoscopy, endoscopy & percutaneous techniques
  • [ISO-abbreviation] Surg Laparosc Endosc Percutan Tech
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


39. Grajkowska W, Kotulska K, Jurkiewicz E, Matyja E: Brain lesions in tuberous sclerosis complex. Review. Folia Neuropathol; 2010;48(3):139-49
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Tuberous sclerosis complex (TSC) is an autosomal dominant, multisystem disease characterized by the development of multiple hamartomas and benign or rarely malignant neoplasms distributed at various sites throughout the body, especially in the brain, skin, retina, kidney, heart, and lungs.
  • The clinical presentations of TSC result from mutations in either of two tumour suppressor genes: TSC1 (located on 9q34) or TSC2 (located on 16p13).
  • Oral rapamycin therapy may induce regression of astrocytomas associated with TSC.
  • In this review, the clinicopathological features of TCS and recent advantages in the diagnosis and genetics of TSC are presented.


40. Bulut AS, Erden E, Sak SD, Doruk H, Kursun N, Dincol D: Significance of inducible nitric oxide synthase expression in benign and malignant breast epithelium: an immunohistochemical study of 151 cases. Virchows Arch; 2005 Jul;447(1):24-30
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Significance of inducible nitric oxide synthase expression in benign and malignant breast epithelium: an immunohistochemical study of 151 cases.
  • We found that 78% of malignant and 75% of benign cases showed iNOS immunoreactivity.
  • However, the intensity and the quantity of iNOS expression were significantly higher in the cancer group when compared with benign breasts (P<0.001), suggesting a role of iNOS in breast carcinogenesis.
  • We were unable to show a correlation between iNOS expression and tumor grade, axillary lymph node status, and estrogen receptor expression.
  • [MeSH-major] Breast / enzymology. Breast Neoplasms / enzymology. Carcinoma, Ductal, Breast / enzymology. Fibroadenoma / enzymology. Nitric Oxide Synthase / metabolism

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J Oncol. 1999 Jun;14(6):1069-73 [10339659.001]
  • [Cites] J Surg Oncol. 1999 Apr;70(4):222-9 [10219017.001]
  • [Cites] APMIS. 2003 Dec;111(12):1137-46 [14678024.001]
  • [Cites] Cancer. 2002 Sep 15;95(6):1191-8 [12216084.001]
  • [Cites] Breast Cancer Res Treat. 1999 Jul;56(2):145-51 [10573107.001]
  • [Cites] Urol Oncol. 2003 Mar-Apr;21(2):117-22 [12856639.001]
  • [Cites] Cancer. 1998 May 15;82(10):1897-903 [9587122.001]
  • [Cites] Virchows Arch. 2000 Dec;437(6):662-6 [11193479.001]
  • [Cites] Hypertension. 1994 Jun;23(6 Pt 2):1121-31 [7515853.001]
  • [Cites] Acta Neuropathol. 2003 Apr;105(4):333-40 [12624786.001]
  • [Cites] J Clin Pathol. 2000 Aug;53(8):634-5 [11002770.001]
  • [Cites] Br J Cancer. 2000 Oct;83(7):880-6 [10970689.001]
  • [Cites] Scand J Gastroenterol. 2000 Nov;35(11):1204-11 [11145294.001]
  • [Cites] World J Gastroenterol. 2004 Mar 1;10(5):725-8 [14991947.001]
  • [Cites] Am Surg. 2001 Jul;67(7):709-13 [11450795.001]
  • [Cites] Int J Cancer. 2000 Apr 1;86(1):30-9 [10728591.001]
  • [Cites] Pathol Int. 2003 Jul;53(7):434-9 [12828608.001]
  • [Cites] Gynecol Oncol. 2004 Mar;92(3):806-12 [14984945.001]
  • [Cites] Clin Cancer Res. 2000 Dec;6(12):4768-75 [11156233.001]
  • [Cites] Int J Oral Maxillofac Surg. 2003 Oct;32(5):534-8 [14759114.001]
  • [Cites] Asian J Surg. 2004 Jan;27(1):10-7 [14719508.001]
  • [Cites] BJU Int. 2000 Aug;86(3):234-9 [10930922.001]
  • [Cites] Lab Invest. 1999 Oct;79(10):1215-25 [10532585.001]
  • [Cites] Essays Biochem. 1997;32:61-72 [9493011.001]
  • [Cites] Oncol Rep. 2002 May-Jun;9(3):521-4 [11956620.001]
  • [Cites] Ai Zheng. 2003 Sep;22(9):978-81 [12969533.001]
  • [Cites] Eur J Surg Oncol. 2003 Sep;29(7):619-23 [12943630.001]
  • [Cites] Thyroid. 1999 Feb;9(2):113-7 [10090309.001]
  • [Cites] Eur J Cancer. 2005 Jan;41(2):265-71 [15661552.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2003 Sep 1;57(1):217-21 [12909236.001]
  • [Cites] Arch Surg. 1999 Mar;134(3):245-51 [10088562.001]
  • [Cites] J Gastroenterol Hepatol. 2002 Aug;17(8):914-21 [12164968.001]
  • [Cites] Mod Pathol. 1997 Jul;10(7):645-9 [9237172.001]
  • [Cites] Ann Anat. 2003 Dec;185(6):549-54 [14704000.001]
  • [Cites] J Zhejiang Univ Sci. 2003 Mar-Apr;4(2):221-7 [12659238.001]
  • [Cites] Br J Cancer. 1998 Aug;78(4):534-41 [9716040.001]
  • [Cites] Clin Cancer Res. 2000 Jun;6(6):2408-16 [10873093.001]
  • [Cites] Laryngoscope. 2002 Jun;112(6):1084-8 [12160278.001]
  • [Cites] Virchows Arch. 2000 Feb;436(2):109-14 [10755599.001]
  • (PMID = 15947943.001).
  • [ISSN] 0945-6317
  • [Journal-full-title] Virchows Archiv : an international journal of pathology
  • [ISO-abbreviation] Virchows Arch.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] EC 1.14.13.39 / NOS2 protein, human; EC 1.14.13.39 / Nitric Oxide Synthase; EC 1.14.13.39 / Nitric Oxide Synthase Type II
  •  go-up   go-down


41. Gómez Oliveira G, García-Rozado A, Luaces Rey R: Intraosseous mandibular hemangioma. A case report and review of the literature. Med Oral Patol Oral Cir Bucal; 2008 Aug;13(8):E496-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Intraosseous vascular lesions are rare conditions, comprising only 0.5% to 1% of all intraosseous tumors.
  • According to the World Health Organization, hemangiomas are benign vasoformative neoplasms of endothelial origin.
  • Some authors believe that it is a true neoplasm, whereas others state it is a hamartomatous lesion.
  • Differential diagnosis includes neoplasms such as ameloblastoma, cystic lesions such as residual cyst, keratocyst and fibro-osseous lesions such as fibrous dysplasia.
  • Clinical, radiological and histological features of this unusual tumor are described.
  • [MeSH-major] Hemangioma. Mandibular Neoplasms

  • Genetic Alliance. consumer health - Hemangioma.
  • MedlinePlus Health Information. consumer health - Birthmarks.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18667983.001).
  • [ISSN] 1698-6946
  • [Journal-full-title] Medicina oral, patología oral y cirugía bucal
  • [ISO-abbreviation] Med Oral Patol Oral Cir Bucal
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Spain
  • [Number-of-references] 10
  •  go-up   go-down


42. Habibi A, Saghravanian N, Zare R, Jafarzadeh H: Clear cell variant of extraosseous calcifying epithelial odontogenic tumor: a case report. J Oral Sci; 2009 Sep;51(3):485-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clear cell variant of extraosseous calcifying epithelial odontogenic tumor: a case report.
  • Calcifying epithelial odontogenic tumor (CEOT) is a benign epithelial odontogenic tumor occurring most frequently in the posterior part of the lower jaw.
  • Extraosseous CEOT is one of the rarest forms of this tumor, and few such cases involving the maxillary gingiva have been reported in the literature.
  • Histologically, the tumor showed proliferation of sheets and cords of epithelial cells with granular, eosinophilic cytoplasm and round to oval nuclei.
  • The present case of extraosseous CEOT with clear cells was considered to be a very rare form of this tumor.
  • [MeSH-major] Gingival Neoplasms / pathology. Odontogenic Tumors / pathology

  • Genetic Alliance. consumer health - Calcifying Epithelial Odontogenic Tumor.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19776521.001).
  • [ISSN] 1880-4926
  • [Journal-full-title] Journal of oral science
  • [ISO-abbreviation] J Oral Sci
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


43. Jaswal A, Jana AK, Biswas M, Sikder B, Nandi TK: Recurrent odontogenic myxoma of maxilla: a diagnostic and operative dilemma. Indian J Otolaryngol Head Neck Surg; 2008 Mar;60(1):41-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • It is a slow growing benign, locally malignant tumor notorious for recurrence.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Br J Oral Maxillofac Surg. 1994 Oct;32(5):298-302 [7999737.001]
  • [Cites] Head Neck. 1996 Sep-Oct;18(5):459-64 [8864738.001]
  • [Cites] Eur J Radiol. 2001 Jan;37(1):1-4 [11274831.001]
  • (PMID = 23120497.001).
  • [ISSN] 2231-3796
  • [Journal-full-title] Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India
  • [ISO-abbreviation] Indian J Otolaryngol Head Neck Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC3450724
  • [Keywords] NOTNLM ; Maxilla / Odontogenic myxoma / Recurrent
  •  go-up   go-down


44. Hwang HS, Lee WJ, Lim HK, Chun HK, Ahn GH: Chondrolipoma in the pelvic cavity: a case report. Korean J Radiol; 2008 Nov-Dec;9(6):563-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Chondrolipoma in the pelvic cavity: a case report.
  • A chondrolipoma is an extremely rare form of a benign mesenchymal tumor containing mature cartilage and fatty tissue.
  • However, to the best of our knowledge, chondrolipomas located in the pelvic cavity have not been reported.
  • [MeSH-major] Chondroma / diagnosis. Lipoma / diagnosis. Mesenchymoma / diagnosis. Pelvic Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Histopathology. 1999 Nov;35(5):478-9 [10583567.001]
  • [Cites] Int Orthop. 2000;24(2):115-7 [10894384.001]
  • [Cites] Skeletal Radiol. 2000 Aug;29(8):459-65 [11026714.001]
  • [Cites] Ear Nose Throat J. 2001 Mar;80(3):146-7 [11269216.001]
  • [Cites] J Dermatol. 2003 Mar;30(3):189-95 [12692354.001]
  • [Cites] Clin Imaging. 2004 May-Jun;28(3):206-8 [15158226.001]
  • [Cites] J Pediatr Surg. 2007 Oct;42(10):E21-3 [17923184.001]
  • [Cites] Int J Oral Maxillofac Surg. 1997 Apr;26(2):127-8 [9151169.001]
  • [Cites] J Dermatol. 2006 Mar;33(3):202-6 [16620227.001]
  • [Cites] Breast. 2006 Jun;15(3):425-6 [16131470.001]
  • [Cites] J Dermatol. 2007 Aug;34(8):570-2 [17683390.001]
  • [Cites] J Comp Pathol. 2007 Aug-Oct;137(2-3):160-4 [17822652.001]
  • [Cites] Cancer. 1990 Dec 15;66(12):2636-41 [2249203.001]
  • (PMID = 19039275.001).
  • [ISSN] 1229-6929
  • [Journal-full-title] Korean journal of radiology
  • [ISO-abbreviation] Korean J Radiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Korea (South)
  • [Other-IDs] NLM/ PMC2627234
  •  go-up   go-down


45. Cakarer S, Selvi F, Isler SC, Soluk M, Olgac V, Keskin C: Intraosseous lipoma of the mandible: a case report and review of the literature. Int J Oral Maxillofac Surg; 2009 Aug;38(8):900-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Intraosseous lipoma is a benign tumor of the bone.
  • Diagnosis is based on clinical, radiological and histopathological features.
  • [MeSH-major] Lipoma / diagnosis. Mandibular Neoplasms / diagnosis
  • [MeSH-minor] Cementoma / diagnosis. Diagnosis, Differential. Female. Follow-Up Studies. Granuloma, Giant Cell / diagnosis. Humans. Mandibular Diseases / diagnosis. Middle Aged. Odontogenic Cysts / diagnosis. Odontogenic Tumors / diagnosis. Radiography, Panoramic

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19386471.001).
  • [ISSN] 1399-0020
  • [Journal-full-title] International journal of oral and maxillofacial surgery
  • [ISO-abbreviation] Int J Oral Maxillofac Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Denmark
  • [Number-of-references] 10
  •  go-up   go-down


46. Chen Y, Tian K, Geng N, Yang MZ, Zhang WP: [The expression of matrix metalloproteinases and their tissue inhibitors in pleomorphic adenoma]. Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Jan;40(1):58-61
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: To examine the expression of MMPs and TIMPs in pleomorphic adenoma of salivary gland and to investigate the relationship between the expression and the biological behaviour of the tumor.
  • Immunohistochemistry for MMP-2, MMP-9, TIMP-1, TIMP-2 and gelatin zymography analysis were performed in these 23 cases and in 6 malignant and 6 benign salivary gland tumors.
  • There was no significant difference in expression of MMP-2, MMP-9, TIMP-1 and TIMP-2 between the salivary malignant tumor and active pleomorphic adenoma, also between the salivary benign tumor and common pleomorphic adenoma.
  • [MeSH-major] Adenoma, Pleomorphic / metabolism. Matrix Metalloproteinase 2 / metabolism. Matrix Metalloproteinase 9 / metabolism. Salivary Gland Neoplasms / metabolism. Tissue Inhibitor of Metalloproteinase-1 / metabolism. Tissue Inhibitor of Metalloproteinase-2 / metabolism

  • MedlinePlus Health Information. consumer health - Salivary Gland Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15774155.001).
  • [ISSN] 1002-0098
  • [Journal-full-title] Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology
  • [ISO-abbreviation] Zhonghua Kou Qiang Yi Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Tissue Inhibitor of Metalloproteinase-1; 127497-59-0 / Tissue Inhibitor of Metalloproteinase-2; EC 3.4.24.24 / MMP2 protein, human; EC 3.4.24.24 / Matrix Metalloproteinase 2; EC 3.4.24.35 / Matrix Metalloproteinase 9
  •  go-up   go-down


47. Colella G, Tozzi U, Pagliarulo V, Bove P: Warthin tumor: a potential source of diagnostic error. J Craniofac Surg; 2010 Nov;21(6):1978-81
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Warthin tumor: a potential source of diagnostic error.
  • PURPOSE: Warthin tumor, also known as papillary cystadenoma lymphomatosum, is a fairly common tumor.
  • It makes up 14% to 30% of parotid tumors.
  • There has been much interest in this tumor because of its typical and intriguing morphologic features: the association of benign-looking lymphoid and epithelial components and its frequent occurrence in the intraparotid or periparotid lymph nodes.
  • Moreover, multifocal and/or bilateral Warthin tumors have been reported, and malignant transformation of Warthin tumor and its association with other malignancies have been documented.
  • Warthin tumor can sometimes be confused with other pathologic lesions because of symptoms and signs that accompany the disease, so it could be treated as other pathologic lesions.
  • The first one had a differentiated squamous cell carcinoma, no lymph node metastasis, and a Warthin tumor of the left parotid gland.
  • RESULTS AND CONCLUSIONS: The aim of this study was to evaluate the clinical and histopathologic features of 3 cases where clinical presentation of a Warthin tumor lies in the possible errors in diagnosis and decision making and not least in the management of the patient.
  • [MeSH-major] Adenolymphoma / diagnosis. Diagnostic Errors. Parotid Neoplasms / diagnosis
  • [MeSH-minor] Aged. Biopsy, Fine-Needle. Carcinoma, Squamous Cell / diagnosis. Diagnosis, Differential. Fluorodeoxyglucose F18. Follow-Up Studies. Humans. Male. Maxillary Neoplasms / diagnosis. Neoplasms, Multiple Primary / diagnosis. Paraproteinemias / diagnosis. Parotid Diseases / diagnosis. Positron-Emission Tomography. Radiopharmaceuticals. Tomography, X-Ray Computed. Whole Body Imaging

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21119475.001).
  • [ISSN] 1536-3732
  • [Journal-full-title] The Journal of craniofacial surgery
  • [ISO-abbreviation] J Craniofac Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


48. Ferreti Bonan PR, Martelli H Jr, Nogueira Dos Santos LA, Comini Mol V, Paes De Almeida O: Multinodular neurilemmoma of the tongue: a case report with differential immunohistochemical profile. Minerva Stomatol; 2008 Jan-Feb;57(1-2):71-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Neurilemmoma is a distinctive, encapsulated, benign tumor, derived from Schwann cells.
  • It is the most common neurogenic tumor, eventually occurring in the mouth, particularly the tongue.
  • The presumptive diagnosis was of a benign mesenchymal neoplasm and an excisional biopsy was performed.
  • Histopathologic evaluation revealed an encapsulated benign tissue, formed by spindle cells forming irregular Antoni A and Antoni B patterns, not easily recognizable.
  • [MeSH-major] Neurilemmoma / pathology. Tongue Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18427374.001).
  • [ISSN] 0026-4970
  • [Journal-full-title] Minerva stomatologica
  • [ISO-abbreviation] Minerva Stomatol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


49. Schirmer I, Reichart PA: [Adenomatoid odontogenic tumor (AOT) of the mandible: a surgical follow-up]. Mund Kiefer Gesichtschir; 2007 Nov;11(5):291-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Adenomatoid odontogenic tumor (AOT) of the mandible: a surgical follow-up].
  • [Transliterated title] Chirurgische Verlaufsbeobachtung eines adenomatoid odontogenen Tumors (AOT) im Unterkiefer: Ein Fallbericht.
  • The AOT is a relative rare benign odontogenic tumor.
  • Radiolucencies in the region of non-erupted or vital teeth may produce diagnostic problems.
  • The histological diagnosis of AOT is characterised by odontogenic epithelium, ductlike structures, amyloid-like material and calcifying areas.
  • The histological diagnosis of an AOT was only revealed after a second operation including tumor removal.
  • [MeSH-major] Mandibular Neoplasms / surgery. Odontogenic Tumors / surgery
  • [MeSH-minor] Child. Cuspid / diagnostic imaging. Cuspid / pathology. Cuspid / surgery. Diagnosis, Differential. Female. Humans. Orthodontics, Corrective. Radiography, Panoramic. Reoperation. Tooth Root / diagnostic imaging. Tooth Root / pathology. Tooth Root / surgery. Tooth, Unerupted / diagnostic imaging. Tooth, Unerupted / pathology. Tooth, Unerupted / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Oral Oncol. 1999 Mar;35(2):125-31 [10435145.001]
  • [Cites] J Oral Pathol Med. 2007 Aug;36(7):383-93 [17617830.001]
  • [Cites] J Oral Pathol Med. 1991 Apr;20(4):149-58 [2061853.001]
  • [Cites] Acta Pathol Microbiol Scand. 1969;75(3):375-98 [5801660.001]
  • (PMID = 17828424.001).
  • [ISSN] 1432-9417
  • [Journal-full-title] Mund-, Kiefer- und Gesichtschirurgie : MKG
  • [ISO-abbreviation] Mund Kiefer Gesichtschir
  • [Language] ger
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


50. Abiko Y, Nagayasu H, Takeshima M, Yamazaki M, Nishimura M, Kusano K, Kitajo H, Saitoh M, Kawakami T, Chiba I, Kaku T: Ameloblastic carcinoma ex ameloblastoma: report of a case-possible involvement of CpG island hypermethylation of the p16 gene in malignant transformation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Jan;103(1):72-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Ameloblastic carcinoma meeting the WHO criteria may arise either as a result of malignant change in a pre-existing benign ameloblastoma (carcinoma ex ameloblastoma) or as a primary malignant ameloblastoma not preceded by an ordinary ameloblastoma (de novo carcinoma).
  • The DNA was extracted separately from benign and malignant areas in paraffin sections of the tumor.
  • Hypermethylation of CpG islands of the p16 gene was detected in the malignant parts of the tumor.
  • [MeSH-major] Ameloblastoma / genetics. Cell Transformation, Neoplastic / genetics. CpG Islands / genetics. DNA Methylation. Genes, p16. Mandibular Neoplasms / genetics
  • [MeSH-minor] Aged. Cadherins / analysis. DNA, Neoplasm / analysis. DNA-Binding Proteins / analysis. Genes, p53. Humans. Male

  • Genetic Alliance. consumer health - Ameloblastic carcinoma.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17178497.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Cadherins; 0 / DNA, Neoplasm; 0 / DNA-Binding Proteins; 0 / PDRG1 protein, human
  •  go-up   go-down


51. Alobid I, Alós L, Maldonado M, Menéndez LM, Bernal-Sprekelsen M: Laryngeal solitary fibrous tumor treated with CO2 laser excision: case report. Eur Arch Otorhinolaryngol; 2005 Apr;262(4):286-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Laryngeal solitary fibrous tumor treated with CO2 laser excision: case report.
  • The solitary fibrous tumor is an uncommon unilateral benign lesion that usually arises from the pleura.
  • Recently, these tumors have been described in many other locations, such as the mediastinum, head and neck, orbit and urogenital system.
  • To date, only two cases of solitary fibrous tumor arising from the larynx have been reported in the scientific literature.
  • We describe a new case of laryngeal solitary fibrous tumor localized at the right false vocal fold.
  • A mass lesion was recognized in the right false vocal fold, and CT scan demonstrated a large, well-defined tumor without signs of infiltration.
  • The tumor was removed by transoral CO(2) laser surgery.
  • The definitive diagnosis was obtained by immunohistochemical analysis that showed vimentin and CD34-positive cells.
  • The patient remains free of tumor after 15 months of follow-up.
  • [MeSH-major] Laryngeal Neoplasms / surgery. Laser Therapy. Neoplasms, Fibrous Tissue / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Mod Pathol. 1999 Nov;12(11):1034-42 [10574600.001]
  • [Cites] Am J Surg Pathol. 1989 Aug;13(8):640-58 [2665534.001]
  • [Cites] Ann Otol Rhinol Laryngol. 1993 Jan;102(1 Pt 1):74-6 [8420474.001]
  • [Cites] AJNR Am J Neuroradiol. 1996 Oct;17(9):1767-72 [8896635.001]
  • [Cites] Hum Pathol. 1991 Jan;22(1):84-91 [1985083.001]
  • [Cites] J Thorac Cardiovasc Surg. 1978 Mar;75(3):363-72 [633933.001]
  • [Cites] Eur Arch Otorhinolaryngol. 1998;255(1):18-21 [9592669.001]
  • [Cites] Mod Pathol. 1997 Oct;10(10):1028-37 [9346183.001]
  • [Cites] Acta Otolaryngol. 2003 Jan;123(1):71-4 [12625577.001]
  • [Cites] J Laryngol Otol. 1998 Mar;112(3):286-9 [9624382.001]
  • [Cites] Oral Oncol. 1998 Sep;34(5):431-4 [9861354.001]
  • [Cites] Chest. 2000 Mar;117(3):897-900 [10713024.001]
  • [Cites] J Laryngol Otol. 1993 Mar;107(3):252-6 [8509708.001]
  • [Cites] J Clin Endocrinol Metab. 1989 Apr;68(4):701-6 [2646313.001]
  • (PMID = 15170575.001).
  • [ISSN] 0937-4477
  • [Journal-full-title] European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
  • [ISO-abbreviation] Eur Arch Otorhinolaryngol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


52. Jani DR, Chawda J, Sundaragiri SK, Parmar G: Mucocele--a study of 36 cases. Indian J Dent Res; 2010 Jul-Sep;21(3):337-40
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Mucocele is one of the most common benign soft tissue tumor present in the oral cavity.
  • MATERIALS AND METHODS: 36 cases of mucocele diagnosed at the Department of the Oral Pathology, Govt.
  • The clinical data were recorded and histopathologic diagnosis was made.
  • RESULTS: A diagnosis of mucocele was established in 36 cases with male-to-female ratio of 1.77:1.
  • [MeSH-major] Mouth Diseases / epidemiology. Mucocele / epidemiology

  • MedlinePlus Health Information. consumer health - Mouth Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20930340.001).
  • [ISSN] 1998-3603
  • [Journal-full-title] Indian journal of dental research : official publication of Indian Society for Dental Research
  • [ISO-abbreviation] Indian J Dent Res
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  •  go-up   go-down


53. Nakamori K, Ohuchi T, Hasegawa T, Hiratsuka H: Carcinoma ex pleomorphic adenoma of the buccal region is composed of salivary duct carcinoma and squamous cell carcinoma components. Int J Oral Maxillofac Surg; 2009 Oct;38(10):1116-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The tumor, which was located in the buccal space, was clinically diagnosed as a salivary gland tumor and treated by excision.
  • The neoplastic lesion contained two malignant and one benign element, with histological characteristics consistent with squamous cell carcinoma (SCC), salivary duct carcinoma (SDC) and pleomorphic adenoma (PA).
  • Both the SCC and SDC nests were surrounded by non-atypical myoepithelial cells, suggesting that both components may have developed from transformation of metaplastic luminal epithelial cells of PA.
  • The tumor was diagnosed as a non-invasive carcinoma (SCC and SDC) ex pleomorphic adenoma (Ca-ex-PA).
  • [MeSH-major] Adenoma, Pleomorphic / pathology. Carcinoma, Ductal / pathology. Carcinoma, Squamous Cell / pathology. Salivary Gland Neoplasms / pathology. Salivary Glands, Minor / pathology


54. Uğuz MZ, Onal K, Demiray U, Ekinci N: Tumoral mass presenting in the nasomalar region arising from the lateral nasal wall: pleomorphic adenoma. Eur Arch Otorhinolaryngol; 2007 Nov;264(11):1377-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Pleomorphic adenoma is the most common benign salivary gland tumor.
  • Although the major salivary glands are the most common sites of its origin, it can also occur in the minor salivary glands of the oral cavity and rarely in the neck, ear, nasal cavity and larynx.
  • We report a rare case of intranasal pleomorphic adenoma arising from lateral nasal wall and discuss the clinical presentation, diagnosis and treatment approaches with the review of the literature.
  • [MeSH-major] Adenoma, Pleomorphic / pathology. Nasal Cavity / pathology. Nasal Septum / pathology. Nose Neoplasms / pathology. Salivary Gland Neoplasms / pathology. Zygoma / pathology
  • [MeSH-minor] Adult. Diagnosis, Differential. Humans. Male. Neoplasm Invasiveness. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • MedlinePlus Health Information. consumer health - Salivary Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Auris Nasus Larynx. 2004 Dec;31(4):439-42 [15571921.001]
  • [Cites] Ann Otol Rhinol Laryngol. 2004 Mar;113(3 Pt 1):210-1 [15053203.001]
  • [Cites] Am J Otolaryngol. 2004 Mar-Apr;25(2):118-20 [14976658.001]
  • [Cites] Auris Nasus Larynx. 2003 Dec;30(4):417-20 [14656569.001]
  • [Cites] J Laryngol Otol. 1999 May;113(5):483-5 [10505170.001]
  • [Cites] Am J Clin Pathol. 1977 Aug;68(2):213-8 [195456.001]
  • [Cites] Nihon Jibiinkoka Gakkai Kaiho. 1990 May;93(5):740-5 [2166781.001]
  • [Cites] Ann Otol Rhinol Laryngol. 1991 Jul;100(7):600 [2064276.001]
  • (PMID = 17549505.001).
  • [ISSN] 1434-4726
  • [Journal-full-title] European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
  • [ISO-abbreviation] Eur Arch Otorhinolaryngol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


55. Nikitakis NG, Scheper MA, Papanikolaou VS, Sklavounou A, Sauk JJ: Immunohistochemical expression of the oncogenic molecules active Stat3 and survivin in benign and malignant salivary gland tumors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jun;107(6):837-43
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Immunohistochemical expression of the oncogenic molecules active Stat3 and survivin in benign and malignant salivary gland tumors.
  • OBJECTIVE: Signal transducer and activator of transcription 3 (Stat3) and survivin have been shown to exert oncogenic effects in various human neoplasms.
  • The purpose of this study was to evaluate the expression of tyrosine phosphorylated (active) Stat3 and survivin in various benign and malignant salivary gland tumors (SGTs).
  • STUDY DESIGN: Eighty-six SGTs (65 malignant and 21 benign tumors of various histopathologic subtypes) were immunohistochemically stained with antisurvivin or anti-phosphorylated tyrosine-705 (p-tyr) Stat3 antibodies.
  • Immunohistochemical reactivity was graded in a semiquantitative manner; a combined score of immunohistochemical positivity (0-6) was calculated for each tumor by adding the individual scores for percentage of tumor cells (0-3) and intensity of staining (0-3).
  • RESULTS: Survivin was immunohistochemically detected in all studied benign and malignant SGTs; p-tyr Stat3 was also detected in the majority (91%) of SGTs.
  • The average combined scores for survivin and p-tyr Stat3 immunohistochemical expression in the studied malignant SGTs was 4.40 and 3.35, respectively; the corresponding combined scores for survivin and p-tyr Stat3 in the studied benign SGTs were 4.37 and 3.22, respectively.
  • No statistically significant differences (P > .05) in p-tyr Stat3 or survivin expression were detected between the benign and malignant groups, or among the various examined histopathologic subtypes of SGTs.
  • CONCLUSIONS: Our data indicate an almost universal expression of activated Stat3 and survivin in benign and malignant SGTs.
  • Considering the well established proliferative and antiapoptotic properties of these molecules and their functional interrelationship, selective targeting techniques against Stat3 and/or survivin may represent promising therapeutic strategies against neoplasms of salivary gland origin.

  • MedlinePlus Health Information. consumer health - Salivary Gland Cancer.
  • MedlinePlus Health Information. consumer health - Salivary Gland Disorders.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19272817.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] ENG
  • [Grant] United States / NIDCR NIH HHS / DE / DE12606; United States / NIDCR NIH HHS / DE / DE13118; United States / NIDCR NIH HHS / DE / R01 DE012606-07; United States / NIDCR NIH HHS / DE / R01 DE012606; United States / NIDCR NIH HHS / DE / R01 DE013118-04; United States / NIDCR NIH HHS / DE / R01 DE013118
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / BIRC5 protein, human; 0 / Inhibitor of Apoptosis Proteins; 0 / Microtubule-Associated Proteins; 0 / STAT3 Transcription Factor
  • [Other-IDs] NLM/ NIHMS121368; NLM/ PMC4287356
  •  go-up   go-down


56. Malejka-Giganti D, Parkin DR, Decker RW, Niehans GA, Bliss RL, Churchwell MI, Beland FA: Tumorigenicity and genotoxicity of an environmental pollutant 2,7-dinitrofluorene after systemic administration at a low dose level to female rats. Int J Cancer; 2008 May 1;122(9):1958-65
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We have examined the tumorigenicity in female Sprague-Dawley rats of 2,7-dinitrofluorene (2,7-diNF) and 9-oxo-2,7-diNF administered by intraperitoneal (i.p.) and oral routes at 10 micromol/kg body weight, 3 times per week for 4 weeks.
  • After i.p. treatment, the estimated median latency for the combined malignant and benign mammary tumors was decreased in 2,7-diNF- (p = 0.003) or 9-oxo-2,7-diNF-treated (p = 0.007), relative to vehicle-treated rats (42 or 64 vs. 80 weeks, respectively), whereas after oral dosing, there were no significant differences.
  • At 90 weeks, the malignant mammary tumor incidence in 2,7-diNF-, 9-oxo-2,7-diNF- and vehicle-i.p. treated rats was 44 (p = 0.02 vs. vehicle-treated), 25 and 6%, respectively.
  • Liver and mammary gland DNA was analyzed by HPLC combined with electrospray tandem mass spectrometry for the presence of a deoxyguanosine (dG-2,7-diNF) adduct and a deoxyadenosine (dA-2,7-diNF) adduct derived from 2,7-diNF, and a deoxyguanosine (dG-9-oxo-2,7-diNF) adduct derived from 9-oxo-2,7-diNF.
  • Both dG-2,7-diNF and dA-2,7-diNF were detected in DNA of 2,7-diNF-treated rats, whereas only very low levels of dG-9-oxo-2,7-diNF were detected in DNA of 9-oxo-2,7-diNF-treated rats.
  • After i.p. treatment, the dA-2,7-diNF level was higher (p < 0.01) in the mammary gland than liver (13.6 vs. 7.8 adducts/10(8) nucleotides).
  • In the mammary gland, the dG-2,7-diNF level was higher (p < 0.05) after i.p. than oral dosing and also higher (p < 0.05) than in the liver (36 vs. 8.6 and vs. 9.1 adducts/10(8) nucleotides, respectively).
  • [MeSH-major] Carcinogens, Environmental / toxicity. Environmental Pollutants / toxicity. Fluorenes / toxicity. Liver Neoplasms, Experimental / chemically induced. Mammary Neoplasms, Experimental / chemically induced. Mutagens / toxicity
  • [MeSH-minor] Administration, Oral. Animals. Ascorbic Acid / pharmacology. Chromatography, High Pressure Liquid. DNA Adducts / drug effects. DNA Adducts / metabolism. Deoxyguanosine / metabolism. Female. Incidence. Injections, Intraperitoneal. Kaplan-Meier Estimate. Nitroso Compounds / toxicity. Rats. Rats, Sprague-Dawley. Tandem Mass Spectrometry

  • Hazardous Substances Data Bank. Sodium ascorbate .
  • Hazardous Substances Data Bank. L-Ascorbic Acid .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2008 Wiley-Liss, Inc.
  • (PMID = 18183586.001).
  • [ISSN] 1097-0215
  • [Journal-full-title] International journal of cancer
  • [ISO-abbreviation] Int. J. Cancer
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / 2-nitroso-7-nitro-9-oxofluorene; 0 / 2-nitroso-7-nitrofluorene; 0 / Carcinogens, Environmental; 0 / DNA Adducts; 0 / Environmental Pollutants; 0 / Fluorenes; 0 / Mutagens; 0 / Nitroso Compounds; 5405-53-8 / 2,7-dinitrofluorene; G9481N71RO / Deoxyguanosine; PQ6CK8PD0R / Ascorbic Acid
  •  go-up   go-down


57. Nagaraj PB, Ongole R, Bhujanga-Rao BR: Granular cell tumor of the tongue in a 6-year-old girl--a case report. Med Oral Patol Oral Cir Bucal; 2006 Mar;11(2):E162-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Granular cell tumor of the tongue in a 6-year-old girl--a case report.
  • Granular cell tumor is a relatively uncommon benign hamartomatous lesion occurring in almost any part of the body.
  • The tongue and the buccal mucosa are common intra oral sites.
  • The tumor generally occurs in middle or older aged adults.
  • As most of the granular cell tumors are benign, surgical excision of the lesion is the treatment of choice.
  • We describe a case of granular cell tumor of the tongue in a 6 year old girl along with a brief review of literature on granular cell tumors.
  • [MeSH-major] Granular Cell Tumor. Tongue Neoplasms

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16505796.001).
  • [ISSN] 1698-6946
  • [Journal-full-title] Medicina oral, patología oral y cirugía bucal
  • [ISO-abbreviation] Med Oral Patol Oral Cir Bucal
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Spain
  • [Number-of-references] 15
  •  go-up   go-down


58. Zhong Y, Wang L, Li T, Chen XM: Calcifying epithelial odontogenic tumour showing malignant transformation: a case report and review of the literature. Chin J Dent Res; 2010;13(2):157-62
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Calcifying epithelial odontogenic tumour showing malignant transformation: a case report and review of the literature.
  • Calcifying epithelial odontogenic tumour (CEOT) is a rare and benign odontogenic neoplasm that affects the jaws.
  • [MeSH-major] Cell Transformation, Neoplastic / pathology. Maxillary Neoplasms / pathology
  • [MeSH-minor] Humans. Keratin-19 / analysis. Ki-67 Antigen / analysis. Male. Middle Aged. Odontogenic Tumors / pathology. Odontogenic Tumors / surgery. Skin Neoplasms / pathology. Skin Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21264368.001).
  • [ISSN] 1462-6446
  • [Journal-full-title] The Chinese journal of dental research : the official journal of the Scientific Section of the Chinese Stomatological Association (CSA)
  • [ISO-abbreviation] Chin J Dent Res
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Keratin-19; 0 / Ki-67 Antigen; Calcifying Epithelial Odontogenic Tumor
  •  go-up   go-down


59. Noudel R, Chauvet E, Cahn V, Mérol JC, Chays A, Rousseaux P: Transcranial resection of a large sinonasal juvenile psammomatoid ossifying fibroma. Childs Nerv Syst; 2009 Sep;25(9):1115-20
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • INTRODUCTION: Juvenile psammomatoid ossifying fibroma (JPOF) is a benign but potentially locally aggressive fibroosseous lesion predominantly arising in the paranasal sinuses in children and young adults.
  • In such cases, tumor resection may often require the combination of neurosurgical and facial approaches.
  • Histological diagnosis remains a challenge because the lesion can be easily mistaken for another fibroosseous lesion or for a meningioma.
  • Despite the tumor had eroded through nasal septum, medial orbit wall, and right maxilla, it could be entirely removed performing an extended frontobasal approach via a bifrontoorbital craniotomy, obviating the need for a transfacial approach.
  • [MeSH-major] Fibroma, Ossifying / surgery. Skull Neoplasms / surgery
  • [MeSH-minor] Child. Craniotomy / methods. Diagnosis, Differential. Humans. Male. Prognosis. Skull / diagnostic imaging. Skull / surgery. Tomography, X-Ray Computed. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer. 1995 Oct 1;76(7):1155-65 [8630892.001]
  • [Cites] J Oral Pathol Med. 2000 Jan;29(1):13-8 [10678711.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 May;101(5):614-9 [16632273.001]
  • [Cites] Head Neck. 1998 Mar;20(2):97-105 [9484939.001]
  • [Cites] Int J Pediatr Otorhinolaryngol. 2000 Aug 31;54(2-3):159-62 [10967388.001]
  • [Cites] Pediatr Neurosurg. 2003 Nov;39(5):270-4 [14512692.001]
  • [Cites] Semin Diagn Pathol. 1996 May;13(2):104-12 [8734416.001]
  • [Cites] Acta Otolaryngol Suppl. 1991;488:1-40 [1843064.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002 Mar;93(3):296-304 [11925539.001]
  • [Cites] J Neurosurg. 2005 Jun;102(6):1151-4 [16028779.001]
  • [Cites] Int J Pediatr Otorhinolaryngol. 2006 Feb;70(2):193-9 [16321450.001]
  • [Cites] Am J Rhinol. 2001 Jan-Feb;15(1):27-30 [11258651.001]
  • [Cites] Adv Anat Pathol. 2001 May;8(3):126-43 [11345237.001]
  • [Cites] Am J Otolaryngol. 2005 Jan-Feb;26(1):54-6 [15635583.001]
  • [Cites] J Oral Pathol Med. 1994 Oct;23(9):385-8 [7823298.001]
  • [Cites] J Craniomaxillofac Surg. 1987 Jun;15(3):154-67 [3475289.001]
  • [Cites] Otolaryngol Head Neck Surg. 1991 Jun;104(6):803-8 [1908971.001]
  • [Cites] Skull Base Surg. 1999;9(2):95-100 [17171124.001]
  • [Cites] J Craniomaxillofac Surg. 1998 Oct;26(5):314-7 [9819682.001]
  • [Cites] AJNR Am J Neuroradiol. 1991 Jan-Feb;12 (1):25-30 [1899514.001]
  • [Cites] Ear Nose Throat J. 2007 Jul;86(7):400-1 [17702320.001]
  • [Cites] J Neurosurg. 1992 Feb;76(2):198-206 [1730948.001]
  • (PMID = 19308423.001).
  • [ISSN] 1433-0350
  • [Journal-full-title] Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
  • [ISO-abbreviation] Childs Nerv Syst
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


60. Mendes RA, Carvalho JF, van der Waal I: Biological pathways involved in the aggressive behavior of the keratocystic odontogenic tumor and possible implications for molecular oriented treatment - an overview. Oral Oncol; 2010 Jan;46(1):19-24
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Biological pathways involved in the aggressive behavior of the keratocystic odontogenic tumor and possible implications for molecular oriented treatment - an overview.
  • In the classification of Head and Neck Tumors, published in 2005 by the World Health Organization Classification, the odontogenic keratocyst has been reclassified as a benign intraosseous neoplasm, calling it "keratocystic odontogenic tumor" (KCOT).
  • Genetic and molecular research regarding odontogenic tumors, and KCOTs in particular, has led to an increasing amount of knowledge and understanding of their physiopathological pathways.
  • A review of the biological behavior of this recognized aggressive pathological entity of the jaws and a contemporary outline of the molecular (growth factors, p53, PCNA and Ki-67, bcl-2) and genetic (PTCH, SHH) alterations associated with this odontogenic neoplasm provides a better understanding of the mechanisms involved in its development and strengthen the current concept that the KCOT should, indeed, be regarded as a neoplasm.
  • Furthermore, markers known to be rapidly induced in response to growth factors, tumor promoters, cytokines, bacterial endotoxins, oncogenes, hormones and shear stress, such as COX-2, may also shed new light on the biological mechanisms involved in the development of these benign but sometimes aggressive neoplasms of the jaws.
  • [MeSH-major] Jaw Neoplasms. Odontogenic Cysts. Odontogenic Tumors

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20004133.001).
  • [ISSN] 1879-0593
  • [Journal-full-title] Oral oncology
  • [ISO-abbreviation] Oral Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  •  go-up   go-down


61. Vigneswaran N, Beckers S, Waigel S, Mensah J, Wu J, Mo J, Fleisher KE, Bouquot J, Sacks PG, Zacharias W: Increased EMMPRIN (CD 147) expression during oral carcinogenesis. Exp Mol Pathol; 2006 Apr;80(2):147-59
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Increased EMMPRIN (CD 147) expression during oral carcinogenesis.
  • Gene expression profiling of oral premalignant (OPM) cells and normal oral epithelial (NOR) cells showed that EMMPRIN expression was markedly upregulated in OPM cells compared to NOR cells.
  • We used an oral squamous cell carcinoma (OSCC) progression model composed of cell lines, organotypic cultures and tissue specimens to characterize EMMPRIN expression patterns by microarray analysis, qRT-PCR, Western blotting and immunohistochemistry.
  • EMMPRIN expression was limited to basal cells of normal, benign hyperkeratotic and inflammatory (lichen planus) oral mucosa.
  • These results suggest that EMMPRIN overexpression occurs at a very early stage of oral carcinogenesis and plays a contributing role in OSCC tumorigenesis.
  • [MeSH-major] Antigens, CD147 / genetics. Gene Expression Regulation, Neoplastic. Mouth Neoplasms / genetics. Up-Regulation / genetics
  • [MeSH-minor] Aged. Carcinoma, Squamous Cell. Cell Line, Tumor. Epithelial Cells / cytology. Female. Gene Expression Profiling. Humans. Keratinocytes / cytology. Leukoplakia, Oral / pathology. Microarray Analysis. Middle Aged. Mouth Mucosa / pathology. RNA, Messenger / genetics. RNA, Messenger / metabolism

  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16310185.001).
  • [ISSN] 0014-4800
  • [Journal-full-title] Experimental and molecular pathology
  • [ISO-abbreviation] Exp. Mol. Pathol.
  • [Language] eng
  • [Grant] United States / NIDCR NIH HHS / DE / DE13150; United States / NIDCR NIH HHS / DE / DE14395
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / RNA, Messenger; 136894-56-9 / Antigens, CD147
  •  go-up   go-down


62. Smullin SE, Faquin W, Susarla SM, Kaban LB: Peripheral desmoplastic ameloblastoma: report of a case and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jan;105(1):37-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The desmoplastic variant of ameloblastoma is a rare, locally invasive, benign tumor of the jaws, typically found in the anterior regions of the maxilla and mandible.
  • This ameloblastoma variant has been described as an intraosseous tumor; to our knowledge, there have been no published cases of a peripheral desmoplastic ameloblastoma.
  • [MeSH-major] Ameloblastoma / pathology. Palatal Neoplasms / pathology

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17764981.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 14
  •  go-up   go-down


63. Brooks MD, Bennett RD, Strehler EE, Sebo TJ, Eckert SE, Carr AB: Human calmodulin-like protein (CLP) expression in oral squamous mucosa and in malignant transformation. J Prosthodont; 2009 Jan;18(1):11-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Human calmodulin-like protein (CLP) expression in oral squamous mucosa and in malignant transformation.
  • PURPOSE: The purpose of this study was to test whether calmodulin-like protein (CLP) is expressed in normal human oral mucosal cells and if downregulation of CLP occurs in malignant transformation.
  • MATERIALS AND METHODS: Oral mucosal tissue was taken from three individuals in a double-blind manner.
  • Three oral mucosal tissue samples with biopsy-confirmed squamous cell carcinoma were obtained.
  • Staining patterns and intensity were noted in normal oral mucosa, comparing them to the normal breast epithelium sample.
  • Staining patterns and intensity were then observed in squamous tumor cells, comparing them to the patterns of benign squamous mucosa.
  • RESULTS: CLP coding sequences were positively identified from the normal oral mucosal tissue samples by reverse transcription and polymerase chain reaction (RT-PCR) with 100% identity to the published CLP sequence (accession #M58026).
  • In the three oral mucosa tissue samples with known squamous cell carcinoma, expression of CLP was readily detected in areas of normal oral mucosa, while a notable downregulation of CLP expression occurred in areas of malignant transformation.
  • The staining intensity was equivalent to the staining seen in the benign breast epithelium used as a control.
  • There was a sharp contrast in staining quality and clarity between benign and malignant tissue.
  • CONCLUSIONS: The RNA for human CLP is found in normal oral mucosa.
  • CLP expression is seen in normal oral mucosa with a downregulation of CLP expression in malignant transformation.
  • [MeSH-major] Calmodulin / biosynthesis. Carcinoma, Squamous Cell / metabolism. Cell Transformation, Neoplastic / metabolism. Mouth Mucosa / metabolism. Mouth Neoplasms / metabolism

  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19166543.001).
  • [ISSN] 1532-849X
  • [Journal-full-title] Journal of prosthodontics : official journal of the American College of Prosthodontists
  • [ISO-abbreviation] J Prosthodont
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / CALML3 protein, human; 0 / Calmodulin
  •  go-up   go-down


64. Liess BD, Lane RV, Frazier S, Zitsch RP 3rd: Bilateral canalicular adenoma of the parotid gland. Arch Otolaryngol Head Neck Surg; 2006 Mar;132(3):339-41
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Canalicular adenoma is a rare benign salivary gland tumor that occurs almost exclusively in the upper lip.
  • Rarely, this benign tumor may occur multifocally in the oral cavity.
  • We report a case of canalicular adenoma in bilateral parotid glands, discuss histological characteristics, and review this tumor.
  • [MeSH-major] Adenoma / pathology. Parotid Neoplasms / pathology

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16549756.001).
  • [ISSN] 0886-4470
  • [Journal-full-title] Archives of otolaryngology--head & neck surgery
  • [ISO-abbreviation] Arch. Otolaryngol. Head Neck Surg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 12
  •  go-up   go-down


65. Malinvaud D, Couloigner V, Badoual C, Halimi P, Bonfils P: Pleomorphic adenoma of the nasal septum and its relationship with Epstein-Barr virus. Auris Nasus Larynx; 2006 Dec;33(4):417-21
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVES: Pleomorphic adenoma is the most common benign tumor of the major salivary glands, especially of the parotid gland.
  • It is much less common in the minor salivary glands of the oral cavity, and it rarely occurs in others sites in the head and neck.
  • Even if virus involvement in salivary glands tumor has been many times discuted, the etiology of this tumor keeps being unknown.
  • As compared to other nasal tumors, we tried to prove if Epstein-Barr virus (EBV) could be involved in the development of pleomorphic adenoma in this particular nasal localization.
  • All the patients had undergone endoscopic surgery to remove the complete tumor.
  • We used hybridation technique in the search for EBV-DNA in the three tumors.
  • RESULTS AND CONCLUSION: We had positive EBV-DNA detection in the tumor in one case, which seemed to prove relationship between pleomorphic adenoma and this virus.
  • The literature concerning the subject is reviewed in order to explain EBV involvement in the development of such tumors in this particular localization.
  • [MeSH-major] Adenoma, Pleomorphic / virology. DNA, Viral / analysis. Herpesvirus 4, Human / isolation & purification. Nasal Septum / surgery. Salivary Gland Neoplasms / virology

  • MedlinePlus Health Information. consumer health - Salivary Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16895748.001).
  • [ISSN] 0385-8146
  • [Journal-full-title] Auris, nasus, larynx
  • [ISO-abbreviation] Auris Nasus Larynx
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Antibodies, Viral; 0 / DNA, Viral
  •  go-up   go-down


66. Karakida K, Aoki T, Sakamoto H, Takahashi M, Akamatsu T, Ogura G, Sekido Y, Ota Y: Ameloblastic carcinoma, secondary type: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Dec;110(6):e33-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Malignant variants of ameloblastoma include metastasizing ameloblastoma, which microscopically appears benign but has metastasized and ameloblastic carcinoma that exhibits malignant histopathologic features.
  • Therefore it is rare to find an untreated secondary type presenting with histologic features of malignant transformation from an earlier benign lesion.
  • The mechanism by which a preexisting benign ameloblastoma goes through a malignant transformation is also described.
  • [MeSH-major] Ameloblastoma / pathology. Cell Transformation, Neoplastic / pathology. Mandibular Neoplasms / pathology. Odontogenic Tumors / pathology
  • [MeSH-minor] Adult. Biopsy. Humans. Ki-67 Antigen / analysis. Male. Radiography, Panoramic. Tomography, X-Ray Computed. Tumor Suppressor Protein p53 / analysis

  • Genetic Alliance. consumer health - Ameloblastic carcinoma.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Crown Copyright © 2010. Published by Mosby, Inc. All rights reserved.
  • (PMID = 21112523.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Ki-67 Antigen; 0 / TP53 protein, human; 0 / Tumor Suppressor Protein p53
  •  go-up   go-down


67. Patsiaoura K, Anagnostou E, Benis N: Intramuscular myxoma of the nasal vestibule. Auris Nasus Larynx; 2010 Feb;37(1):100-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Intramuscular myxoma is an uncommon benign soft tissue neoplasm and a distinct histopathological entity within the heterogeneous group of myxomas.
  • We report on a case of a myxoma within the mimetic muscles of the nasal and mouth region in a 52-year-old man.
  • The tumor was surgically removed and the patient is free of recurrence or complications 8 months after treatment.
  • To the very best of our knowledge, there is no report of this neoplasm located within the nasal and oral mimetic muscles.
  • [MeSH-major] Muscle, Skeletal / pathology. Myxoma / pathology. Paranasal Sinus Neoplasms / pathology
  • [MeSH-minor] Humans. Male. Middle Aged. Nasal Cavity. Otorhinolaryngologic Surgical Procedures. Soft Tissue Neoplasms / pathology. Soft Tissue Neoplasms / surgery. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2009 Elsevier Ireland Ltd. All rights reserved.
  • (PMID = 19414229.001).
  • [ISSN] 1879-1476
  • [Journal-full-title] Auris, nasus, larynx
  • [ISO-abbreviation] Auris Nasus Larynx
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


68. Demicco EG, Deshpande V, Nielsen GP, Kattapuram SV, Rosenberg AE: Well-differentiated osteosarcoma of the jaw bones: a clinicopathologic study of 15 cases. Am J Surg Pathol; 2010 Nov;34(11):1647-55
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Well-differentiated osteosarcoma of the jaw bones is rare, and is often confused with a variety of benign fibroosseous lesions.
  • Six of the tumors arose in the mandible, and 9 in the maxilla.
  • Microscopically, the tumors were infiltrative, relatively hypocellular, and consisted of monomorphic, minimally atypical spindle cells that were usually arranged in fascicles.
  • The tumor cells were intimately related to the surfaces of elongated trabeculae of neoplastic woven bone that lacked osteoblastic rimming.
  • [MeSH-major] Cell Differentiation. Mandibular Neoplasms / pathology. Maxillary Neoplasms / pathology. Osteosarcoma / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Female. Humans. Male. Middle Aged. Neoplasm Invasiveness. Oral Surgical Procedures. Radiotherapy, Adjuvant. Time Factors. Tomography, X-Ray Computed. Treatment Outcome. Young Adult

  • Genetic Alliance. consumer health - Osteosarcoma.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20975343.001).
  • [ISSN] 1532-0979
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


69. Revonta M, Raitanen J, Sihvo S, Koponen P, Klemetti R, Männistö S, Luoto R: Health and life style among infertile men and women. Sex Reprod Healthc; 2010 Aug;1(3):91-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Infertile women also had Chlamydia trachomatis infection, benign tumor in their uterus and intestinal disease more often than fertile women.
  • CONCLUSIONS: Women with infertility experience reported more diseases and less use of oral contraceptives than other women, possibly reflecting reasons to infertility.
  • [MeSH-minor] Adult. Age Factors. Chlamydia Infections / microbiology. Chlamydia trachomatis. Cross-Sectional Studies. Female. Fertility. Finland. Humans. Hypersensitivity. Infertility, Female. Intestinal Diseases. Male. Middle Aged. Odds Ratio. Prevalence. Uterine Neoplasms

  • MedlinePlus Health Information. consumer health - Alcohol.
  • MedlinePlus Health Information. consumer health - Dietary Fats.
  • MedlinePlus Health Information. consumer health - Infertility.
  • MedlinePlus Health Information. consumer health - Smoking.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier B.V. All rights reserved.
  • (PMID = 21122604.001).
  • [ISSN] 1877-5764
  • [Journal-full-title] Sexual & reproductive healthcare : official journal of the Swedish Association of Midwives
  • [ISO-abbreviation] Sex Reprod Healthc
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Dietary Fats; 0 / Fatty Acids
  •  go-up   go-down


70. Frassica FJ, Papp D, McCarthy E, Weber K: Analysis of the pathology section of the OITE will aid in trainee preparation. Clin Orthop Relat Res; 2008 Jun;466(6):1323-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We analyzed the tumor-related questions on the Orthopaedic In-Training Examinations (OITE) over a 5-year period (2002-2006).
  • Each year approximately 27 of the 275 examination questions (10%) are tumor-related.
  • Malignant conditions are tested more than benign ones (1.2:1).
  • Approximately nine questions per year are immediate recall of specific entities, while eight questions tested the examinees' ability to establish a diagnosis from imaging studies with or without biopsy material.
  • Participants were required to establish a diagnosis from imaging studies and/or biopsy material and then choose treatment an average of seven times per examination.
  • [MeSH-major] Bone Neoplasms / diagnosis. Bone Neoplasms / therapy. Educational Measurement / statistics & numerical data. Internship and Residency. Orthopedics / education. Pathology / education

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Surg. 1982 Sep;144(3):292-4 [7114363.001]
  • [Cites] J Med Educ. 1981 Feb;56(2):115-21 [7463444.001]
  • [Cites] J Bone Joint Surg Am. 1996 May;78(5):656-63 [8642021.001]
  • [Cites] Acad Radiol. 1998 May;5(5):374-9 [9597105.001]
  • [Cites] J Gen Intern Med. 1998 Jun;13(6):414-6 [9669571.001]
  • [Cites] South Med J. 2005 May;98(5):528-32 [15954509.001]
  • [Cites] Clin Orthop Relat Res. 2006 Aug;449:44-9 [16735876.001]
  • [Cites] J Reprod Med. 2006 Aug;51(8):621-2 [16967631.001]
  • [Cites] Clin Orthop Relat Res. 2002 Jun;(399):265-71 [12011720.001]
  • [Cites] J Oral Maxillofac Surg. 2000 Dec;58(12):1401-6 [11117689.001]
  • [Cites] J Bone Joint Surg Am. 1982 Oct;64(8):1121-7 [7130225.001]
  • [Cites] J Med Educ. 1969 Sep;44(9):878-89 [5820838.001]
  • [Cites] Clin Orthop Relat Res. 1971 Mar-Apr;75:108-16 [5554614.001]
  • [Cites] J Bone Joint Surg Am. 1978 Sep;60(6):853-9 [701328.001]
  • [ErratumIn] Clin Orthop Relat Res. 2016 Apr;474(4):1077 [26797906.001]
  • (PMID = 18425562.001).
  • [ISSN] 1528-1132
  • [Journal-full-title] Clinical orthopaedics and related research
  • [ISO-abbreviation] Clin. Orthop. Relat. Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC2384018
  •  go-up   go-down


71. Li LJ, Li Y, Wen YM, Liu H, Zhao HW: Clinical analysis of salivary gland tumor cases in West China in past 50 years. Oral Oncol; 2008 Feb;44(2):187-92
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clinical analysis of salivary gland tumor cases in West China in past 50 years.
  • In our study, 3461 cases of salivary gland tumor treated between 1955 and 2002 at West China Stomatology Hospital of Sichuan University were retrospectively analyzed, and compared with the previous reports.
  • Measures such as age, tumor location, tumor histological type, and the nature of the growth (benign or malignant) were recorded at the same time.
  • The findings are as follows: the average ages of salivary gland tumor patients were 41.38 years for the benign cases and 45.20 for the malignant ones; the male:female ratio was 0.
  • 99:1 in the benign cases and 1.34:1 in the malignant ones; primary tumors were mostly in the parotid gland, palate and submandibular gland in sequence.
  • Pleomorphic adenoma was the most frequent benign tumor followed by Warthin's tumor and basal cell adenoma, whereas mucoepidermoid carcinoma, adenoid cystic carcinoma and adenocarcinoma not otherwise specified were the most frequent malignant tumors.
  • The incidence of salivary gland tumors increased with age.
  • The male:female ratio of malignant tumors was higher than that of benign ones.
  • The parotid gland and palate were the most common locations of salivary gland tumors.
  • Pleomorphic adenoma and mucoepidermoid carcinoma were the most frequent benign and malignant tumors, respectively.
  • [MeSH-major] Adenoma, Pleomorphic / epidemiology. Carcinoma, Mucoepidermoid / epidemiology. Salivary Gland Neoplasms / epidemiology
  • [MeSH-minor] Adenocarcinoma / pathology. Adenolymphoma / pathology. Adolescent. Adult. Aged. Aged, 80 and over. Carcinoma, Adenoid Cystic / pathology. Child. Child, Preschool. China / epidemiology. Female. Humans. Incidence. Infant. Male. Middle Aged. Palatal Neoplasms / pathology. Parotid Neoplasms / pathology. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Salivary Gland Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumIn] Oral Oncol. 2011 Sep;47(9):929-30
  • (PMID = 17418612.001).
  • [ISSN] 1368-8375
  • [Journal-full-title] Oral oncology
  • [ISO-abbreviation] Oral Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


72. Tawfik MA, Zyada MM: Odontogenic tumors in Dakahlia, Egypt: analysis of 82 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Feb;109(2):e67-73
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Odontogenic tumors in Dakahlia, Egypt: analysis of 82 cases.
  • OBJECTIVE: This study was designed to analyze the frequency and distribution of different types of odontogenic tumors in Dakahlia, Egypt, and to compare them with various reports from other parts of the world.
  • STUDY DESIGN: Records of the Oral and Maxillofacial Surgery and Oral Pathology Departments, Faculty of Dentistry, Mansoura University, with histologic diagnosis of odontogenic tumors (based on the World Health Organization classification, 2005), during a 15-year period, were analyzed.
  • RESULTS: A total of 82 cases of odontogenic tumors were reported.
  • Of these, (96.3%) were benign and (3.7%) were malignant.
  • Ameloblastoma (41.5%) was the most frequent type, followed by keratocystic odontogenic tumor (19.5%), odontoma (13.4%), and odontogenic myxoma (8.5%).
  • CONCLUSIONS: Odontogenic tumors show a definite geographic variation.
  • In Dakahlia, Egypt, ameloblastoma and keratocystic odontogenic tumor are the most frequent odontogenic tumors, with distinct anatomic predilections.
  • [MeSH-major] Mandibular Neoplasms / pathology. Maxillary Neoplasms / pathology. Odontogenic Tumors / pathology

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2010 Mosby, Inc. All rights reserved.
  • (PMID = 19969486.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


73. Pimenta FJ, Gontijo Silveira LF, Tavares GC, Silva AC, Perdigão PF, Castro WH, Gomez MV, Teh BT, De Marco L, Gomez RS: HRPT2 gene alterations in ossifying fibroma of the jaws. Oral Oncol; 2006 Aug;42(7):735-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Ossifying fibroma (OF) is a benign neoplasm related to bone characterized by a progressive enlargement of the affected jaw.
  • Recently, the candidate tumor suppressor gene HRPT2 was identified and alterations in this gene were related with the Hyperparathyroidism-jaw tumor syndrome that is characterized by parathyroid adenoma or carcinoma, fibro-osseous lesions (mainly OF) of the jaws, and renal lesions.
  • Tumour and blood samples were obtained from 3 patients with OF and one with juvenile ossifying fibroma (JOF).
  • [MeSH-major] Fibroma, Ossifying / genetics. Genes, Tumor Suppressor. Mandibular Neoplasms / genetics. Tumor Suppressor Proteins / genetics
  • [MeSH-minor] Adolescent. Adult. Female. Gene Expression. Humans. Male. Middle Aged. Mutation. RNA, Messenger / genetics. RNA, Neoplasm / genetics. Reverse Transcriptase Polymerase Chain Reaction / methods

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16458039.001).
  • [ISSN] 1368-8375
  • [Journal-full-title] Oral oncology
  • [ISO-abbreviation] Oral Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / CDC73 protein, human; 0 / RNA, Messenger; 0 / RNA, Neoplasm; 0 / Tumor Suppressor Proteins
  •  go-up   go-down


74. Scivoletti-Polan NA, Valentino DJ, Rosenberg SB, Cowan SW, Soiferman EI: A 65-year-old man with shortness of breath, pleuritic chest pain, and recurrent pneumonia. J Am Osteopath Assoc; 2010 Dec;110(12):733-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The patient in the present case report experienced recurrent pneumonias despite adequate treatment with intravenous and oral antibiotics.
  • This finding prompted a fiberoptic bronchoscopy, which revealed an endobronchial tumor.
  • Given the patient's history of cigarette smoking, it was surprising to find that he had a benign endobronchial neurogenic tumor, which was removed in subsequent rigid bronchoscopy.
  • [MeSH-major] Bronchial Neoplasms / diagnosis. Bronchopneumonia / etiology. Lung Neoplasms / diagnosis
  • [MeSH-minor] Aged. Chest Pain / diagnosis. Chest Pain / etiology. Dyspnea / diagnosis. Dyspnea / etiology. Humans. Male. Pleurisy / diagnosis. Pleurisy / etiology. Prognosis. Recurrence

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21178155.001).
  • [ISSN] 1945-1997
  • [Journal-full-title] The Journal of the American Osteopathic Association
  • [ISO-abbreviation] J Am Osteopath Assoc
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


75. Villarreal-Colín SP, Soto-Dávalos BA, Bargalló-Rocha JE, Bandera-Delgado A, Zumaran-Cuéllar O, Robles-Vidal CD: [Breast fibromatosis: a lesion mimicking cancer]. Cir Cir; 2008 Mar-Apr;76(2):169-71
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Fibromatosis de mama: una lesión simuladora de cáncer.
  • BACKGROUND: Breast fibromatosis (BF) is a rare benign pathological entity.
  • A core-needle biopsy was taken with a pathology report of a phyllodes tumor.
  • Oral colchicine was administered and at 3 months of follow-up the patient is disease free. CASE 2.
  • Differential diagnosis should be made before attempting treatment.
  • [MeSH-major] Breast Neoplasms / diagnosis. Fibroma / diagnosis
  • [MeSH-minor] Adolescent. Diagnosis, Differential. Female. Humans. Middle Aged


76. Anil S: Solitary plasmacytoma of the maxilla--a case report and review of the literature. Gen Dent; 2007 Jan-Feb;55(1):39-43
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Plasma cell neoplasms have been classified as multiple myeloma, solitary plasmacytoma, and extramedullary plasmacytoma.
  • Some lesions appear to be benign and do not recur after complete removal, while others are locally invasive.
  • The dense plasma cell infiltration that commonly is associated with inflammatory lesions within the oral tissues makes diagnosing plasmacytoma at this site problematic.
  • A CT scan showed that the tumor mass occupied the right maxillary sinus and the lateral wall of the nasal cavity.
  • The tumor cells were composed of densely packed, round, polygonal cell structures that were scattered in relatively sparse stoma.
  • [MeSH-major] Maxillary Neoplasms / pathology. Maxillary Sinus Neoplasms / pathology. Palatal Neoplasms / pathology. Plasmacytoma / pathology
  • [MeSH-minor] Diagnosis, Differential. Humans. Male. Middle Aged. Neoplasm Invasiveness. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17333965.001).
  • [ISSN] 0363-6771
  • [Journal-full-title] General dentistry
  • [ISO-abbreviation] Gen Dent
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 36
  •  go-up   go-down


77. Jundt G, Reichart PA: [Benign odontogenic ectomesenchymal tumors]. Pathologe; 2008 May;29(3):199-204
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Benign odontogenic ectomesenchymal tumors].
  • [Transliterated title] Benigne odontogene ektomesenchymale Tumoren.
  • The group of odontogenic ectomesenchymal tumors consists of odontogenic fibroma (epithelium-rich and epithelium-poor types), odontogenic myxoma, and cementoblastoma.
  • Whereas odontogenic fibromas and cementoblastomas are very rare lesions, odontogenic myxoma is the fourth common odontogenic tumor, preceded only by keratocystic odontogenic tumor, the odontomas, and ameloblastoma.
  • The diagnosis of cementoblastoma rests on its connection to the root of a tooth.
  • [MeSH-major] Jaw Neoplasms / pathology. Odontogenic Tumors / pathology
  • [MeSH-minor] Adolescent. Adult. Age Factors. Ameloblastoma / classification. Ameloblastoma / pathology. Ameloblastoma / surgery. Cementoma / classification. Cementoma / pathology. Cementoma / surgery. Child. Child, Preschool. Dental Cementum / pathology. Diagnosis, Differential. Fibroma / classification. Fibroma / pathology. Fibroma / surgery. Humans. Mandible / pathology. Mandible / surgery. Mandibular Neoplasms / classification. Mandibular Neoplasms / pathology. Mandibular Neoplasms / surgery. Maxilla / pathology. Maxilla / surgery. Maxillary Neoplasms / pathology. Maxillary Neoplasms / surgery. Myxoma / classification. Myxoma / pathology. Myxoma / surgery. Osteolysis / classification. Osteolysis / pathology. Osteolysis / surgery. Prognosis. Tomography, X-Ray Computed. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Dentomaxillofac Radiol. 2007 Oct;36(7):423-7 [17881604.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1980 Nov;50(5):425-32 [6935598.001]
  • [Cites] Int J Oral Maxillofac Surg. 2007 Jan;36(1):20-5 [17156974.001]
  • [Cites] Cell Mol Life Sci. 2004 Oct;61(19-20):2510-22 [15526158.001]
  • [Cites] J Laryngol Otol. 2000 Jul;114(7):533-5 [10992937.001]
  • [Cites] J Oral Maxillofac Surg. 1993 Jul;51(7):762-7; discussion 767-8 [8509916.001]
  • [Cites] J Oral Pathol Med. 1996 Nov;25(10):556-61 [8986968.001]
  • [Cites] J Clin Pathol. 2006 Mar;59(3):240-5 [16505272.001]
  • [Cites] J Dent Res. 2005 May;84(5):390-406 [15840773.001]
  • [Cites] Oral Oncol. 2006 Sep;42(8):757-8 [16679047.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002 Mar;93(3):311-20 [11925541.001]
  • [Cites] J Oral Maxillofac Surg. 1995 May;53(5):518-21 [7722719.001]
  • [Cites] Scand J Dent Res. 1984 Aug;92(4):352-7 [6591371.001]
  • [Cites] Ann Otol Rhinol Laryngol. 1996 Jun;105(6):490-4 [8638904.001]
  • [Cites] Periodontol 2000. 2006;41:196-217 [16686935.001]
  • [Cites] Cell. 1990 Feb 23;60(4):585-95 [1689217.001]
  • [Cites] J Oral Maxillofac Surg. 1985 Dec;43(12 ):987-90 [3864957.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 Sep;98 (3):295-300 [15356466.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1982 Jul;54(1):40-8 [6750498.001]
  • (PMID = 18392828.001).
  • [ISSN] 1432-1963
  • [Journal-full-title] Der Pathologe
  • [ISO-abbreviation] Pathologe
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


78. Tamborini F, Cherubino M, Scamoni S, Valdatta LA: Granular cell tumor of the toe: a case report. Dermatol Res Pract; 2010;2010
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Granular cell tumor of the toe: a case report.
  • Granular cell tumor is a rare tumor of unknown etiology that more commonly affects the oral cavity but can also occur at other sites.
  • The majorities of granular cell tumors are benign and present as a singular dermal nodule.
  • We discuss a case of granular cell tumor of the fourth toe in a 54-year-old patient that was treated with conservative surgery, instead of amputation, and reconstruction with a dermal regeneration template.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20862204.001).
  • [ISSN] 1687-6113
  • [Journal-full-title] Dermatology research and practice
  • [ISO-abbreviation] Dermatol Res Pract
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Egypt
  • [Other-IDs] NLM/ PMC2938433
  •  go-up   go-down


79. Oda D: Soft-tissue lesions in children. Oral Maxillofac Surg Clin North Am; 2005 Nov;17(4):383-402
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This article reviews some of the benign and malignant oral soft-tissue swellings that occur in children, with an emphasis on their clinical presentation, etiology, histopathology, and treatment.
  • These lesions include single and multiple nodules, reactive lesions, and benign and malignant neoplasms.
  • Diseases discussed include reactive gingival swelling, generalized gingival fibromatosis, melanotic neuroectodermal tumor of infancy, fibromas, vascular lesions, salivary gland lesions, and infantile rhabdomyomas.
  • Also covered are lesions that may present in multiples, such as neuromas, multiple endocrine neoplasia type 2b, neurofibromatosis, and human papilloma virus-related benign epithelial lesions.
  • Benign but locally aggressive and malignant neoplasms are discussed, such as aggressive fibromatosis, myofibromatosis, fibrosarcoma, and rhabdomyosarcoma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18088794.001).
  • [ISSN] 1042-3699
  • [Journal-full-title] Oral and maxillofacial surgery clinics of North America
  • [ISO-abbreviation] Oral Maxillofac Surg Clin North Am
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


80. Huurman VA, Schaapherder AF: Management of ruptured hepatocellular adenoma. Dig Surg; 2010;27(1):56-60
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Hepatocellular adenoma (HA) is an increasingly prevalent benign liver tumor that is strongly associated with use of oral contraceptive medication.
  • The diagnosis is often made after abdominal imaging in female patients with sudden abdominal pain, with or without signs of hemorrhage.
  • Standard treatment of larger adenomas has since long consisted in surgical resection, both for non-ruptured and for ruptured tumors.
  • Recently, newer and less invasive methods using selective transarterial embolization have been described that can successfully stop bleeding and even lead to tumor regression.
  • This review addresses different treatment options and recent advances regarding this relatively new condition, focusing mainly on treatment of bleeding and ruptured tumors in an acute setting.
  • [MeSH-major] Adenoma, Liver Cell / therapy. Liver Neoplasms / therapy

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 S. Karger AG, Basel.
  • (PMID = 20357452.001).
  • [ISSN] 1421-9883
  • [Journal-full-title] Digestive surgery
  • [ISO-abbreviation] Dig Surg
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Switzerland
  • [Number-of-references] 29
  •  go-up   go-down


81. Safadi RA, Hellstein JW, Diab MM, Hammad HM: Nerve sheath myxoma (neurothekeoma) of the gingiva, a case report and review of the literature. Head Neck Pathol; 2010 Sep;4(3):242-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Nerve sheath myxoma (NSM) is a benign peripheral nerve sheath tumor that rarely occurs in the oral cavity.
  • In this report, we describe the first gingival case of oral neurothekeoma with histopathologic and immunohistochemical characteristics.
  • Immunohistochemically, the tumor cells were sporadically positive for S-100 and NSE and negative for GFAP, EMA, SMA, CD68 and HMB45.
  • [MeSH-major] Gingival Neoplasms / pathology. Neurothekeoma / pathology
  • [MeSH-minor] Adult. Biomarkers, Tumor / metabolism. Female. Gingiva. Humans. Schwann Cells / metabolism. Schwann Cells / pathology. Treatment Outcome

  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J Oral Maxillofac Surg. 2002 Aug;31(4):451-4 [12361085.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000 Jul;90(1):74-7 [10884639.001]
  • [Cites] Oral Dis. 2001 May;7(3):196-9 [11495197.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 May;107(5):e28-33 [19272803.001]
  • [Cites] Am J Surg Pathol. 2007 Jul;31(7):1103-14 [17592278.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996 Oct;82(4):423-5 [8899781.001]
  • [Cites] J Oral Maxillofac Surg. 1996 Jul;54(7):904-6 [8676238.001]
  • [Cites] J Cutan Pathol. 1993 Aug;20(4):294-303 [7693776.001]
  • [Cites] Histopathology. 1992 May;20(5):397-404 [1587488.001]
  • [Cites] J Dermatol. 1990 Sep;17(9):564-8 [2277145.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1979 May;47(5):441-4 [286259.001]
  • [Cites] Am J Clin Pathol. 1980 Dec;74(6):759-64 [7446487.001]
  • [Cites] Cancer. 1984 Apr 15;53(8):1752-9 [6365307.001]
  • [Cites] Acta Neuropathol. 1987;75(2):160-5 [3434224.001]
  • (PMID = 20502996.001).
  • [ISSN] 1936-0568
  • [Journal-full-title] Head and neck pathology
  • [ISO-abbreviation] Head Neck Pathol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  • [Other-IDs] NLM/ PMC2923317
  •  go-up   go-down


82. Soares CP, Zuanon JA, Teresa DB, Fregonezi PA, Neto CB, Oliveira MR, Donadi EA, Martinelli-Kläy CP, Soares EG: Quantitative cell-cycle protein expression in oral cancer assessed by computer-assisted system. Histol Histopathol; 2006 07;21(7):721-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Quantitative cell-cycle protein expression in oral cancer assessed by computer-assisted system.
  • The knowledge of cell-cycle control has shown that the capacity of malignant growth is acquired by the stepwise accumulation of defects in specific genes regulating cell growth.
  • Histologic diagnosis might be improved by a quantitative evaluation of more specific diagnosis biomarkers, which could help to precisely identify pre-malignant and malignant oral lesions.
  • The aim of the present study is to evaluate whether computer-based quantitative assessment of p53, PCNA and Ki-67 immunohistochemical expression, could be used clinically to foresee the risk of oral malignant transformation.
  • This retrospective study was carried out in ninety-five oral biopsies, 27 were classified as fibrous inflammatory hyperplasia, 40 as leukoplakia and 28 as oral squamous cell carcinoma.
  • Sixteen out of the 40 leukoplakia were diagnosed as non-dysplastic leukoplakia, the other 24 being dysplastic leukoplakia, of which 50.0% were classified as moderate to severe dysplasia.
  • Comparison of the four groups of oral tissues showed significant rises in p53 and Ki-67 positivity index, which increased steadily in the order benign, pre-malignant, and malignant.
  • In contrast, it was not possible to relate higher PCNA levels with pre-malignant and malignant oral lesions.
  • We therefore conclude that PCNA immunohistochemistry expression is probably an inappropriate marker to identify oral carcinogenesis, whereas joint quantitative evaluation of p53 and Ki-67, appears to be useful as a tumor marker, providing a pre-diagnostic estimate of the potential for cell-cycle deregulation of the oral proliferate status.
  • [MeSH-major] Carcinoma, Squamous Cell / pathology. Cell Cycle Proteins / metabolism. Diagnosis, Computer-Assisted. Leukoplakia, Oral / pathology. Mouth Neoplasms / pathology
  • [MeSH-minor] Biomarkers, Tumor / metabolism. Humans. Immunoenzyme Techniques. Ki-67 Antigen / metabolism. Proliferating Cell Nuclear Antigen / metabolism. Retrospective Studies. Tumor Suppressor Protein p53 / metabolism

  • Genetic Alliance. consumer health - Oral cancer.
  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16598671.001).
  • [ISSN] 1699-5848
  • [Journal-full-title] Histology and histopathology
  • [ISO-abbreviation] Histol. Histopathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Spain
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Cell Cycle Proteins; 0 / Ki-67 Antigen; 0 / Proliferating Cell Nuclear Antigen; 0 / Tumor Suppressor Protein p53
  •  go-up   go-down


83. Moreira PR, Guimarães MM, Guimarães AL, Diniz MG, Gomes CC, Brito JA, Gomez RS: Methylation of P16, P21, P27, RB1 and P53 genes in odontogenic keratocysts. J Oral Pathol Med; 2009 Jan;38(1):99-103
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Odontogenic keratocyst (OKC) is a benign neoplasm with an aggressive clinical behavior and a high recurrence rate.
  • Although epigenetic alterations have been reported in different tumors, these events were not investigated in OKC yet.
  • The aim of this study was to investigate the presence of methylation in P16, P21, P27, P53 and RB1 genes in OKC tumors.
  • METHODS: Methylation-specific polymerase chain reaction (MSP) was used to evaluate the presence of methylation in 10 samples of OKCs, 10 samples of dental follicles and six samples of normal mucosa.
  • [MeSH-major] DNA Methylation / genetics. Genes, Tumor Suppressor. Odontogenic Cysts / genetics
  • [MeSH-minor] Adolescent. Adult. Child. Cyclin-Dependent Kinase Inhibitor p21 / genetics. Cyclin-Dependent Kinase Inhibitor p27 / genetics. Dental Sac / metabolism. Epigenesis, Genetic / genetics. Female. Genes, p16. Genes, p53. Humans. Male. Mouth Mucosa / metabolism. Promoter Regions, Genetic / genetics. Retinoblastoma Protein / genetics. Young Adult

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19192054.001).
  • [ISSN] 1600-0714
  • [Journal-full-title] Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
  • [ISO-abbreviation] J. Oral Pathol. Med.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / CDKN1A protein, human; 0 / Cyclin-Dependent Kinase Inhibitor p21; 0 / Retinoblastoma Protein; 147604-94-2 / Cyclin-Dependent Kinase Inhibitor p27
  •  go-up   go-down


84. Kruse AL, Zwahlen RA, Grätz KW: New classification of maxillary ameloblastic carcinoma based on an evidence-based literature review over the last 60 years. Head Neck Oncol; 2009;1:31
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: The ameloblastic carcinoma is a rare malignant odontogenic tumor which rather occurs in the mandible than in the maxilla.
  • Current classifications do not consider benign histopathological features at the primary and malignant features at the metastatic tumour site.
  • In 54% the primary diagnosis was ameloblastic carcinoma, 34.6% revealed pulmonary metastases, however, only in one patient cervical lymph node metastasis could be found.
  • Nineteen of 26 patients (73,1%) were controlled during a median follow-up time of 54,3 months (6 to 156 months); 6 patients died of disease after a median time of 62,7 months (7 to 156 months) after initial diagnosis.
  • [MeSH-major] Ameloblastoma / classification. Maxillary Neoplasms / classification
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Child. Child, Preschool. Evidence-Based Medicine. Female. Humans. Male. Middle Aged. Neoplasm Recurrence, Local

  • Genetic Alliance. consumer health - Ameloblastic carcinoma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Oral Maxillofac Surg. 1993 Oct;51(10):1152-5; discussion 1156-7 [8410456.001]
  • [Cites] Eur J Cancer B Oral Oncol. 1993 Jul;29B(3):169-71 [8298419.001]
  • [Cites] Eur J Cancer B Oral Oncol. 1995 Mar;31B(2):86-99 [7633291.001]
  • [Cites] J Laryngol Otol. 1995 Oct;109(10):1019-22 [7499939.001]
  • [Cites] Diagn Cytopathol. 1996 May;14(3):249-52 [8732656.001]
  • [Cites] J Oral Pathol Med. 1998 Jan;27(1):39-42 [9466734.001]
  • [Cites] J Craniomaxillofac Surg. 1998 Jun;26(3):159-62 [9702634.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999 Aug;88(2):170-6 [10468461.001]
  • [Cites] J Oral Maxillofac Surg. 2007 Apr;65(4):777-83 [17368379.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Jun;103(6):799-807 [17448710.001]
  • [Cites] J Oral Maxillofac Surg. 2007 Sep;65(9):1800-3 [17719401.001]
  • [Cites] Ann Surg. 1948 Nov;128(5):999-1005 [17859260.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Dec;104(6):e17-24 [17942338.001]
  • [Cites] Pediatr Blood Cancer. 2008 Jan;50(1):175-6 [16652346.001]
  • [Cites] Pathologe. 2008 May;29(3):214-20 [18330573.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Jun;91(6):649-53 [11402276.001]
  • [Cites] J Oral Maxillofac Surg. 2002 Jan;60(1):102-4 [11757019.001]
  • [Cites] J Craniomaxillofac Surg. 2002 Oct;30(5):273-9 [12377199.001]
  • [Cites] J Oral Maxillofac Surg. 2003 Jun;61(6):731-4 [12796889.001]
  • [Cites] Oral Oncol. 2003 Oct;39(7):736-41 [12907214.001]
  • [Cites] J Can Dent Assoc. 2003 Oct;69(9):573-6 [14653932.001]
  • [Cites] J Craniofac Surg. 2004 Mar;15(2):264-9 [15167247.001]
  • [Cites] Laryngoscope. 2004 Oct;114(10):1770-4 [15454770.001]
  • [Cites] Bull Tokyo Dent Coll. 1972 May;13(2):91-101 [4504978.001]
  • [Cites] Virchows Arch A Pathol Anat Histol. 1979 Feb 9;381(2):211-22 [154765.001]
  • [Cites] J Oral Surg. 1980 Mar;38(3):203-6 [6928185.001]
  • [Cites] Am J Clin Pathol. 1981 Apr;75(4):585-91 [7223720.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1982 Sep;54(3):299-303 [6957827.001]
  • [Cites] Ann Otol Rhinol Laryngol. 1983 Sep-Oct;92(5 Pt 1):532 [6625456.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1984 Feb;57(2):168-76 [6366686.001]
  • [Cites] J Oral Med. 1986 Apr-Jun;41(2):79-81 [3459830.001]
  • [Cites] J Maxillofac Surg. 1986 Dec;14(6):338-40 [3467002.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1987 Nov;64(5):570-6 [3313152.001]
  • [Cites] Am J Clin Pathol. 1988 Oct;90(4):474-81 [3052019.001]
  • [Cites] J Otolaryngol. 1989 Apr;18(3):109-11 [2716084.001]
  • [Cites] J Craniomaxillofac Surg. 1990 Aug;18(6):247-50 [2212021.001]
  • (PMID = 19674470.001).
  • [ISSN] 1758-3284
  • [Journal-full-title] Head & neck oncology
  • [ISO-abbreviation] Head Neck Oncol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2733136
  • [General-notes] NLM/ Original DateCompleted: 20100629
  •  go-up   go-down


85. Poomsawat S, Punyasingh J: Calcifying epithelial odontogenic tumor: an immunohistochemical case study. J Mol Histol; 2007 Mar;38(1):103-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Calcifying epithelial odontogenic tumor: an immunohistochemical case study.
  • Calcifying epithelial odontogenic tumor (CEOT) is a rare benign odontogenic tumor.
  • Globules of amyloid-like material among the tumor cells were prominent.
  • Tumor cells expressed laminins 1 and 5, fibronectin, cytokeratins and vimentin.
  • A number of dendritic cells among sheets of tumor cells were revealed with strong staining for S-100 protein and CD 1a.
  • [MeSH-major] Mandibular Neoplasms / metabolism. Mandibular Neoplasms / pathology. Neoplasm Proteins / metabolism. Odontogenic Cyst, Calcifying / metabolism. Odontogenic Cyst, Calcifying / pathology

  • Genetic Alliance. consumer health - Calcifying Epithelial Odontogenic Tumor.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Oral Pathol Med. 1993 Sep;22(8):378-83 [8283404.001]
  • [Cites] J Oral Pathol. 1985 Feb;14(2):133-40 [2580070.001]
  • [Cites] Oral Dis. 2001 May;7(3):171-6 [11495193.001]
  • [Cites] Biotech Histochem. 1995 May;70(3):114-8 [7548432.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Nov;104(5):666-75 [17150384.001]
  • [Cites] J Oral Maxillofac Surg. 2005 Sep;63(9):1377-82 [16122606.001]
  • [Cites] J Lab Clin Med. 2003 Nov;142(5):348-55 [14647039.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003 Mar;95(3):332-9 [12627106.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Oct;102(4):e12-5 [16997086.001]
  • [Cites] Hum Pathol. 1983 Feb;14(2):108-26 [6339357.001]
  • [Cites] J Oral Pathol Med. 1990 Oct;19(9):430-4 [2269939.001]
  • [Cites] J Oral Pathol Med. 1992 Mar;21(3):113-9 [1374797.001]
  • [Cites] Oral Oncol. 2000 Jan;36(1):17-26 [10889914.001]
  • [Cites] J Oral Pathol. 1981 Dec;10(6):417-29 [6174718.001]
  • [Cites] Cancer. 1987 Feb 1;59(3):501-5 [3539313.001]
  • [Cites] J Oral Pathol Med. 1991 Feb;20(2):93-5 [2016701.001]
  • [Cites] J Oral Pathol. 1982;11(5):399-406 [6815318.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002 Mar;93(3):287-95 [11925538.001]
  • [Cites] J Oral Maxillofac Surg. 2005 Jun;63(6):852-5 [15944987.001]
  • [Cites] J Oral Maxillofac Surg. 2005 Sep;63(9):1361-8 [16122602.001]
  • [Cites] J Oral Pathol Med. 1999 Apr;28(4):187-91 [10235374.001]
  • [Cites] Int Dent J. 2004 Dec;54(6):457-60 [15633503.001]
  • [Cites] J Oral Pathol. 1988 May;17(5):236-40 [2462621.001]
  • [Cites] J Oral Pathol. 1983 Oct;12(5):366-74 [6415257.001]
  • [Cites] Arch Pathol Lab Med. 2000 Jun;124(6):872-6 [10835524.001]
  • [Cites] Connect Tissue Res. 1995;32(1-4):9-15 [7554939.001]
  • [Cites] Oral Dis. 2003 Jan;9(1):1-6 [12617250.001]
  • (PMID = 17318341.001).
  • [ISSN] 1567-2379
  • [Journal-full-title] Journal of molecular histology
  • [ISO-abbreviation] J. Mol. Histol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Neoplasm Proteins
  •  go-up   go-down


86. Asadi Amoli F, Sina AH, Kasai A, Ayan Z: A well-known lesion in an unusual location: infantile myofibroma of the eyelid: a case report and review of literature. Acta Med Iran; 2010 Nov-Dec;48(6):412-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Myofibroma is a neoplasia of myofibroblasts that can be solitary or multiple and it is found most commonly in the head & neck region including scalp, forehead, parotid region and oral cavity.
  • It has a benign course in the solitary form and fatal in its multiple form.
  • Its pattern of growth and architecture rules out the other differential diagnoses like nodular fasciitis, fibrous histiocytoma, infantile fibromatosis, and peripheral primitive neuroectodermal tumor, mesenchymal chondrosarcoma, malignant hemangiopericytoma, juvenile fibrosarcoma and poorly differentiated synovial sarcoma.

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21287484.001).
  • [ISSN] 1735-9694
  • [Journal-full-title] Acta medica Iranica
  • [ISO-abbreviation] Acta Med Iran
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Iran
  •  go-up   go-down


87. Kabasawa Y, Nagumo K, Takeda Y, Kawashima N, Okada N, Omura K, Yamaguchi A, Katsube K: Amelogenin positive cells scattered in the interstitial component of odontogenic fibromas. J Clin Pathol; 2008 Jul;61(7):851-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • AIMS: To investigate the origin of this tumour by immunohistochemistry.
  • In one case that had received a test biopsy before whole resection of tumour, amelogenin positive cells were distributed in the regenerating mucosal epithelium or subepithelial tissue.
  • CONCLUSIONS: Results indicate that amelogenin positive cells of odontogenic fibromas have an epithelial origin and may have the potential for epithelial mesenchymal transition, which has not to date been investigated in benign tumours.
  • [MeSH-major] Amelogenin / metabolism. Biomarkers, Tumor / metabolism. Odontogenic Tumors / metabolism
  • [MeSH-minor] Adult. Cadherins / metabolism. Female. Humans. Male. Mandibular Neoplasms / metabolism. Mandibular Neoplasms / pathology. Maxillary Neoplasms / metabolism. Maxillary Neoplasms / pathology. Middle Aged. Neoplasm Proteins / metabolism

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • antibodies-online. View related products from antibodies-online.com (subscription/membership/fee required).
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18344235.001).
  • [ISSN] 1472-4146
  • [Journal-full-title] Journal of clinical pathology
  • [ISO-abbreviation] J. Clin. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Amelogenin; 0 / Biomarkers, Tumor; 0 / Cadherins; 0 / Neoplasm Proteins
  •  go-up   go-down


88. Morris LG, Rihani J, Lebowitz RA, Wang BY: Chondromyxoid fibroma of sphenoid sinus with unusual calcifications: case report with literature review. Head Neck Pathol; 2009 Jun;3(2):169-73
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Chondromyxoid fibroma (CMF) is a rare benign primary tumor which usually affects the metaphyses of the long bone of the lower extremities in childhood and young adults.
  • Rarely, CMF occurs in the skull base and parasinuses, which may be difficult to distinguish from chondrosarcoma or chordoma and other tumors in the head.
  • The tumor mass showed calcifications on images and histology.
  • [MeSH-major] Paranasal Sinus Neoplasms / pathology. Sphenoid Sinus / pathology

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Bone Joint Surg Br. 1971 May;53(2):198-216 [5578216.001]
  • [Cites] Am J Otolaryngol. 2006 Nov-Dec;27(6):406-8 [17084225.001]
  • [Cites] J Bone Joint Surg Am. 1983 Feb;65(2):198-204 [6337162.001]
  • [Cites] Int J Oral Maxillofac Surg. 1986 Oct;15(5):553-64 [3097180.001]
  • [Cites] Surg Neurol. 1987 Feb;27(2):182-6 [3810448.001]
  • [Cites] Ann Otol Rhinol Laryngol. 1989 Jul;98(7 Pt 1):571-2 [2751216.001]
  • [Cites] Hum Pathol. 1989 Oct;20(10):952-64 [2793160.001]
  • [Cites] Am J Otolaryngol. 1995 May-Jun;16(3):205-8 [7661320.001]
  • [Cites] Skeletal Radiol. 1996 Nov;25(8):779-82 [8958628.001]
  • [Cites] Am J Surg Pathol. 1997 May;21(5):577-82 [9158683.001]
  • [Cites] Hum Pathol. 1998 May;29(5):438-46 [9596266.001]
  • [Cites] Skeletal Radiol. 1998 Oct;27(10):559-64 [9840392.001]
  • [Cites] Mod Pathol. 1999 May;12(5):514-7 [10349990.001]
  • [Cites] J Laryngol Otol. 1999 Apr;113(4):380-5 [10474681.001]
  • [Cites] Neuropathology. 2005 Mar;25(1):84-8 [15822822.001]
  • [Cites] Cancer Genet Cytogenet. 2006 Dec;171(2):97-100 [17116486.001]
  • [Cites] Am J Surg Pathol. 2007 Nov;31(11):1662-8 [18059222.001]
  • [Cites] Ann Diagn Pathol. 2009 Feb;13(1):41-6 [19118781.001]
  • [Cites] Am J Surg Pathol. 1999 Nov;23(11):1370-8 [10555005.001]
  • [Cites] Hum Pathol. 2000 Mar;31(3):306-11 [10746672.001]
  • [Cites] Am J Otolaryngol. 2001 Mar-Apr;22(2):150-3 [11283833.001]
  • [Cites] Br J Oral Maxillofac Surg. 2003 Dec;41(6):418-20 [14614877.001]
  • [Cites] Radiology. 1970 Feb;94(2):249-60 [5412788.001]
  • [Cites] Int J Pediatr Otorhinolaryngol. 1981 Apr;3(2):151-6 [7287318.001]
  • (PMID = 19644549.001).
  • [ISSN] 1936-0568
  • [Journal-full-title] Head and neck pathology
  • [ISO-abbreviation] Head Neck Pathol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 26
  • [Keywords] NOTNLM ; Calcification / Chondromyxoid fibroma / Sphenoid sinus
  •  go-up   go-down


89. Troisi R, Montalti R, Smeets P, Van Huysse J, Van Vlierberghe H, Colle I, De Gendt S, de Hemptinne B: The value of laparoscopic liver surgery for solid benign hepatic tumors. Surg Endosc; 2008 Jan;22(1):38-44
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The value of laparoscopic liver surgery for solid benign hepatic tumors.
  • BACKGROUND: Laparoscopic liver resection (LLR) has gained wide acceptance for various liver resection procedures, mainly for benign diseases.
  • The indication was solid benign liver tumor in 56 (8.9%) patients.
  • LLR was characterized by faster time to first oral intake and shorter hospital stay compared to OS (p = 0.001 and 0.008, respectively).
  • CONCLUSIONS: LLR significantly reduced time to oral intake, hospital stay, and incisional hernias compared to OS.
  • Bleeding is a major risk and should be carefully considered when resecting benign tumors.
  • In the hands of expert surgeons, LLR may become the gold standard for the resection of benign liver tumors located in the anterior and lateral sectors and for minor hepatic resections.
  • [MeSH-major] Hepatectomy / methods. Laparoscopy / methods. Liver Neoplasms / pathology. Liver Neoplasms / surgery
  • [MeSH-minor] Adult. Aged. Case-Control Studies. Chi-Square Distribution. Female. Follow-Up Studies. Humans. Laparotomy / adverse effects. Laparotomy / methods. Length of Stay. Male. Middle Aged. Minimally Invasive Surgical Procedures / adverse effects. Minimally Invasive Surgical Procedures / methods. Neoplasm Staging. Pain, Postoperative / physiopathology. Probability. Retrospective Studies. Risk Assessment. Statistics, Nonparametric. Survival Rate. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] World J Surg. 1997 Nov-Dec;21(9):983-90; discussion 990-1 [9361515.001]
  • [Cites] Ann Surg. 1999 Apr;229(4):460-6 [10203077.001]
  • [Cites] Ann Chir. 2002 Mar;127(3):164-70 [11933628.001]
  • [Cites] Surg Endosc. 1998 Jan;12(1):76-8 [9419311.001]
  • [Cites] Gut. 1991 Jun;32(6):677-80 [2060877.001]
  • [Cites] Ann Surg. 1988 Nov;208(5):558-64 [3190282.001]
  • [Cites] Surgery. 2004 Oct;136(4):804-11 [15467665.001]
  • [Cites] Gut. 1991 May;32(5):524-7 [2040476.001]
  • [Cites] J Hepatol. 1993 Jul;18(3):276-8 [8228119.001]
  • [Cites] Br J Surg. 2007 Jan;94(1):58-63 [17054316.001]
  • [Cites] Surg Endosc. 2003 Dec;17(12):1914-8 [14574547.001]
  • [Cites] Surg Endosc. 2002 Jun;16(6):899-904 [12163951.001]
  • [Cites] Radiology. 1994 Nov;193(2):507-12 [7972769.001]
  • [Cites] Hepatogastroenterology. 1998 Nov-Dec;45(24):2333-8 [9951918.001]
  • [Cites] Cancer. 1991 Jul 15;68(2):341-7 [1712664.001]
  • [Cites] Surg Endosc. 2003 Jan;17(1):23-30 [12364994.001]
  • [Cites] Hum Pathol. 2005 Nov;36(11):1210-6 [16260275.001]
  • [Cites] Am Surg. 1996 Oct;62(10 ):825-9 [8813164.001]
  • [Cites] Lancet. 1980 Feb 9;1(8163):273-6 [6101735.001]
  • [Cites] Hepatology. 1995 Dec;22(6):1674-81 [7489973.001]
  • [Cites] J Hepatobiliary Pancreat Surg. 2002;9(2):242-8 [12140614.001]
  • [Cites] Hepatology. 2006 Dec;44(6):1694-700 [17133494.001]
  • [Cites] Br J Surg. 2006 Jan;93(1):67-72 [16273531.001]
  • [Cites] Surg Endosc. 1996 Jul;10(7):758-61 [8662435.001]
  • [Cites] J Hepatobiliary Pancreat Surg. 2005;12(5):351-5 [16258801.001]
  • [Cites] J Hepatol. 1996;25 Suppl 1:30-4 [8954189.001]
  • [Cites] World J Surg. 1995 Jan-Feb;19(1):13-8 [7740799.001]
  • [Cites] World J Surg. 1995 Jan-Feb;19(1):19-24 [7740805.001]
  • [Cites] J Clin Ultrasound. 1996 Sep;24(7):345-50 [8873856.001]
  • [Cites] Ann Surg. 2000 Dec;232(6):753-62 [11088070.001]
  • [Cites] Surgery. 2007 Feb;141(2):203-211 [17263977.001]
  • [Cites] Chirurg. 2002 May;73(5):474-80 [12089832.001]
  • [Cites] J Am Coll Surg. 2003 Feb;196(2):236-42 [12595052.001]
  • [Cites] Surg Gynecol Obstet. 1992 May;174(5):403-7 [1315081.001]
  • (PMID = 17705077.001).
  • [ISSN] 1432-2218
  • [Journal-full-title] Surgical endoscopy
  • [ISO-abbreviation] Surg Endosc
  • [Language] eng
  • [Publication-type] Comparative Study; Evaluation Studies; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


90. Park JY, Kim HS, Zo JI, Lee S, Choi SW: Initial presentation of lung sarcomatoid carcinoma as a metastatic lesion in the mandibular gingiva. J Periodontol; 2006 Apr;77(4):734-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Sarcomatoid carcinoma of the lung is a very rare type of tumor characterized by distant metastasis.
  • Occasionally, an oral metastatic lesion may be the preliminary clinical feature observed before the diagnosis of the primary tumor.
  • RESULTS: The histologic and immunohistochemical diagnosis was metastatic carcinoma.
  • To locate the primary tumor, we analyzed the lung lesion by chest computerized tomography (CT) scans and biopsy.
  • CONCLUSION: Although this case is unusual, periodontists should recognize that gingival masses similar to benign or inflammatory lesions may represent an initial sign of underlying malignant tumors.
  • [MeSH-major] Carcinoma / secondary. Gingival Neoplasms / secondary. Lung Neoplasms / pathology. Sarcoma / secondary

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16584358.001).
  • [ISSN] 0022-3492
  • [Journal-full-title] Journal of periodontology
  • [ISO-abbreviation] J. Periodontol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


91. Kumamoto H, Ooya K: Immunohistochemical detection of platelet-derived endothelial cell growth factor/thymidine phosphorylase and angiopoietins in ameloblastic tumors. J Oral Pathol Med; 2006 Nov;35(10):606-12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Immunohistochemical detection of platelet-derived endothelial cell growth factor/thymidine phosphorylase and angiopoietins in ameloblastic tumors.
  • BACKGROUND: To evaluate the roles of angiogenic factors in the development and progression of odontogenic tumors, expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase (PD-ECGF/TP) and of angiopoietins in ameloblastic tumors as well as in tooth germs.
  • METHODS: Tissue specimens of 11 tooth germs, 44 ameloblastomas, and five malignant ameloblastic tumors were examined immunohistochemically with the use of antibodies against PD-ECGF/TP and angiopoietin-1 and -2.
  • RESULTS: Immunohistochemical reactivity for PD-ECGF/TP was detected in mesenchymal cells in tooth germs and stromal cells in ameloblastic tumors, and the level of immunoreactivity for PD-ECGF/TP was significantly higher in ameloblastomas than in tooth germs.
  • Immunoreactivity for angiopoietin-1 and -2 was detected predominantly in odontogenic epithelial cells near the basement membrane in tooth germs and in benign and malignant ameloblastic tumors.
  • Malignant ameloblastic tumors had decreased angiopoietin-1 reactivity and ameloblastic carcinomas had increased angiopoietin-2 reactivity as compared with the respective levels in tooth germs and ameloblastomas.
  • CONCLUSION: Expression of PD-ECGF/TP and angiopoietin-1 and -2 in tooth germs and ameloblastic tumors suggests that these angiogenic factors participate in tooth development and odontogenic tumor progression by regulating angiogenesis.
  • Altered expression of PD-ECGF/TP and angiopoietins in ameloblastic tumors may be involved in oncogenesis, malignant potential, and tumor cell differentiation.
  • [MeSH-major] Ameloblastoma / chemistry. Angiopoietin-1 / analysis. Angiopoietin-2 / analysis. Jaw Neoplasms / chemistry. Thymidine Phosphorylase / analysis

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17032393.001).
  • [ISSN] 0904-2512
  • [Journal-full-title] Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
  • [ISO-abbreviation] J. Oral Pathol. Med.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / ANGPT1 protein, human; 0 / Angiopoietin-1; 0 / Angiopoietin-2; EC 2.4.2.4 / Thymidine Phosphorylase
  •  go-up   go-down


92. Teruhisa U, Murakami J, Hisatomi M, Yanagi Y, Asaumi J: A case of unerupted lower primary second molar associated with compound odontoma. Open Dent J; 2009;3:173-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Odontoma is the most common type of benign odontogenic tumor, and often causes disturbances in the eruption of its associated tooth.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Shoni Shikagaku Zasshi. 1988;26(3):621-30 [3272484.001]
  • [Cites] J Pedod. 1988 Summer;12(4):415-20 [3078011.001]
  • [Cites] ASDC J Dent Child. 1989 Nov-Dec;56(6):445-9 [2808859.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1989 Feb;67(2):172-6 [2919061.001]
  • [Cites] Shoni Shikagaku Zasshi. 1987;25(3):660-70 [3506315.001]
  • [Cites] Br Dent J. 1987 Apr 11;162(7):265-6 [3472560.001]
  • [Cites] J Oral Maxillofac Surg. 1987 Jan;45(1):60-4 [3467039.001]
  • [Cites] ASDC J Dent Child. 1983 Sep-Oct;50(5):376-8 [6580303.001]
  • [Cites] Int J Oral Surg. 1980 Apr;9(2):81-91 [6773900.001]
  • [Cites] Br J Oral Surg. 1978 Jul;16(1):78-85 [280375.001]
  • [Cites] ASDC J Dent Child. 1978 May-Jun;45(3):223-5 [277447.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1976 Oct;42(4):501-6 [1067549.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1971 Nov;32(5):740-2 [5286232.001]
  • [Cites] Br Dent J. 1971 Jun 1;130(11):475-82 [5281128.001]
  • [Cites] Br J Oral Surg. 1970 Jul;8(1):93-100 [4918185.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1970 Feb;29(2):237-41 [5262845.001]
  • [Cites] Oral Dis. 2002 Mar;8(2):100-5 [11991304.001]
  • [Cites] Pediatr Dent. 2001 Mar-Apr;23(2):151-7 [11340730.001]
  • [Cites] J Endod. 2000 Aug;26(8):477-9 [11199784.001]
  • [Cites] J Indian Soc Pedod Prev Dent. 1998 Dec;16(4):111-4 [10635136.001]
  • [Cites] J Clin Pediatr Dent. 1999 Winter;23(2):147-9 [10204457.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998 Jul;86(1):131-4 [9690259.001]
  • [Cites] ASDC J Dent Child. 1998 May-Jun;65(3):212-3 [9668953.001]
  • [Cites] J Endod. 1996 Oct;22(10):561-3 [9198447.001]
  • [Cites] Quintessence Int. 1990 Feb;21(2):159-62 [2374801.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1991 Apr;71(4):521-2 [2052345.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1991 Aug;72(2):263 [1923409.001]
  • [Cites] Int J Paediatr Dent. 1991 Dec;1(3):151-3 [1812970.001]
  • [Cites] Pediatr Dent. 1991 Sep-Oct;13(5):301-2 [1815203.001]
  • [Cites] Dent Clin North Am. 1993 Apr;37(2):181-204 [8477864.001]
  • [Cites] Int J Paediatr Dent. 1994 Dec;4(4):251-6 [7748865.001]
  • [Cites] J Am Dent Assoc. 1995 May;126(5):643-4 [7759689.001]
  • [Cites] Acta Stomatol Belg. 1995 Sep;92(3):129-30 [8669364.001]
  • (PMID = 19707289.001).
  • [ISSN] 1874-2106
  • [Journal-full-title] The open dentistry journal
  • [ISO-abbreviation] Open Dent J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Other-IDs] NLM/ PMC2731108
  • [Keywords] NOTNLM ; Odontoma / eruption disturbance. / primary tooth
  •  go-up   go-down


93. Schache AG, Hall G, Woolgar JA, Nikolaidis G, Triantafyllou A, Lowe D, Risk JM, Shaw RJ, Liloglou T: Quantitative promoter methylation differentiates carcinoma ex pleomorphic adenoma from pleomorphic salivary adenoma. Br J Cancer; 2010 Dec 7;103(12):1846-51
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: potential epigenetic biomarkers for malignant transformation to carcinoma ex pleomorphic adenoma (Ca ex PSA) have been sought previously with and without specific comparison with the benign variant, pleomorphic salivary adenoma (PSA).
  • Previous analysis has been limited by a non-quantitative approach.
  • We sought to demonstrate quantitative promoter methylation across a panel of tumour suppressor genes (TSGs) in both Ca ex PSA and PSA.
  • METHODS: quantitative methylation-specific real-time polymerase chain reaction (qMSP) analysis of p16(INK4A), CYGB, RASSF1, RARβ, human telomerase reverse transcriptase (hTERT), Wilms' tumour 1 (WT1) and TMEFF2 gene promoters was undertaken on bisulphite-converted DNA, previously extracted from archival fixed tissue specimens of 31 Ca ex PSA and an unrelated cohort of 28 PSA.
  • CONCLUSIONS: we demonstrate the successful application of qMSP to a large series of historical Ca ex PSA samples and report on a panel of TSGs with significant differences in their methylation profiles between benign and malignant variants of pleomorphic salivary adenoma. qMSP analysis could be developed as a useful clinical tool to differentiate between Ca ex PSA and its benign precursor.
  • [MeSH-major] Adenoma, Pleomorphic / genetics. DNA Methylation. Promoter Regions, Genetic. Salivary Gland Neoplasms / genetics
  • [MeSH-minor] Genes, Tumor Suppressor. Humans. Membrane Proteins / genetics. Neoplasm Proteins / genetics. Polymerase Chain Reaction. Telomerase / genetics. WT1 Proteins / genetics

  • MedlinePlus Health Information. consumer health - Salivary Gland Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] 2010 Cancer Resaerch UK.
  • [Cites] J Oral Pathol Med. 2008 May;37(5):309-18 [18248354.001]
  • [Cites] Acta Otolaryngol. 2007 Nov;127(11):1207-13 [17851915.001]
  • [Cites] Clin Cancer Res. 2008 May 1;14(9):2664-72 [18451230.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):2174-9 [18708411.001]
  • [Cites] Int J Cancer. 2008 Dec 1;123(11):2594-604 [18792900.001]
  • [Cites] Carcinogenesis. 2009 Jan;30(1):28-34 [18952593.001]
  • [Cites] Ann Surg Oncol. 2009 Apr;16(4):1051-9 [19194757.001]
  • [Cites] Oncol Rep. 2009 Jul;22(1):199-204 [19513524.001]
  • [Cites] Clin Cancer Res. 2009 Jun 15;15(12):4174-80 [19509163.001]
  • [Cites] Int J Cancer. 2010 Apr 1;126(7):1630-9 [19795445.001]
  • [Cites] Diagn Cytopathol. 1999 Sep;21(3):163-6 [10450099.001]
  • [Cites] Cancer. 2005 Nov 1;104(9):1924-30 [16134181.001]
  • [Cites] Br J Cancer. 2006 Feb 27;94(4):561-8 [16449996.001]
  • [Cites] J Cell Physiol. 2006 Jun;207(3):654-9 [16447252.001]
  • [Cites] Clin Cancer Res. 2006 Dec 15;12(24):7353-8 [17189407.001]
  • [Cites] Int J Oncol. 2007 Jun;30(6):1349-57 [17487355.001]
  • [Cites] Oral Oncol. 2007 Oct;43(9):878-86 [17257884.001]
  • [Cites] J Cell Sci. 2007 Sep 15;120(Pt 18):3163-72 [17878233.001]
  • [Cites] J Natl Cancer Inst. 2001 May 2;93(9):691-9 [11333291.001]
  • [Cites] Hum Pathol. 2001 Jun;32(6):596-604 [11431714.001]
  • [Cites] Head Neck. 2001 Sep;23(9):705-12 [11505478.001]
  • [Cites] J Natl Cancer Inst. 2001 Nov 21;93(22):1747-52 [11717336.001]
  • [Cites] Mol Cell Biol. 2002 Jun;22(12):4309-18 [12024041.001]
  • [Cites] ORL J Otorhinolaryngol Relat Spec. 2003 Jan-Feb;65(1):26-32 [12624503.001]
  • [Cites] Cancer Sci. 2003 Jun;94(6):523-9 [12824878.001]
  • [Cites] Mol Pathol. 2003 Aug;56(4):226-31 [12890744.001]
  • [Cites] Gynecol Oncol. 2004 May;93(2):407-16 [15099954.001]
  • [Cites] J Mol Diagn. 2004 Aug;6(3):180-90 [15269293.001]
  • [Cites] Acta Otolaryngol. 1974 Jun;77(6):426-32 [4365171.001]
  • [Cites] Biotechniques. 1995 May;18(5):768-70, 772-3 [7619474.001]
  • [Cites] Cancer Res. 1999 Feb 1;59(3):551-7 [9973199.001]
  • [Cites] Jpn J Cancer Res. 1999 Feb;90(2):194-204 [10189890.001]
  • [Cites] Histopathology. 2007 Nov;51(5):691-6 [17927591.001]
  • [Cites] Int J Cancer. 2008 Jul 1;123(1):161-7 [18398837.001]
  • (PMID = 21063414.001).
  • [ISSN] 1532-1827
  • [Journal-full-title] British journal of cancer
  • [ISO-abbreviation] Br. J. Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Membrane Proteins; 0 / Neoplasm Proteins; 0 / TMEFF2 protein, human; 0 / WT1 Proteins; EC 2.7.7.49 / TERT protein, human; EC 2.7.7.49 / Telomerase
  • [Other-IDs] NLM/ PMC3008600
  •  go-up   go-down


94. Dudrap E, Lemierre G, Auquit-Auckbur I, Courville P, Milliez PY: [Abrikossoff's tumor: about one case of inter-mammary cutaneous localization and review of literature]. Ann Chir Plast Esthet; 2008 Dec;53(6):521-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Abrikossoff's tumor: about one case of inter-mammary cutaneous localization and review of literature].
  • [Transliterated title] Tumeur d'Abrikossoff : à propos d'une localisation cutanée du sillon intermammaire et revue de la littérature.
  • SUBJECT: Our report concerns a large inter-mammary cutaneous Abrikossoff tumor on a 41-year-old female patient, which has prompted us to review the literature.
  • CASE: It was a low pre-sternal skin tumor; CT-Scanning showed a homogeneous mass 5 cm high, 4 cm wide and 4 cm deep.
  • DISCUSSION: Abrikossoff tumors (or granular cell tumors) are rare ubiquity tumors locating preferably in ENT and oral cavity mucosa.
  • They are overwhelmingly single and benign but on occasion multifocal or malignant.
  • The use of flaps is not advised as it may delay local recidivation diagnosis.
  • CONCLUSION: Abrikossoff tumors require complete exeresis and mandatory histological examination into possible signs of malignity.
  • [MeSH-major] Granular Cell Tumor / surgery. Skin Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18541358.001).
  • [ISSN] 1768-319X
  • [Journal-full-title] Annales de chirurgie plastique et esthétique
  • [ISO-abbreviation] Ann Chir Plast Esthet
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] France
  • [Number-of-references] 14
  •  go-up   go-down


95. Horn TL, Cwik MJ, Morrissey RL, Kapetanovic I, Crowell JA, Booth TD, McCormick DL: Oncogenicity evaluation of resveratrol in p53(+/-) (p53 knockout) mice. Food Chem Toxicol; 2007 Jan;45(1):55-63
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The incidences of both benign and malignant tumors in mice exposed to resveratrol were comparable to those in vehicle controls.

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. P-CRESIDINE .
  • Hazardous Substances Data Bank. RESVERATROL .
  • Hazardous Substances Data Bank. CHOLESTEROL .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Mutat Res. 2001 Jul 25;494(1-2):107-13 [11423350.001]
  • [Cites] Cardiovasc Res. 2000 Aug 18;47(3):549-55 [10963727.001]
  • [Cites] Toxicol Pathol. 2001;29 Suppl:30-50 [11695560.001]
  • [Cites] J Nutr. 2002 Feb;132(2):257-60 [11823587.001]
  • [Cites] Clin Cancer Res. 2002 Mar;8(3):893-903 [11895924.001]
  • [Cites] J Pharmacol Exp Ther. 2002 Jul;302(1):369-73 [12065739.001]
  • [Cites] Pharmacol Res. 2002 Jun;45(6):499-505 [12162952.001]
  • [Cites] Carcinogenesis. 2002 Sep;23(9):1531-6 [12189197.001]
  • [Cites] Cancer Res. 2002 Sep 1;62(17):4945-54 [12208745.001]
  • [Cites] Toxicol Lett. 2002 Dec 15;136(2):133-42 [12425963.001]
  • [Cites] Mutat Res. 2002 Nov 26;521(1-2):29-35 [12438001.001]
  • [Cites] Pharm Res. 2002 Dec;19(12):1907-14 [12523673.001]
  • [Cites] Mutat Res. 2003 Feb-Mar;523-524:145-50 [12628512.001]
  • [Cites] Oncogene. 2003 Apr 10;22(14):2143-50 [12687016.001]
  • [Cites] Nature. 2003 Sep 11;425(6954):191-6 [12939617.001]
  • [Cites] Biochem Biophys Res Commun. 2003 Oct 3;309(4):1017-26 [13679076.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2003 Oct;12(10):953-7 [14578128.001]
  • [Cites] Br J Cancer. 2004 Feb 9;90(3):736-44 [14760392.001]
  • [Cites] Toxicol Sci. 2004 Feb;77(2):188-94 [14657512.001]
  • [Cites] Clin Cancer Res. 2004 Mar 15;10(6):2190-202 [15041740.001]
  • [Cites] J Biol Chem. 2004 May 21;279(21):22727-37 [15020596.001]
  • [Cites] Br J Cancer. 2004 Oct 4;91(7):1380-3 [15316568.001]
  • [Cites] J Chromatogr A. 1996 Apr 12;730(1-2):47-52 [8680595.001]
  • [Cites] Science. 1997 Jan 10;275(5297):218-20 [8985016.001]
  • [Cites] J Biol Chem. 1998 Aug 21;273(34):21875-82 [9705326.001]
  • [Cites] Drugs Exp Clin Res. 1999;25(2-3):65-77 [10370867.001]
  • [Cites] Cancer Lett. 1999 Apr 1;137(2):123-30 [10374832.001]
  • [Cites] Cancer Lett. 1999 Jun 1;140(1-2):1-10 [10403535.001]
  • [Cites] Biochem Biophys Res Commun. 1999 Aug 19;262(1):20-4 [10448061.001]
  • [Cites] Mol Pharmacol. 1999 Oct;56(4):760-7 [10496959.001]
  • [Cites] Toxicol Sci. 2004 Dec;82(2):614-9 [15329443.001]
  • [Cites] Eur J Cancer Prev. 2005 Apr;14(2):139-42 [15785317.001]
  • [Cites] Int J Cancer. 2005 May 20;115(1):36-45 [15688416.001]
  • [Cites] Int J Cancer. 2005 Jun 10;115(2):194-201 [15688382.001]
  • [Cites] FASEB J. 2005 Jul;19(9):1193-5 [15837718.001]
  • [Cites] Cancer Lett. 2006 Jan 8;231(1):113-22 [16356836.001]
  • [Cites] Bioorg Med Chem. 2006 Mar 1;14(5):1437-43 [16249091.001]
  • [Cites] Curr Biol. 2006 Feb 7;16(3):296-300 [16461283.001]
  • [Cites] Int J Oncol. 2006 Mar;28(3):641-8 [16465368.001]
  • [Cites] Int J Toxicol. 2006 May-Jun;25(3):219-28 [16717037.001]
  • [Cites] J Agric Food Chem. 2000 Apr;48(4):1243-6 [10775379.001]
  • [Cites] Mutat Res. 2001 Sep 20;496(1-2):171-80 [11551493.001]
  • (PMID = 16965847.001).
  • [ISSN] 0278-6915
  • [Journal-full-title] Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
  • [ISO-abbreviation] Food Chem. Toxicol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CN / CN005135-000; United States / NCI NIH HHS / CN / N01 CN005135-000; United States / NCI NIH HHS / CN / N01-CN-05135
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Aniline Compounds; 0 / Anticarcinogenic Agents; 0 / Carcinogens; 0 / Stilbenes; 0 / Tumor Suppressor Protein p53; 4C11L78UR3 / cresidine; 97C5T2UQ7J / Cholesterol; Q369O8926L / resveratrol
  • [Other-IDs] NLM/ NIHMS16493; NLM/ PMC1855246
  •  go-up   go-down


96. Wittekindt C, Burmeister HP, Guntinas-Lichius O: [Diagnostic and therapy of salivary gland diseases: relevant aspects for the pathologist from the clinical perspective]. Pathologe; 2009 Nov;30(6):424-31
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Diagnostik und Therapie von Speicheldrüsenerkrankungen: Relevantes für den Pathologen aus Sicht der Klinik.
  • Significant progress in the diagnosis and therapy of salivary gland diseases has been made in recent years.
  • Due to recent publications on the appropriate extent of salivary gland resection in benign tumors, more and more specimens with reduced cuffs of healthy salivary gland tissue will be sent to the pathologists.
  • In combination with fine-needle aspiration cytology high sensitivity and specificity for the assessment of salivary gland tumors can be achieved.
  • Diffusion-weighted magnetic resonance imaging (MRI) is a new imaging tool and the power of distinction of pleomorphic adenoma from malignant tumors is promising.
  • [MeSH-major] Salivary Gland Neoplasms / diagnosis. Sjogren's Syndrome / diagnosis
  • [MeSH-minor] AIDS-Related Opportunistic Infections / diagnosis. AIDS-Related Opportunistic Infections / pathology. AIDS-Related Opportunistic Infections / therapy. Biomarkers, Tumor / analysis. Cell Proliferation. Cell Transformation, Neoplastic / pathology. Cysts / pathology. Diagnosis, Differential. Epithelium / pathology. Humans. Keratins / analysis. Lymph Nodes / pathology. Lymphoma, B-Cell, Marginal Zone / diagnosis. Lymphoma, B-Cell, Marginal Zone / pathology. Lymphoma, B-Cell, Marginal Zone / therapy. Parotid Diseases / diagnosis. Parotid Diseases / pathology. Parotid Diseases / therapy. Salivary Ducts / pathology. Salivary Glands / pathology. Sialadenitis / diagnosis. Sialadenitis / pathology

  • MedlinePlus Health Information. consumer health - Salivary Gland Cancer.
  • MedlinePlus Health Information. consumer health - Sjogren's Syndrome.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Laryngoscope. 2006 Apr;116(4):534-40 [16585855.001]
  • [Cites] Laryngoscope. 2007 Aug;117(8):1364-7 [17762270.001]
  • [Cites] Ann Rheum Dis. 2009 Feb;68(2):284-5 [19139205.001]
  • [Cites] J Laryngol Otol. 1998 Mar;112(3):248-51 [9624373.001]
  • [Cites] Clin Otolaryngol. 2008 Feb;33(1):18-24 [18302546.001]
  • [Cites] Laryngoscope. 2002 Mar;112(3):586-7 [12148877.001]
  • [Cites] Ophthal Plast Reconstr Surg. 2006 Nov-Dec;22(6):453-6 [17117101.001]
  • [Cites] J Oral Maxillofac Surg. 2004 Oct;62(10):1198-202 [15452805.001]
  • [Cites] Eur Radiol. 2008 Oct;18(10):2251-7 [18458907.001]
  • [Cites] Curr Opin Otolaryngol Head Neck Surg. 2008 Feb;16(1):60-3 [18197024.001]
  • [Cites] Ann Rheum Dis. 2008 Nov;67(11):1541-4 [18276741.001]
  • [Cites] Laryngoscope. 2007 Feb;117(2):373-7 [17204984.001]
  • [Cites] Facial Plast Surg Clin North Am. 2003 Nov;11(4):503-13 [15062255.001]
  • [Cites] Arthritis Rheum. 2005 Sep;52(9):2740-50 [16142737.001]
  • [Cites] Clin Imaging. 2005 May-Jun;29(3):189-94 [15855064.001]
  • [Cites] Clin Neurol Neurosurg. 2009 Jan;111(1):79-82 [18977585.001]
  • [Cites] Br J Cancer. 2003 Nov 3;89(9):1610-3 [14583757.001]
  • [Cites] HNO. 2008 Feb;56(2):105-7 [18210009.001]
  • [Cites] HNO. 2006 Nov;54(11):868-74 [16670876.001]
  • [Cites] J Surg Oncol. 2000 Nov;75(3):208-9 [11088054.001]
  • [Cites] Br J Dermatol. 2000 Oct;143(4):824-7 [11069464.001]
  • [Cites] Arthritis Rheum. 2003 Aug 15;49(4):585-93 [12910567.001]
  • [Cites] Rofo. 2005 Jul;177(7):940-5 [15973595.001]
  • [Cites] Radiology. 2000 Jul;216(1):19-29 [10887223.001]
  • [Cites] Br J Pharmacol. 2007 Sep;152(1):161-7 [17618309.001]
  • [Cites] J Laryngol Otol. 2007 Dec;121(12):1126-8 [17666140.001]
  • [Cites] Rev Stomatol Chir Maxillofac. 2009 Feb;110(1):e1-4 [19108856.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2008 Jul;134(7):715-9 [18645120.001]
  • [Cites] Arthritis Res Ther. 2006;8(4):R129 [16859536.001]
  • [Cites] Radiology. 1998 Dec;209(3):683-8 [9844659.001]
  • [Cites] Neurology. 2004 Oct 26;63(8):1371-5 [15505151.001]
  • [Cites] Rofo. 2009 Mar;181(3):242-8 [19229790.001]
  • [Cites] Ann Otol Rhinol Laryngol. 2001 Dec;110(12):1162-4 [11768708.001]
  • (PMID = 19756611.001).
  • [ISSN] 1432-1963
  • [Journal-full-title] Der Pathologe
  • [ISO-abbreviation] Pathologe
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 68238-35-7 / Keratins
  • [Number-of-references] 28
  •  go-up   go-down


97. Tilakaratne WM, Jayasooriya PR, Tennakoon TM, Saku T: Epithelial salivary tumors in Sri Lanka: a retrospective study of 713 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jul;108(1):90-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Epithelial salivary tumors in Sri Lanka: a retrospective study of 713 cases.
  • OBJECTIVE: The aim of this retrospective study was to evaluate the clinicopathologic data to determine the distribution of epithelial salivary tumors, especially minor salivary tumors, in Sri Lanka.
  • MATERIALS AND METHODS: A total of 713 salivary tumors diagnosed at the Department of Oral Pathology, during the period from 1990 to 2007 were reviewed.
  • RESULTS: Out of the 713 epithelial salivary tumors, 356 (49.9%) were classified as benign and 357 (50.1%) as malignant, indicating a benign-to-malignant ratio of 1:1.
  • The majority of both benign (29%) and malignant (39%) tumors occurred in the minor salivary glands.
  • Malignant tumors were slightly more common in minor salivary glands, indicating a benign-to-malignant ratio of 1:0.75.
  • Among the minor salivary sites, palate was the most frequent location, accounting for 51% of the tumors (246 out of 486).
  • The tumors affected adult patients more commonly, and a slight female predominance (1:1.15) was also evident.
  • Pleomorphic adenoma was the most frequent tumor, representing 38% of all tumors (274 out of 713), followed by mucoepidermoid carcinoma 21.6% (154 out of 713) and adenoid cystic carcinoma 13.5% (96 out of 713).
  • The commonest benign and malignant tumors were pleomorphic adenoma and mucoepidermoid carcinoma in both major and minor salivary glands.
  • CONCLUSION: According to the findings of this study, equal frequencies of benign and malignant tumors indicate higher occurrences of malignancies, especially in the minor salivary glands, in the Sri Lankan population.
  • [MeSH-major] Neoplasms, Glandular and Epithelial / epidemiology. Salivary Gland Neoplasms / epidemiology
  • [MeSH-minor] Adenolymphoma / epidemiology. Adenoma, Pleomorphic / epidemiology. Adult. Age Factors. Aged. Aged, 80 and over. Carcinoma / epidemiology. Carcinoma, Adenoid Cystic / epidemiology. Carcinoma, Mucoepidermoid / epidemiology. Female. Humans. Male. Middle Aged. Palatal Neoplasms / epidemiology. Parotid Neoplasms / epidemiology. Retrospective Studies. Salivary Glands, Minor / pathology. Sex Factors. Sri Lanka / epidemiology

  • MedlinePlus Health Information. consumer health - Salivary Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19403317.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


98. Prochasek W, Koszowski R, Steplewska K: [A rare case of neurilemmoma of the floor of the mouth]. Wiad Lek; 2008;61(7-9):236-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A rare case of neurilemmoma of the floor of the mouth].
  • Neurilemmoma is a benign neoplasm of neuroectodermal origin.
  • The authors present a rare case of this lesion localized in the oral cavity.
  • Clinical symptoms, histologic structure of the tumor, methods of treatment and differential diagnosis are described.
  • [MeSH-major] Mouth Floor. Mouth Neoplasms / pathology. Mouth Neoplasms / surgery. Neurilemmoma / pathology. Neurilemmoma / surgery
  • [MeSH-minor] Diagnosis, Differential. Humans. Male. Mouth Mucosa / pathology. Mouth Mucosa / surgery. Treatment Outcome. Young Adult

  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19172839.001).
  • [ISSN] 0043-5147
  • [Journal-full-title] Wiadomości lekarskie (Warsaw, Poland : 1960)
  • [ISO-abbreviation] Wiad. Lek.
  • [Language] pol
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Poland
  •  go-up   go-down


99. Acikalin MF, Pasaoglu O, Cakli H, Gürbüz K, Canaz F: Malignant myoepithelioma of the palate: a case report with review of the clinicopathological characteristics. Yonsei Med J; 2009 Dec 31;50(6):848-51
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A malignant myoepithelioma is one of the rarest salivary gland neoplasms which may either arise de novo or develop within a preexisting pleomorphic adenoma or benign myoepithelioma.
  • The parotid gland is the most common primary site and the palate the most common intra-oral site of occurrence.
  • The patient underwent a wide local tumor resection.
  • [MeSH-major] Myoepithelioma / diagnosis. Myoepithelioma / pathology. Palatal Neoplasms / diagnosis. Palatal Neoplasms / pathology. Palate / pathology. Palate / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Surg Pathol. 2000 Jun;24(6):761-74 [10843278.001]
  • [Cites] Int J Oral Maxillofac Surg. 2003 Jun;32(3):339-41 [12767885.001]
  • [Cites] Anticancer Res. 2003 May-Jun;23(3C):3041-4 [12926158.001]
  • [Cites] Pathol Int. 2003 Oct;53(10):704-9 [14516322.001]
  • [Cites] Yonsei Med J. 2004 Feb 29;45(1):161-5 [15004886.001]
  • [Cites] Arch Pathol. 1975 May;99(5):242-5 [48374.001]
  • [Cites] Br J Oral Maxillofac Surg. 1999 Feb;37(1):64-6 [10203226.001]
  • [Cites] Virchows Arch A Pathol Anat Histopathol. 1993;423(5):389-96 [8116228.001]
  • [Cites] J Oral Maxillofac Surg. 1994 Oct;52(10):1080-2 [8089798.001]
  • [Cites] Anticancer Res. 1997 Jul-Aug;17(4A):2671-5 [9252699.001]
  • [Cites] Cancer. 1998 Oct 1;83(7):1292-9 [9762928.001]
  • [Cites] J Clin Pathol. 1998 Jul;51(7):552-6 [9797738.001]
  • [Cites] Cancer. 1982 Feb 1;49(3):562-72 [6277451.001]
  • (PMID = 20046429.001).
  • [ISSN] 1976-2437
  • [Journal-full-title] Yonsei medical journal
  • [ISO-abbreviation] Yonsei Med. J.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Korea (South)
  • [Other-IDs] NLM/ PMC2796415
  • [Keywords] NOTNLM ; Malignant myoepithelioma / palate
  •  go-up   go-down


100. Pons Vicente O, Almendros Marqués N, Berini Aytés L, Gay Escoda C: Minor salivary gland tumors: A clinicopathological study of 18 cases. Med Oral Patol Oral Cir Bucal; 2008 Sep;13(9):E582-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Minor salivary gland tumors: A clinicopathological study of 18 cases.
  • INTRODUCTION: Minor salivary gland tumors (MSGTs) are infrequent, representing 10-15% of all salivary neoplasms.
  • Despite this low frequency, MSGTs conform a heterogeneous group of neoplasms characterized by a broad range of histological types.
  • PATIENTS AND METHOD: We identified cases of MSGT in a retrospective study of the biopsies made in the period 1997-2007 in the Service of Oral Surgery (Dental Clinic of the University of Barcelona, Spain).
  • The data collected comprised patient age and sex, the clinical characteristics and location of the tumor, the duration of the lesion, its size, the treatment provided, and the histopathological findings.
  • The great majority (94.4%) were benign tumors.
  • The histopathological diagnoses of our MSGTs comprised 10 pleomorphic adenomas (55.3%), 2 cystadenomas (11.1%), 1 myoepithelioma (5.6%), 1 sialadenoma papilliferum (5.6%), 1 basal cell adenoma (5.6%), 1 Warthin's tumor (5.6%), 1 canalicular adenoma (5.6%), and 1 low-grade polymorphic adenocarcinoma (5.6%).
  • Six percent of all benign minor salivary gland tumors are considered to relapse, versus 65% of all malignant lesions.
  • [MeSH-major] Salivary Gland Neoplasms / pathology. Salivary Glands, Minor

  • MedlinePlus Health Information. consumer health - Salivary Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18758404.001).
  • [ISSN] 1698-6946
  • [Journal-full-title] Medicina oral, patología oral y cirugía bucal
  • [ISO-abbreviation] Med Oral Patol Oral Cir Bucal
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Spain
  • [Number-of-references] 30
  •  go-up   go-down






Advertisement